Legalize / Eesti / Tervisekassa ravimite loetelu / History

Reform history

Tervisekassa ravimite loetelu

100 versions · 2026-03-25

2026-03-31

Tervisekassa ravimite loetelu

View changes Text at this date

2025-12-31

Tervisekassa ravimite loetelu

View changes Text at this date

2025-09-30

Tervisekassa ravimite loetelu

View changes Text at this date

2025-06-30

Tervisekassa ravimite loetelu

View changes Text at this date

2025-03-31

Tervisekassa ravimite loetelu

View changes Text at this date

2024-12-31

Tervisekassa ravimite loetelu

View changes Text at this date

2024-09-30

Tervisekassa ravimite loetelu

View changes Text at this date

2024-06-30

Tervisekassa ravimite loetelu

View changes Text at this date

2024-03-31

Tervisekassa ravimite loetelu

View changes Text at this date

2023-12-31

Tervisekassa ravimite loetelu

View changes Text at this date

2023-09-30

Tervisekassa ravimite loetelu

View changes Text at this date

2023-06-30

Tervisekassa ravimite loetelu

View changes Text at this date

2023-03-31

Tervisekassa ravimite loetelu

View changes Text at this date

2022-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2022-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2022-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2022-04-02

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2021-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2021-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2021-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2021-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2020-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2020-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2020-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2020-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2019-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2019-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2019-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2019-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2018-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2018-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2018-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2018-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2017-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2017-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2017-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2017-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2017-01-01

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2016-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2016-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2016-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2016-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2015-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2015-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2015-08-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2015-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2015-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2014-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2014-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2014-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2014-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2013-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2013-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2013-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2013-05-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2013-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2012-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2012-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2012-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2012-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2011-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2011-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2011-08-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

Changes on 2011-08-31

@@ -24,37 +24,37 @@

| 1011430 | adapaleen, 1mg 1g | D10AD03 | DIFFERIN, kreem, 30g 1TK | GALDERMA INTERNATIONAL | 50 | | | | | | |

| 1074350 | alendroonhape, 70mg | M05BA04 | FOSAMAX 70 MG, tablett, 4TK | Merck Sharp & Dohme OÜ | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1240120 | alendroonhape, 70mg | M05BA04 | SEDRON, õhukese polümeerikattega tablett, 4TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| 1238712 | alendroonhape, 70mg | M05BA04 | RALENOST 70MG, tablett, 4TK | Ranbaxy (UK) Limited | 50 | | | | | | |

| | | | | | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1245338 | alendroonhape, 70mg | M05BA04 | ALENOTOP, tablett, 4TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| 1341302 | alendroonhape, 70mg | M05BA04 | LENDRATE, tablett, 4TK | Actavis Group PTC ehf | 50 | | | | | | |

| | | | | | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1238712 | alendroonhape, 70mg | M05BA04 | RALENOST 70MG, tablett, 4TK | Ranbaxy (UK) Limited | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| | | | | | 50 | | | | | | |

| 1341302 | alendroonhape, 70mg | M05BA04 | LENDRATE, tablett, 4TK | Actavis Group PTC ehf | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| | | | | | 50 | | | | | | |

| 1339141 | alendroonhape+koleka ltsiferool, 70mg+5600RÜ | M05BB03 | FOSAVANCE, tablett, 4TK | Merck Sharp & Dohme Limited | 50 | | | | | | |

| | | | | | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| 1163854 | alfa-2a-interferoon, 3000000RÜ 0,5ml | L03AB04 | ROFERON-A, süstelahus, 1TK | Roche Eesti OÜ | 100 | C43-C43 | Onkoloog | | | | adjuvantraviks AJCC II staadiumi korral pärast kasvaja kirurgilist resektsiooni |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 100 | C43-C43 | Onkoloog | | | | adjuvantraviks AJCC II staadiumi korral pärast kasvaja kirurgilist resektsiooni |

| | | | | | 50 | | | | | | |

| | | | | | 100 | B18.2-B18.2 | Gastroenteroloog, Infektsionist | | | | |

| 1110384 | alfa-2a-peginterferoon, 135mcg 0,5ml | L03AB11 | PEGASYS, süstelahus süstlis, 0.5ml 1TK | Roche Registration Limited | 50 | | | | | | |

| | | | | | 100 | B18.2-B18.2 | Infektsionist, Gastroenteroloog | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| 1110407 | alfa-2a-peginterferoon, 180mcg 0,5ml | L03AB11 | PEGASYS, süstelahus süstlis, 0.5ml 1TK | Roche Registration Limited | 50 | | | | | | |

| 1110407 | alfa-2a-peginterferoon, 180mcg 0,5ml | L03AB11 | PEGASYS, süstelahus süstlis, 0.5ml 1TK | Roche Registration Limited | 100 | B18.2-B18.2 | Gastroenteroloog, Infektsionist | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1011856 | alfa-2b-peginterferoon, 100mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 100 | B18.2-B18.2 | Infektsionist, Gastroenteroloog | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| | | | | | 50 | | | | | | |

| 1336519 | alfa-2b-peginterferoon, 100mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1011856 | alfa-2b-peginterferoon, 100mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 100 | B18.2-B18.2 | Gastroenteroloog, Infektsionist | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| | | | | | 50 | | | | | | |

| 1336519 | alfa-2b-peginterferoon, 100mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| | | | | | 100 | B18.2-B18.2 | Gastroenteroloog, Infektsionist | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| 1011867 | alfa-2b-peginterferoon, 120mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

@@ -62,15 +62,15 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1336553 | alfa-2b-peginterferoon, 120mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 100 | B18.2-B18.2 | Gastroenteroloog, Infektsionist | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| | | | | | 50 | | | | | | |

| 1209912 | alfa-2b-peginterferoon, 150mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 100 | B18.2-B18.2 | Infektsionist, Gastroenteroloog | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| 1209912 | alfa-2b-peginterferoon, 150mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 100 | B18.2-B18.2 | Gastroenteroloog, Infektsionist | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| | | | | | 50 | | | | | | |

| 1336609 | alfa-2b-peginterferoon, 150mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 100 | B18.2-B18.2 | Infektsionist, Gastroenteroloog | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1011834 | alfa-2b-peginterferoon, 50mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1011834 | alfa-2b-peginterferoon, 50mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 100 | B18.2-B18.2 | Infektsionist, Gastroenteroloog | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| | | | | | 50 | | | | | | |

| 1336430 | alfa-2b-peginterferoon, 50mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1011845 | alfa-2b-peginterferoon, 80mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 100 | B18.2-B18.2 | Infektsionist, Gastroenteroloog | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

@@ -78,20 +78,20 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1336474 | alfa-2b-peginterferoon, 80mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 100 | B18.2-B18.2 | Gastroenteroloog, Infektsionist | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| | | | | | 50 | | | | | | |

| 1336474 | alfa-2b-peginterferoon, 80mcg | L03AB10 | PEGINTRON, süstelahuse pulber ja lahusti, 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1176207 | alfadarbepoetiin, 10mcg 0,4ml | B03XA02 | ARANESP, süstelahus süstlis, 0.4ml 1TK | Amgen Europe B.V. | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1207314 | alfadarbepoetiin, 30mcg 0,3ml | B03XA02 | ARANESP, süstelahus süstlis, 0.3ml 1TK | Amgen Europe B.V. | 50 | | | | | | |

| 1207370 | alfadarbepoetiin, 40mcg 0,4ml | B03XA02 | ARANESP, süstelahus süstlis, 0.4ml 1TK | Amgen Europe B.V. | 50 | | | | | | |

| 1207415 | alfadarbepoetiin, 50mcg 0,5ml | B03XA02 | ARANESP, süstelahus süstlis, 0.5ml 1TK | Amgen Europe B.V. | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

@@ -104,9 +104,9 @@

| 1084148 | alfaepoetiin, 10000TÜ 1ml | B03XA01 | EPREX, süstelahus, 0.4ml 6TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1084137 | alfaepoetiin, 4000TÜ 1ml | B03XA01 | EPREX, süstelahus, 0.5ml 6TK | Johnson & Johnson UAB | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1088366 | alfaepoetiin, 6000TÜ 0,6ml | B03XA01 | EPREX, süstelahus, 0.6ml 6TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1173855 | alfafollitropiin, 300RÜ 0,5ml | G03GA05 | GONAL-F, süstelahus pen- süstlis, 0.5ml 1TK | Merck Serono Europe Limited | 50 | | | | | | |

| 1213513 | alfafollitropiin, 450RÜ 0,75ml | G03GA05 | GONAL-F, süstelahus pen- süstlis, 0.75ml 1TK | Merck Serono Europe Limited | 50 | | | | | | |

| 1035784 | alfafollitropiin, 75RÜ | G03GA05 | GONAL-F, süstelahuse pulber ja lahusti, 1TK | Merck Serono Europe Limited | 50 | | | | | | |

@@ -120,19 +120,19 @@

| 1278176 | alfusosiin, 10mg | G04CA01 | ALFUZOSIN-TEVA, toimeainet prolongeeritult vabastav tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| 1001619 | allopurinool, 100mg | M04AA01 | ALLOPURINOL NYCOMED, tablett, 50TK | Nycomed Sefa AS | 75 | M10-M10, N20-N23 | | | | | |

| | | | | | 50 | | | | | | |

| 1001686 | allopurinool, 300mg | M04AA01 | ALLOPURINOL NYCOMED, tablett, 50TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 75 | M10-M10, N20-N23 | | | | | |

| 1001686 | allopurinool, 300mg | M04AA01 | ALLOPURINOL NYCOMED, tablett, 50TK | Nycomed Sefa AS | 75 | M10-M10, N20-N23 | | | | | |

| | | | | | 50 | | | | | | |

| 1064472 | amantadiin, 100mg | N04BB01 | PK-MERZ 100 MG, õhukese polümeerikattega tablett, 90TK | Merz Pharmaceuticals GmbH | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1064517 | amantadiin, 100mg | N04BB01 | AMANTADIN-RATIOPHARM 100 MG, õhukese polümeerikattega tablett, 100TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1349872 | ambrisentaan, 10mg | C02KX02 | VOLIBRIS, õhukese polümeerikattega tablett, 30TK | Glaxo Group Limited | 100 | I27.0-I27.0 | Pulmonoloog, Reumatoloog, Kardioloog, Pediaater | | | | NYHA III-IV kl idiopaatilise, süsteemse sidekoehaiguse või kaasasündinud südamerikkega seotud pulmonaalse arteriaalse hüpertensiooni raviks patsientidele konsiiliumi (vähemalt 3 vastava eriala spetsialisti) otsuse alusel, kui sildenafiil on vastunäidustatud, osutunud ebaefektiivseks või põhjustanud olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1349850 | ambrisentaan, 5mg | C02KX02 | VOLIBRIS, õhukese polümeerikattega tablett, 30TK | Glaxo Group Limited | 100 | I27.0-I27.0 | Pediaater, Reumatoloog, Kardioloog, Pulmonoloog | | | | NYHA III-IV kl idiopaatilise, süsteemse sidekoehaiguse või kaasasündinud südamerikkega seotud pulmonaalse arteriaalse hüpertensiooni raviks patsientidele konsiiliumi (vähemalt 3 vastava eriala spetsialisti) otsuse alusel, kui sildenafiil on vastunäidustatud, osutunud ebaefektiivseks või põhjustanud olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1064517 | amantadiin, 100mg | N04BB01 | AMANTADIN-RATIOPHARM 100 MG, õhukese polümeerikattega tablett, 100TK | ratiopharm GmbH | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1349872 | ambrisentaan, 10mg | C02KX02 | VOLIBRIS, õhukese polümeerikattega tablett, 30TK | Glaxo Group Limited | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | Pulmonoloog, Pediaater, Reumatoloog, Kardioloog | | | | NYHA III-IV kl idiopaatilise, süsteemse sidekoehaiguse või kaasasündinud südamerikkega seotud pulmonaalse arteriaalse hüpertensiooni raviks patsientidele konsiiliumi (vähemalt 3 vastava eriala spetsialisti) otsuse alusel, kui sildenafiil on vastunäidustatud, osutunud ebaefektiivseks või põhjustanud olulisi kõrvaltoimeid |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1349850 | ambrisentaan, 5mg | C02KX02 | VOLIBRIS, õhukese polümeerikattega tablett, 30TK | Glaxo Group Limited | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | Pediaater, Reumatoloog, Pulmonoloog, Kardioloog | | | | NYHA III-IV kl idiopaatilise, süsteemse sidekoehaiguse või kaasasündinud südamerikkega seotud pulmonaalse arteriaalse hüpertensiooni raviks patsientidele konsiiliumi (vähemalt 3 vastava eriala spetsialisti) otsuse alusel, kui sildenafiil on vastunäidustatud, osutunud ebaefektiivseks või põhjustanud olulisi kõrvaltoimeid |

| 1016244 | amiodaroon, 200mg | C01BD01 | CORDARONE 200 MG, tablett, 30TK | Sanofi-Aventis Estonia OÜ | 75 | I47-I49 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1044616 | amiodaroon, 200mg | C01BD01 | AMIOKORDIN, tablett, 60TK | KRKA d.d., Novo Mesto | 75 | I47-I49 | Pediaater, Kardioloog | esmane | | | |

@@ -146,42 +146,42 @@

| | | | | | 100 | F32.2-F32.3, F70- F79, F11.4-F11.7, F18.4-F18.7, F20- F29, F12.4-F12.7, F16.4-F16.7, F19.4- F19.7, F33.2-F33.3, F14.4-F14.7, F00- F09, F60.3-F60.3, F13.4-F13.7, F10.4- F10.7, F17.4-F17.7, F15.4-F15.7, F30- F31 | Psühhiaater | esmane | | | |

| | | | | | 75 | G62.0-G62.0, G63- G63 | | | | | |

| 1107391 | amitriptüliin, 10mg | N06AA09 | AMITRIPTYLINE-GRINDEKS, õhukese polümeerikattega tablett, 50TK | Grindeks | 50 | | | | | | |

| | | | | | 75 | G62.0-G62.0, G63- G63 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1005860 | amitriptüliin, 10mg | N06AA09 | SAROTEN, õhukese polümeerikattega tablett, 100TK | H. LUNDBECK A/S | 50 | | | | | | |

| | | | | | 75 | G62.0-G62.0, G63- G63 | | | | | |

| 1008683 | amitriptüliin, 25mg | N06AA09 | AMITRIPTYLINE NYCOMED, õhukese polümeerikattega tablett, 50TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 75 | G62.0-G62.0, G63- G63 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1012475 | amitriptüliin, 25mg | N06AA09 | AMITRIPTYLINE-GRINDEKS, õhukese polümeerikattega tablett, 50TK | Grindeks | 50 | | | | | | |

| | | | | | 75 | G62.0-G62.0, G63- G63 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1012475 | amitriptüliin, 25mg | N06AA09 | AMITRIPTYLINE-GRINDEKS, õhukese polümeerikattega tablett, 50TK | Grindeks | 75 | G62.0-G62.0, G63- G63 | | | | | |

| 1005893 | amitriptüliin, 25mg | N06AA09 | SAROTEN, õhukese polümeerikattega tablett, 100TK | H. LUNDBECK A/S | 75 | G62.0-G62.0, G63- G63 | | | | | |

| | | | | | 50 | | | | | | |

| 1005893 | amitriptüliin, 25mg | N06AA09 | SAROTEN, õhukese polümeerikattega tablett, 100TK | H. LUNDBECK A/S | 75 | G62.0-G62.0, G63- G63 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1005848 | amitriptüliin, 50mg | N06AA09 | SAROTEN RETARD, toimeainet prolongeeritult vabastav kõvakapsel, 100TK | H. LUNDBECK A/S | 75 | G62.0-G62.0, G63- G63 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 75 | G62.0-G62.0, G63- G63 | | | | | |

| | | | | | 50 | | | | | | |

| 1012363 | amlodipiin, 10mg | C08CA01 | NORMODIPINE, tablett, 30TK | Gedeon Richter Plc. | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1018527 | amlodipiin, 10mg | C08CA01 | NORVASC, tablett, 30TK | Pfizer Europe MA EEIG | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1012363 | amlodipiin, 10mg | C08CA01 | NORMODIPINE, tablett, 30TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1018527 | amlodipiin, 10mg | C08CA01 | NORVASC, tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1087905 | amlodipiin, 10mg | C08CA01 | AMLOCARD 10MG, tablett, 30TK | HEXAL AG | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1109900 | amlodipiin, 10mg | C08CA01 | AGEN, tablett, 30TK | Zentiva, k.s. | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1122972 | amlodipiin, 10mg | C08CA01 | HIPRES, tablett, 30TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1122972 | amlodipiin, 10mg | C08CA01 | HIPRES, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1147003 | amlodipiin, 10mg | C08CA01 | AMLODIPIN-RATIOPHARM 10 MG, tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1147733 | amlodipiin, 10mg | C08CA01 | LOFRAL, tablett, 30TK | MEPHA Lda. | 50 | | | | | | |

@@ -189,53 +189,53 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1241514 | amlodipiin, 10mg | C08CA01 | AMLODIGAMMA 10MG, tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1295748 | amlodipiin, 10mg | C08CA01 | AMLODIPINE MEDOCHEMIE, tablett, 30TK | Medochemie Ltd | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1241514 | amlodipiin, 10mg | C08CA01 | AMLODIGAMMA 10MG, tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1295748 | amlodipiin, 10mg | C08CA01 | AMLODIPINE MEDOCHEMIE, tablett, 30TK | Medochemie Ltd | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1318946 | amlodipiin, 10mg | C08CA01 | AMLODIPINE TEVA, tablett, 30TK | Teva Pharma B.V. | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1416934 | amlodipiin, 10mg | C08CA01 | AMLODIPINE ACTAVIS, tablett, 30TK | Actavis Group PTC ehf | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1012352 | amlodipiin, 5mg | C08CA01 | NORMODIPINE, tablett, 30TK | Gedeon Richter Plc. | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1012352 | amlodipiin, 5mg | C08CA01 | NORMODIPINE, tablett, 30TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1018538 | amlodipiin, 5mg | C08CA01 | NORVASC, tablett, 30TK | Pfizer Europe MA EEIG | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1087871 | amlodipiin, 5mg | C08CA01 | AMLOCARD 5 MG, tablett, 30TK | HEXAL AG | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1109775 | amlodipiin, 5mg | C08CA01 | AMLODIPIN-RATIOPHARM 5 MG, tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1109887 | amlodipiin, 5mg | C08CA01 | AGEN, tablett, 30TK | Zentiva, k.s. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1109775 | amlodipiin, 5mg | C08CA01 | AMLODIPIN-RATIOPHARM 5 MG, tablett, 30TK | ratiopharm GmbH | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1109887 | amlodipiin, 5mg | C08CA01 | AGEN, tablett, 30TK | Zentiva, k.s. | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1122961 | amlodipiin, 5mg | C08CA01 | HIPRES, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1147711 | amlodipiin, 5mg | C08CA01 | LOFRAL, tablett, 30TK | MEPHA Lda. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1147711 | amlodipiin, 5mg | C08CA01 | LOFRAL, tablett, 30TK | MEPHA Lda. | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1241424 | amlodipiin, 5mg | C08CA01 | AMLODIGAMMA 5MG, tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1295737 | amlodipiin, 5mg | C08CA01 | AMLODIPINE MEDOCHEMIE, tablett, 30TK | Medochemie Ltd | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1295737 | amlodipiin, 5mg | C08CA01 | AMLODIPINE MEDOCHEMIE, tablett, 30TK | Medochemie Ltd | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1318834 | amlodipiin, 5mg | C08CA01 | AMLODIPINE TEVA, tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1416899 | amlodipiin, 5mg | C08CA01 | AMLODIPINE ACTAVIS, tablett, 30TK | Actavis Group PTC ehf | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1008919 | amoksitsilliin, 1000mg | J01CA04 | AMOXICILLIN- RATIOPHARM 1000 MG, õhukese polümeerikattega tablett, 10TK | ratiopharm GmbH | 75 | H66-H66, J13-J15 | | | | 16,00 | |

| | | | | | 50 | | | | | | |

| 1008919 | amoksitsilliin, 1000mg | J01CA04 | AMOXICILLIN- RATIOPHARM 1000 MG, õhukese polümeerikattega tablett, 10TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | H66-H66, J13-J15 | | | | 16,00 | |

| 1066058 | amoksitsilliin, 1000mg | J01CA04 | OSPAMOX, õhukese polümeerikattega tablett, 12TK | Sandoz GmbH | 50 | | | | | | |

| | | | | | 75 | H66-H66, J13-J15 | | | | 16,00 | |

| 1000551 | amoksitsilliin, 500mg | J01CA04 | AMOXICILLIN- RATIOPHARM 500 MG, õhukese polümeerikattega tablett, 10TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | J13-J15, H66-H66 | | | | 16,00 | |

| 1066047 | amoksitsilliin, 500mg | J01CA04 | OSPAMOX, õhukese polümeerikattega tablett, 12TK | Sandoz GmbH | 75 | H66-H66, J13-J15 | | | | 16,00 | |

| | | | | | 50 | | | | | | |

| 1066047 | amoksitsilliin, 500mg | J01CA04 | OSPAMOX, õhukese polümeerikattega tablett, 12TK | Sandoz GmbH | 50 | | | | | | |

| | | | | | 75 | H66-H66, J13-J15 | | | | 16,00 | |

| 1000382 | amoksitsilliin, 50mg 1ml | J01CA04 | AMOXICILLIN- RATIOPHARM TS, suukaudse suspensiooni graanulid, 100ml 1TK | ratiopharm GmbH | 75 | J13-J15, H66-H66 | | | | 16,00 | |

| | | | | | 50 | | | | | | |

| 1181999 | amoksitsilliin, 50mg 1ml | J01CA04 | OSPAMOX 250 MG/5 ML, suukaudse suspensiooni pulber, 60ml 1TK | Sandoz GmbH | 50 | | | | | | |

| | | | | | 75 | J13-J15, H66-H66 | | | | 16,00 | |

| 1182002 | amoksitsilliin, 50mg 1ml | J01CA04 | OSPAMOX 250 MG/5 ML, suukaudse suspensiooni pulber, 100ml 1TK | Sandoz GmbH | 50 | | | | | | |

| | | | | | 75 | J13-J15, H66-H66 | | | | 16,00 | |

| 1182002 | amoksitsilliin, 50mg 1ml | J01CA04 | OSPAMOX 250 MG/5 ML, suukaudse suspensiooni pulber, 100ml 1TK | Sandoz GmbH | 75 | J13-J15, H66-H66 | | | | 16,00 | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

@@ -258,40 +258,39 @@

| 1208359 | anagreliid, 0,5mg | L01XX35 | XAGRID, kõvakapsel, 100TK | Shire Pharmaceutical Contracts Limited | 100 | D47.3-D47.3 | Hematoloog | | | | patsientidele, kellel ravi alustamine on hinnatud konsiiliumi (vähemalt 3 hematoloogi) poolt vastavaks järgmistele kriteeriumidele: esmavaliku ravi (hüdroksüuurea annuses vähemalt 2g päevas vähemalt 3 kuu jooksul või alfainterferoon) on osutunud ebaefektiivseks või talumatuks ning esineb trombotsütoos 1000x109/l või on ilmnenud trombohemorraagilised juhud |

| 1240490 | anastrosool, 1mg | L02BG03 | ANASTROZOLE SANOSWISS 1 MG, õhukese polümeerikattega tablett, 28TK | UAB SanoSwiss | 50 | | | | | | |

| | | | | | 100 | C50-C50 | Onkoloog | | | | |

| 1033546 | anastrosool, 1mg | L02BG03 | ARIMIDEX, õhukese polümeerikattega tablett, 28TK | AstraZeneca UK Limited | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1240636 | anastrosool, 1mg | L02BG03 | ANASTROZOLE SANDOZ 1 MG, õhukese polümeerikattega tablett, 28TK | Sandoz d.d. | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1240771 | anastrosool, 1mg | L02BG03 | ANASTROZOLE ACTAVIS, õhukese polümeerikattega tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| | | | | | 100 | C50-C50 | Onkoloog | | | | |

| 1244438 | anastrosool, 1mg | L02BG03 | ANASTROZOLE-TEVA 1MG, õhukese polümeerikattega tablett, 28TK | Teva Pharma B.V. | 50 | | | | | | |

| 1244438 | anastrosool, 1mg | L02BG03 | ANASTROZOLE-TEVA 1MG, õhukese polümeerikattega tablett, 28TK | Teva Pharma B.V. | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1033546 | anastrosool, 1mg | L02BG03 | ARIMIDEX, õhukese polümeerikattega tablett, 28TK | AstraZeneca UK Limited | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1240636 | anastrosool, 1mg | L02BG03 | ANASTROZOLE SANDOZ 1 MG, õhukese polümeerikattega tablett, 28TK | Sandoz d.d. | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1275319 | anastrosool, 1mg | L02BG03 | MAMMOZOLE, õhukese polümeerikattega tablett, 28TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 100 | C50-C50 | Onkoloog | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1275319 | anastrosool, 1mg | L02BG03 | MAMMOZOLE, õhukese polümeerikattega tablett, 28TK | Gedeon Richter Plc. | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1299023 | anastrosool, 1mg | L02BG03 | AXASTROL, õhukese polümeerikattega tablett, 28TK | JSC Grindeks | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1330445 | anastrosool, 1mg | L02BG03 | ANASTROZOL- RATIOPHARM 1 MG, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1330445 | anastrosool, 1mg | L02BG03 | ANASTROZOL- RATIOPHARM 1 MG, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 100 | C50-C50 | Onkoloog | | | | |

| 1330580 | anastrosool, 1mg | L02BG03 | ZYNZOL, õhukese polümeerikattega tablett, 30TK | LANNACHER HEILMITTEL GmbH | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1203523 | aripiprasool, 10mg | N05AX12 | ABILIFY, tablett, 28TK | Otsuka Pharmaceutical Europe Ltd | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid, soodustus ei kehti enne hinnakokkuleppe jõustumist |

| 1203578 | aripiprasool, 15mg | N05AX12 | ABILIFY, tablett, 28TK | Otsuka Pharmaceutical Europe Ltd | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1004500 | asatiopriin, 50mg | L04AX01 | IMURAN, õhukese polümeerikattega tablett, 100TK | Aspen Europe GmbH | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 100 | G70-G70 | Neuroloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1004500 | asatiopriin, 50mg | L04AX01 | IMURAN, õhukese polümeerikattega tablett, 100TK | Aspen Europe GmbH | 100 | G70-G70 | Pediaater, Neuroloog | esmane | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 75 | N00-N08 | Pediaater, Nefroloog | | | | |

| 1005736 | aselaiinhape, 200mg 1g | D10AX03 | SKINOREN, kreem, 30g 1TK | Intendis GmbH | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1019809 | asitromütsiin, 20mg 1ml | J01FA10 | SUMAMED, suukaudse suspensiooni pulber, 20ml 1TK | Teva Pharma B.V. | 50 | | | | | | |

| 1019775 | asitromütsiin, 250mg | J01FA10 | SUMAMED, kõvakapsel, 6TK | Teva Pharma B.V. | 50 | | | | | | |

| 1113400 | asitromütsiin, 250mg | J01FA10 | AZITROX 250, õhukese polümeerikattega tablett, 3TK | Zentiva, k.s. | 50 | | | | | | |

@@ -301,9 +300,6 @@

| 1304402 | asitromütsiin, 250mg | J01FA10 | AZIMEPHA 250 MG, õhukese polümeerikattega tablett, 6TK | MEPHA Lda. | 50 | | | | | | |

| 1373396 | asitromütsiin, 2g | J01FA10 | ZITRAVAL, suukaudse suspensiooni toimeainet prolongeeritult vabastavad graanulid, 1TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1168130 | asitromütsiin, 40mg 1ml | J01FA10 | SUMAMED FORTE, suukaudse suspensiooni pulber, 15ml 1TK | Teva Pharma B.V. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1267309 | asitromütsiin, 40mg 1ml | J01FA10 | SUMAMED FORTE, suukaudse suspensiooni pulber, 30ml 1TK | Teva Pharma B.V. | 50 | | | | | | |

| 1019797 | asitromütsiin, 500mg | J01FA10 | SUMAMED, õhukese polümeerikattega tablett, 3TK | Teva Pharma B.V. | 50 | | | | | | |

| 1184992 | asitromütsiin, 500mg | J01FA10 | AZITHROMYCIN SANDOZ 500MG, õhukese polümeerikattega tablett, 3TK | Sandoz GmbH | 50 | | | | | | |

@@ -311,169 +307,172 @@

| 1304514 | asitromütsiin, 500mg | J01FA10 | AZIMEPHA 500 MG, õhukese polümeerikattega tablett, 3TK | MEPHA Lda. | 50 | | | | | | |

| 1045796 | aspart-insuliin, 100ühik 1ml | A10AB05 | NOVORAPID PENFILL, süstelahus kolbampullis, 3ml 5TK | Novo Nordisk A/S | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1084788 | aspart-insuliin, 100ühik 1ml | A10AD05 | NOVOMIX 30 FLEXPEN, süstesuspensioon pen-süstlis, 3ml 5TK | Novo Nordisk A/S | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1084788 | aspart-insuliin, 100ühik 1ml | A10AD05 | NOVOMIX 30 FLEXPEN, süstesuspensioon pen-süstlis, 3ml 5TK | Novo Nordisk A/S | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1092541 | aspart-insuliin, 100ühik 1ml | A10AB05 | NOVORAPID FLEXPEN, süstelahus pen-süstlis, 3ml 5TK | Novo Nordisk A/S | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1007851 | atenolool, 100mg | C07AB03 | ATENOLOL-RATIOPHARM 100MG, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1007895 | atenolool, 25mg | C07AB03 | ATENOLOL-RATIOPHARM 25MG, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1007851 | atenolool, 100mg | C07AB03 | ATENOLOL-RATIOPHARM 100MG, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1007895 | atenolool, 25mg | C07AB03 | ATENOLOL-RATIOPHARM 25MG, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1007873 | atenolool, 50mg | C07AB03 | ATENOLOL-RATIOPHARM 50MG, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1427228 | atorvastatiin, 10mg | C10AA05 | ATORVASTATIN- RATIOPHARM, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1030521 | atorvastatiin, 10mg | C10AA05 | SORTIS, õhukese polümeerikattega tablett, 30TK | Pfizer Europe MA EEIG | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1180213 | atorvastatiin, 10mg | C10AA05 | TORVACARD 10 MG, õhukese polümeerikattega tablett, 30TK | Zentiva, k.s. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1253607 | atorvastatiin, 10mg | C10AA05 | ATORVASTATIN ACTAVIS, õhukese polümeerikattega tablett, 30TK | Actavis Group Hf | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1427228 | atorvastatiin, 10mg | C10AA05 | ATORVASTATIN- RATIOPHARM, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1030521 | atorvastatiin, 10mg | C10AA05 | SORTIS, õhukese polümeerikattega tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1138047 | atorvastatiin, 10mg | C10AA05 | ATORIS, õhukese polümeerikattega tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1253180 | atorvastatiin, 10mg | C10AA05 | LOPAMOL, õhukese polümeerikattega tablett, 30TK | Gedeon Richter Plc. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1254024 | atorvastatiin, 10mg | C10AA05 | ATORVASTATIN POLPHARMA, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1397741 | atorvastatiin, 10mg | C10AA05 | TULIP 10MG, õhukese polümeerikattega tablett, 30TK | Sandoz d.d. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1427363 | atorvastatiin, 20mg | C10AA05 | ATORVASTATIN- RATIOPHARM, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1030532 | atorvastatiin, 20mg | C10AA05 | SORTIS, õhukese polümeerikattega tablett, 30TK | Pfizer Europe MA EEIG | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1138058 | atorvastatiin, 20mg | C10AA05 | ATORIS, õhukese polümeerikattega tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1253326 | atorvastatiin, 20mg | C10AA05 | LOPAMOL, õhukese polümeerikattega tablett, 30TK | Gedeon Richter Plc. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1253742 | atorvastatiin, 20mg | C10AA05 | ATORVASTATIN ACTAVIS, õhukese polümeerikattega tablett, 30TK | Actavis Group Hf | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1180235 | atorvastatiin, 20mg | C10AA05 | TORVACARD 20 MG, õhukese polümeerikattega tablett, 30TK | Zentiva, k.s. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1253742 | atorvastatiin, 20mg | C10AA05 | ATORVASTATIN ACTAVIS, õhukese polümeerikattega tablett, 30TK | Actavis Group Hf | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1335800 | atorvastatiin, 20mg | C10AA05 | ATILEN 20MG, õhukese polümeerikattega tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1254169 | atorvastatiin, 20mg | C10AA05 | ATORVASTATIN POLPHARMA, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1397909 | atorvastatiin, 20mg | C10AA05 | TULIP 20MG, õhukese polümeerikattega tablett, 30TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1180257 | atorvastatiin, 40mg | C10AA05 | TORVACARD 40 MG, õhukese polümeerikattega tablett, 30TK | Zentiva, k.s. | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1253887 | atorvastatiin, 40mg | C10AA05 | ATORVASTATIN ACTAVIS, õhukese polümeerikattega tablett, 30TK | Actavis Group Hf | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1030543 | atorvastatiin, 40mg | C10AA05 | SORTIS, õhukese polümeerikattega tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1220993 | atorvastatiin, 40mg | C10AA05 | ATORIS, õhukese polümeerikattega tablett, 30TK | KRKA d.d., Novo Mesto | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1253461 | atorvastatiin, 40mg | C10AA05 | LOPAMOL, õhukese polümeerikattega tablett, 30TK | Gedeon Richter Plc. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1253887 | atorvastatiin, 40mg | C10AA05 | ATORVASTATIN ACTAVIS, õhukese polümeerikattega tablett, 30TK | Actavis Group Hf | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1335945 | atorvastatiin, 40mg | C10AA05 | ATILEN 40MG, õhukese polümeerikattega tablett, 30TK | Teva Pharma B.V. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1254305 | atorvastatiin, 40mg | C10AA05 | ATORVASTATIN POLPHARMA, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1124996 | atorvastatiin, 80mg | C10AA05 | SORTIS 80 MG, õhukese polümeerikattega tablett, 30TK | Pfizer Europe MA EEIG | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1122635 | atsetüültsüsteiin, 200mg | R05CB01 | MUCOFLUID, lahustuv tablett, 30TK | Spirig Baltikum Lithuanian-Swiss Ltd. | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| 1039250 | atsetüültsüsteiin, 600mg | R05CB01 | ACC LONG, kihisev tablett, 10TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 100 | E84-E84 | Pediaater, Pulmonoloog | esmane | | | |

| 1086274 | atsikloviir, 200mg | J05AB01 | ACICLOVIR ACTAVIS, tablett, 20TK | Actavis Nordic A/S | 50 | | | | | | |

| | | | | | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| 1086274 | atsikloviir, 200mg | J05AB01 | ACICLOVIR ACTAVIS, tablett, 20TK | Actavis Nordic A/S | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| 1013623 | atsikloviir, 200mg | J05AB01 | ACIC 200 MG, tablett, 25TK | Sandoz d.d. | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| 1006625 | atsikloviir, 30mg 1g | S01AD03 | ZOVIRAX, silmasalv, 4.5g 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| 1086285 | atsikloviir, 400mg | J05AB01 | ACICLOVIR ACTAVIS, tablett, 10TK | Actavis Nordic A/S | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| 1165384 | atsikloviir, 400mg | J05AB01 | ACIC 400 MG, tablett, 35TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1013623 | atsikloviir, 200mg | J05AB01 | ACIC 200 MG, tablett, 25TK | Sandoz d.d. | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| 1006625 | atsikloviir, 30mg 1g | S01AD03 | ZOVIRAX, silmasalv, 4.5g 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| 1086285 | atsikloviir, 400mg | J05AB01 | ACICLOVIR ACTAVIS, tablett, 10TK | Actavis Nordic A/S | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| 1165384 | atsikloviir, 400mg | J05AB01 | ACIC 400 MG, tablett, 35TK | Sandoz d.d. | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| 1000731 | atsitretiin, 10mg | D05BB02 | NEOTIGASON, kõvakapsel, 30TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1019483 | batsitratsiin+ neomütsiin, 250TÜ+5000TÜ 1g | D06AX80 | BANEOCIN, salv, 20g 1TK | Sandoz GmbH | 50 | | | | | | |

| 1036369 | beeta-1a-interferoon, 30mcg | L03AB07 | AVONEX, süstelahuse pulber ja lahusti, 4TK | Biogen Idec Limited | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1117640 | beeta-1a-interferoon, 44mcg 0,5ml | L03AB07 | REBIF, süstelahus süstlis, 0.5ml 12TK | Merck Serono Europe Limited | 50 | | | | | | |

| 1430671 | beeta-1a-interferoon, 44mcg 0,5ml | L03AB07 | REBIF, süstelahus kolbampullis, 1.5ml 4TK | Merck Serono Europe Limited | 50 | | | | | | |

| 1361393 | beeta-1b-interferoon, 250mcg 1ml | L03AB08 | EXTAVIA, süstelahuse pulber ja lahusti, 15TK | Novartis Europharm Limited | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1071245 | beeta-1b-interferoon, 9600000RÜ | L03AB08 | BETAFERON, süstelahuse pulber ja lahusti, 15TK | Bayer Schering Pharma AG | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1205435 | beetaepoetiin, 10000RÜ 0,6ml | B03XA80 | NEORECORMON, süstelahus süstlis, 0.6ml 6TK | Roche Registration Limited | 50 | | | | | | |

| 1066384 | beetaepoetiin, 2000RÜ 0,3ml | B03XA80 | NEORECORMON, süstelahus süstlis, 0.3ml 6TK | Roche Registration Limited | 50 | | | | | | |

| 1061389 | beetaepoetiin, 4000RÜ 0,3ml | B03XA80 | NEORECORMON, süstelahus süstlis, 0.3ml 6TK | Roche Registration Limited | 50 | | | | | | |

| 1066418 | beetaepoetiin, 5000RÜ 0,3ml | B03XA80 | NEORECORMON, süstelahus süstlis, 0.3ml 6TK | Roche Registration Limited | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1099403 | beetafollitropiin, 300RÜ 0.36ml | G03GA06 | PUREGON, süstelahus, 0.525ml 1TK | N.V. Organon | 50 | | | | | | |

| 1064045 | beetafollitropiin, 50RÜ 0.5ml | G03GA06 | PUREGON, süstelahus, 0.5ml 5TK | N.V. Organon | 50 | | | | | | |

@@ -482,13 +481,13 @@

| 1115738 | beetahistiin, 24mg | N07CA01 | BETASERC, tablett, 50TK | Abbott Healthcare Products B.V. | 50 | | | | | | |

| 1236866 | beetahistiin, 8mg | N07CA01 | BETAHISTIN ACTAVIS 8MG, tablett, 100TK | Actavis Group Hf | 50 | | | | | | |

| 1004263 | beetametasoon, 1mg 1g | D07AC01 | BETNOVATE OINTMENT, salv, 15g 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1004870 | beetametasoon, 1mg 1g | D07AC01 | BETNOVATE CREAM, kreem, 15g 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| 1018448 | beetametasoon, 1mg 1g | D07AC01 | CELESTODERM-V, kreem, 30g 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1018459 | beetametasoon, 1mg 1g | D07AC01 | CELESTODERM-V, salv, 30g 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1007514 | beetametasoon+ fusidiinhape, 1mg+20mg 1g | D07CC80 | FUCICORT, kreem, 15g 1TK | Leo Pharmaceutical Products | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1062403 | beetametasoon+ salitsüülhape, 0,5mg+20mg 1g | D07BC80 | DIPROSALIC, nahalahus, 50ml 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1062436 | beetametasoon+ salitsüülhape, 0,5mg+30mg 1g | D07BC80 | DIPROSALIC, salv, 50g 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1004320 | beetametasoon+neom ütsiin, 1mg+5mg 1g | D07CC81 | BETNOVATE N CREAM, kreem, 15g 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

@@ -496,113 +495,113 @@

| | | | | | 75 | J45-J45 | | | | | |

| 1045550 | beklometasoon, 250mcg 1annust | R03BA01 | ECOBEC 250, inhalatsiooniaerosool, lahus, 200annust 1TK | TEVA Czech Industries s.r.o. | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| 1045561 | beklometasoon, 250mcg 1annust | R03BA01 | ECOBEC 250 MCG EASI- BREATHE, inhalatsiooniaerosool, lahus, 200annust 1TK | TEVA Czech Industries s.r.o. | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| 1045561 | beklometasoon, 250mcg 1annust | R03BA01 | ECOBEC 250 MCG EASI- BREATHE, inhalatsiooniaerosool, lahus, 200annust 1TK | TEVA Czech Industries s.r.o. | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| 1152201 | beklometasoon, 250mcg 1annust | R03BA01 | BECLOFORTE INHALER, inhalatsiooniaerosool, lahus, 200annust 1TK | Glaxo Group Ltd | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| 1001103 | beklometasoon, 50mcg 1annust | R01AD01 | BECONASE, ninasprei, 200annust 1TK | Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 75 | J30-J30 | | | | 17,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1013128 | beklometasoon, 50mcg 1annust | R01AD01 | NASOBEC, ninasprei, suspensioon, 200annust 1TK | TEVA Czech Industries s.r.o. | 75 | J30-J30 | | | | 17,00 | |

| | | | | | 50 | | | | | | |

| 1232569 | beklometasoon, 50mcg 1annust | R01AD01 | BECLONASAL, ninasprei, suspensioon, 200annust 1TK | Orion Corporation Orion Pharma | 50 | | | | | | |

| | | | | | 75 | J30-J30 | | | | 17,00 | |

| 1232569 | beklometasoon, 50mcg 1annust | R01AD01 | BECLONASAL, ninasprei, suspensioon, 200annust 1TK | Orion Corporation Orion Pharma | 75 | J30-J30 | | | | 17,00 | |

| | | | | | 50 | | | | | | |

| 1034042 | betaksolool, 2,5mg 1ml | S01ED02 | BETOPTIC S, silmatilgad, suspensioon, 5ml 1TK | s.a. ALCON- COUVREUR n.v. | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1012194 | bikalutamiid, 150mg | L02BB03 | CASODEX 150, õhukese polümeerikattega tablett, 28TK | AstraZeneca UK Limited | 50 | | | | | | |

| | | | | | 100 | C61-C61 | Onkoloog, Uroloog | | | | juhul, kui haigus on pärast kirurgilist või medikamentoosset kastratsiooni progresseerunud, metastaatilise haiguse korral lühiajaliselt ravi alustamisel LHRH analoogiga, kombinatsioonis kiiritusraviga või juhul, kui patsient keeldub eelistatud hormoonravist (kirurgilisest või medikamentoossest kastratsioonist) |

| 1258017 | bikalutamiid, 150mg | L02BB03 | BICALUTAMIDE - TEVA, õhukese polümeerikattega tablett, 28TK | Teva Pharma B.V. | 100 | C61-C61 | Uroloog, Onkoloog | | | | juhul, kui haigus on pärast kirurgilist või medikamentoosset kastratsiooni progresseerunud, metastaatilise haiguse korral lühiajaliselt ravi alustamisel LHRH analoogiga, kombinatsioonis kiiritusraviga või juhul, kui patsient keeldub eelistatud hormoonravist (kirurgilisest või medikamentoossest kastratsioonist) |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1266173 | bikalutamiid, 150mg | L02BB03 | BICALUTAMID ACTAVIS 150MG, õhukese polümeerikattega tablett, 28TK | Actavis Group PTC ehf | 100 | C61-C61 | Uroloog, Onkoloog | | | | juhul, kui haigus on pärast kirurgilist või medikamentoosset kastratsiooni progresseerunud, metastaatilise haiguse korral lühiajaliselt ravi alustamisel LHRH analoogiga, kombinatsioonis kiiritusraviga või juhul, kui patsient keeldub eelistatud hormoonravist (kirurgilisest või medikamentoossest kastratsioonist) |

| | | | | | 50 | | | | | | |

| 1257803 | bikalutamiid, 50mg | L02BB03 | BICALUTAMIDE - TEVA, õhukese polümeerikattega tablett, 28TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 100 | C61-C61 | Uroloog, Onkoloog | | | | juhul, kui haigus on pärast kirurgilist või medikamentoosset kastratsiooni progresseerunud, metastaatilise haiguse korral lühiajaliselt ravi alustamisel LHRH analoogiga, kombinatsioonis kiiritusraviga või juhul, kui patsient keeldub eelistatud hormoonravist (kirurgilisest või medikamentoossest kastratsioonist) |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1266173 | bikalutamiid, 150mg | L02BB03 | BICALUTAMID ACTAVIS 150MG, õhukese polümeerikattega tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1026560 | bikalutamiid, 50mg | L02BB03 | CASODEX, õhukese polümeerikattega tablett, 28TK | AstraZeneca UK Limited | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1257803 | bikalutamiid, 50mg | L02BB03 | BICALUTAMIDE - TEVA, õhukese polümeerikattega tablett, 28TK | Teva Pharma B.V. | 100 | C61-C61 | Uroloog, Onkoloog | | | | juhul, kui haigus on pärast kirurgilist või medikamentoosset kastratsiooni progresseerunud, metastaatilise haiguse korral lühiajaliselt ravi alustamisel LHRH analoogiga, kombinatsioonis kiiritusraviga või juhul, kui patsient keeldub eelistatud hormoonravist (kirurgilisest või medikamentoossest kastratsioonist) |

| | | | | | 50 | | | | | | |

| 1026560 | bikalutamiid, 50mg | L02BB03 | CASODEX, õhukese polümeerikattega tablett, 28TK | AstraZeneca UK Limited | 100 | C61-C61 | Onkoloog, Uroloog | | | | juhul, kui haigus on pärast kirurgilist või medikamentoosset kastratsiooni progresseerunud, metastaatilise haiguse korral lühiajaliselt ravi alustamisel LHRH analoogiga, kombinatsioonis kiiritusraviga või juhul, kui patsient keeldub eelistatud hormoonravist (kirurgilisest või medikamentoossest kastratsioonist) |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1265891 | bikalutamiid, 50mg | L02BB03 | BICALUTAMID ACTAVIS 50MG, õhukese polümeerikattega tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1431919 | bikalutamiid, 50mg | L02BB03 | BICALUTAMIDE GRINDEKS 50MG, õhukese polümeerikattega tablett, 28TK | Grindeks | 100 | C61-C61 | Onkoloog, Uroloog | | | | juhul, kui haigus on pärast kirurgilist või medikamentoosset kastratsiooni progresseerunud, metastaatilise haiguse korral lühiajaliselt ravi alustamisel LHRH analoogiga, kombinatsioonis kiiritusraviga või juhul, kui patsient keeldub eelistatud hormoonravist (kirurgilisest või medikamentoossest kastratsioonist) |

| 1265891 | bikalutamiid, 50mg | L02BB03 | BICALUTAMID ACTAVIS 50MG, õhukese polümeerikattega tablett, 28TK | Actavis Group PTC ehf | 100 | C61-C61 | Onkoloog, Uroloog | | | | juhul, kui haigus on pärast kirurgilist või medikamentoosset kastratsiooni progresseerunud, metastaatilise haiguse korral lühiajaliselt ravi alustamisel LHRH analoogiga, kombinatsioonis kiiritusraviga või juhul, kui patsient keeldub eelistatud hormoonravist (kirurgilisest või medikamentoossest kastratsioonist) |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1431919 | bikalutamiid, 50mg | L02BB03 | BICALUTAMIDE GRINDEKS 50MG, õhukese polümeerikattega tablett, 28TK | Grindeks | 100 | C61-C61 | Uroloog, Onkoloog | | | | juhul, kui haigus on pärast kirurgilist või medikamentoosset kastratsiooni progresseerunud, metastaatilise haiguse korral lühiajaliselt ravi alustamisel LHRH analoogiga, kombinatsioonis kiiritusraviga või juhul, kui patsient keeldub eelistatud hormoonravist (kirurgilisest või medikamentoossest kastratsioonist) |

| | | | | | 50 | | | | | | |

| 1077005 | biperideen, 2mg | N04AA02 | AKINETON, tablett, 100TK | Desma GmbH | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1258983 | bisoprolool, 10mg | C07AB07 | BISOPROLOL VITABALANS, tablett, 30TK | VITABALANS OY | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1258983 | bisoprolool, 10mg | C07AB07 | BISOPROLOL VITABALANS, tablett, 30TK | VITABALANS OY | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1258905 | bisoprolool, 5mg | C07AB07 | BISOPROLOL VITABALANS, tablett, 30TK | VITABALANS OY | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1207921 | bosentaan, 125mg | C02KX01 | TRACLEER, õhukese polümeerikattega tablett, 56TK | Actelion Registration Ltd. | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | Reumatoloog, Kardioloog, Pulmonoloog, Pediaater | | | | NYHA III-IV kl idiopaatilise, süsteemse sidekoehaiguse või kaasasündinud südamerikkega seotud pulmonaalse arteriaalse hüpertensiooni raviks patsientidele konsiiliumi (vähemalt 3 vastava eriala spetsialisti) otsuse alusel, kui sildenafiil on vastunäidustatud, ostunud ebaefektiivseks või põhjustanud olulisi kõrvaltoimeid |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1207921 | bosentaan, 125mg | C02KX01 | TRACLEER, õhukese polümeerikattega tablett, 56TK | Actelion Registration Ltd. | 100 | I27.0-I27.0 | Kardioloog, Reumatoloog, Pediaater, Pulmonoloog | | | | NYHA III-IV kl idiopaatilise, süsteemse sidekoehaiguse või kaasasündinud südamerikkega seotud pulmonaalse arteriaalse hüpertensiooni raviks patsientidele konsiiliumi (vähemalt 3 vastava eriala spetsialisti) otsuse alusel, kui sildenafiil on vastunäidustatud, ostunud ebaefektiivseks või põhjustanud olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1207909 | bosentaan, 62,5mg | C02KX01 | TRACLEER, õhukese polümeerikattega tablett, 56TK | Actelion Registration Ltd. | 50 | | | | | | |

| 1042782 | brinsolamiid, 10mg 1ml | S01EC04 | AZOPT, silmatilgad, suspensioon, 5ml 1TK | ALCON LABORATORIES (UK) Ltd. | 50 | | | | | | |

| | | | | | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 100 | I27.0-I27.0 | Kardioloog, Pulmonoloog, Reumatoloog, Pediaater | | | | NYHA III-IV kl idiopaatilise, süsteemse sidekoehaiguse või kaasasündinud südamerikkega seotud pulmonaalse arteriaalse hüpertensiooni raviks patsientidele konsiiliumi (vähemalt 3 vastava eriala spetsialisti) otsuse alusel, kui sildenafiil on vastunäidustatud, ostunud ebaefektiivseks või põhjustanud olulisi kõrvaltoimeid |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1042782 | brinsolamiid, 10mg 1ml | S01EC04 | AZOPT, silmatilgad, suspensioon, 5ml 1TK | ALCON LABORATORIES (UK) Ltd. | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1057542 | budesoniid, 0,1mg 1annust | R03BA02 | PULMICORT TURBUHALER, inhalatsioonipulber, 200annust 1TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| 1038316 | budesoniid, 0,25mg 1ml | R03BA02 | PULMICORT, nebuliseeritav suspensioon, 2ml 20TK | AstraZeneca AB | 50 | | | | | | |

| 1038316 | budesoniid, 0,25mg 1ml | R03BA02 | PULMICORT, nebuliseeritav suspensioon, 2ml 20TK | AstraZeneca AB | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| 1114827 | budesoniid, 0,2mg 1annust | R03BA02 | PULMICORT TURBUHALER, inhalatsioonipulber, 100annust 1TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| 1114827 | budesoniid, 0,2mg 1annust | R03BA02 | PULMICORT TURBUHALER, inhalatsioonipulber, 100annust 1TK | AstraZeneca AB | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| 1198649 | budesoniid, 100mcg 1annust | R03BA02 | PULMICORT pMDI, inhalatsiooniaerosool, suspensioon, 120TK | AstraZeneca AB | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1198649 | budesoniid, 100mcg 1annust | R03BA02 | PULMICORT pMDI, inhalatsiooniaerosool, suspensioon, 120TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| 1124390 | budesoniid, 200mcg | R03BA02 | MIFLONIDE 200mcg, inhalatsioonipulber kõvakapslis, 60TK | Novartis Finland OY | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| 1174160 | budesoniid, 200mcg 1annust | R03BA02 | NEPLIT EASYHALER 200, inhalatsioonipulber, 200annust 1TK | Menarini International Operations Luxembourg S.A. | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| 1124413 | budesoniid, 400mcg | R03BA02 | MIFLONIDE 400 mcg, inhalatsioonipulber kõvakapslis, 60TK | Novartis Finland OY | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| 1174182 | budesoniid, 400mcg 1annust | R03BA02 | NEPLIT EASYHALER 400, inhalatsioonipulber, 100annust 1TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| 1124413 | budesoniid, 400mcg | R03BA02 | MIFLONIDE 400 mcg, inhalatsioonipulber kõvakapslis, 60TK | Novartis Finland OY | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| 1011070 | budesoniid, 50mcg 1annust | R01AD05 | BUDESONID SANDOZ, ninasprei, suspensioon, 200annust 1TK | Sandoz GmbH | 50 | | | | | | |

| | | | | | 75 | J30-J30 | | | | 17,00 | |

| 1174182 | budesoniid, 400mcg 1annust | R03BA02 | NEPLIT EASYHALER 400, inhalatsioonipulber, 100annust 1TK | Menarini International Operations Luxembourg S.A. | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| 1011070 | budesoniid, 50mcg 1annust | R01AD05 | BUDESONID SANDOZ, ninasprei, suspensioon, 200annust 1TK | Sandoz GmbH | 75 | J30-J30 | | | | 17,00 | |

| | | | | | 50 | | | | | | |

| 1043389 | budesoniid, 64mcg 1annust | R01AD05 | RHINOCORT AQUA, ninasprei, suspensioon, 10ml 120annust | AstraZeneca AB | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1232660 | bupropioon, 150mg | N06AX12 | ELONTRIL, toimeainet modifitseeritult vabastav tablett, 30TK | Glaxo Group Ltd | 50 | F33-F33, F32-F32 | | | | | |

| 1232693 | bupropioon, 300mg | N06AX12 | ELONTRIL, toimeainet modifitseeritult vabastav tablett, 30TK | Glaxo Group Ltd | 50 | F33-F33, F32-F32 | | | | | |

| 1005006 | busulfaan, 2mg | L01AB01 | MYLERAN, õhukese polümeerikattega tablett, 100TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Hematoloog, Onkoloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| 1005006 | busulfaan, 2mg | L01AB01 | MYLERAN, õhukese polümeerikattega tablett, 100TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 100 | C00-D48 | Onkoloog, Hematoloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| 1343382 | dabigatraaneteksilaat, 110mg | B01AE07 | PRADAXA, kõvakapsel, 10TK | Boehringer Ingelheim International GmbH | 50 | | | | | | |

| 1343393 | dabigatraaneteksilaat, 110mg | B01AE07 | PRADAXA, kõvakapsel, 30TK | Boehringer Ingelheim International GmbH | 50 | | | | | | |

| 1343359 | dabigatraaneteksilaat, 75mg | B01AE07 | PRADAXA, kõvakapsel, 10TK | Boehringer Ingelheim International GmbH | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1343360 | dabigatraaneteksilaat, 75mg | B01AE07 | PRADAXA, kõvakapsel, 30TK | Boehringer Ingelheim International GmbH | 50 | | | | | | |

| 1275768 | dasatiniib, 50mg | L01XE06 | SPRYCEL, õhukese polümeerikattega tablett, 60TK | Bristol-Myers Squibb Pharma EEIG | 50 | | | | | | |

| | | | | | 100 | C92.1-C92.1 | Hematoloog | | | | patsiendile, kelle ravi alustamine ja jätkamine dasatiniibiga on hinnatud konsiiliumi (vähemalt 3 hematoloogi) poolt vastavaks järgmistele kriteeriumidele: näidustatud on tsütogeneetilist vastust indutseeriv ravi, eelnev ravi imatiniibiga annuses 600 mg on ebaõnnestunud või osutunud talumatuks (imatiniibravi on põhjustanud III või IV astme kõrvaltoime või üle 3 kuu püsinud II astme kõrvaltoime CTC klassifikatsiooni järgi), dasatiniibravi foonil püsib hematoloogiline ravivastus (haigus ei progresseeru). Soodustus ei laiene patsientidele, kelle ravi dasatiniibiga on ravimitootja vastutusel alustatud ja tagatud enne 1. oktoobrit 2009. a. |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1275768 | dasatiniib, 50mg | L01XE06 | SPRYCEL, ohukese polumeerikattega tablet!, 60TK | Bristol-Myers Squibb Pharma EEIG | 50 | | | | | | |

| | | | | | 100 | C92.1-C92.1 | Hematoloog | | | | patsiendile, kelle r avi alustamine ja jatkamine dasatiniibiga on hinnatud konsiiliumi (vahemalt 3 hematoloogi) pool! vastavaks jargmistele kriteeriumidele: naidustatud on tsut ogeneetilist vastust indutseeriv ravi, eelnev ravi imat iniibiga annuses 600 mg on ebaonnestunud voi osutunud taiumatuks (imatiniibravi on pohjustanud Ill voi IV astme korvaltoime voi ule 3 kuu pusinud II astme korvaltoime CTC klassifikatsiooni jargi), dasatiniibravi foonil pu sib hematoloogiline ravivastus (haigus ei progr esseeru). Soodustu s ei laiene patsient idele, kelle ravi dasatiniibiga on ravimitootja vastutusel alustatud ja tagatud enne 1. okt oobrit 2009. a. |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1258668 | deferasiroks, 500mg | V03AC03 | EXJADE, dispergeeruv tablett, 28TK | Novartis Europharm Limited | 100 | D57-D57, D47.1- D47.1, D56-D56, D60-D61, C81-C96, D46-D46 | Hematoloog | | | | konsiiliumi (vähemasti 3 hematoloogi) otsuse alusel järgmistele kriteeriumidele vastavate patsientide raviks: seerumi ferritiinitase on >1000 mcg/l; esineb jätkuv regulaarne vereülekannete vajadus (vähemasti 1 aasta jooksul on manustatud vähemasti 2 erütrotsüütide doosi kuu kohta ning sarnane vereülekannete vajadus püsib) või plaanitakse vereloome tüvirakkude siirdamist; müelodüsplastilise sündroomi või müelofibroosiga (D46, D47.1) patsientide riskiskoor on madal või madal-mõõdukas (IPSS 0-1) |

| 1014972 | deksametasoon, 0,5mg | H02AB02 | DEXAMETHASON KRKA, tablett, 10TK | KRKA d.d., Novo Mesto | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| 1090932 | deksametasoon, 1mg 1g | S01BA01 | MAXIDEX, silmasalv, 3.5g 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| 1007479 | deksametasoon, 1mg 1ml | S01BA01 | OFTAN DEXA, silmatilgad, lahus, 5ml 1TK | SANTEN OY | 50 | | | | | | |

@@ -613,36 +612,36 @@

| | | | | | 100 | C00-D48 | | | | | |

| 1044379 | deksametasoon+ klooramfenikool, 1mg+2mg 1g | S01CA82 | OFTAN DEXA-CHLORA, silmasalv, 3.5g 1TK | SANTEN OY | 50 | | | | | | |

| 1044368 | deksametasoon+ klooramfenikool, 1mg+2mg 1ml | S01CA82 | OFTAN DEXA-CHLORA, silmatilgad, lahus, 10ml 1TK | SANTEN OY | 50 | | | | | | |

| 1124301 | deksametasoon+ neomütsiin+ polümüksiin B, 1mg+3500TÜ+6000TÜ 1ml | S01CA80 | MAXITROL, silmatilgad, suspensioon, 5ml 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| 1150276 | deksametasoon+ tobramütsiin, 1mg+3mg 1g | S01CA81 | TOBRADEX EYE OINTMENT, silmasalv, 3.5g 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| 1124266 | deksametasoon+ tobramütsiin, 1mg+3mg 1ml | S01CA81 | TOBRADEX, silmatilgad, suspensioon, 5ml 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| 1124301 | deksametasoon+neom ütsiin+polümüksiin B, 1mg+3500TÜ+6000TÜ 1ml | S01CA80 | MAXITROL, silmatilgad, suspensioon, 5ml 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| 1011979 | deksketoprofeen, 25mg | M01AE17 | DOLMEN, õhukese polümeerikattega tablett, 10TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| 1077971 | desloratadiin, 5mg | R06AX27 | AERIUS, õhukese polümeerikattega tablett, 10TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1077982 | desloratadiin, 5mg | R06AX27 | AERIUS, õhukese polümeerikattega tablett, 30TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1064360 | desmopressiin, 0,1mg | H01BA02 | MINIRIN, tablett, 30TK | Ferring Lääkkeet Oy | 100 | E23.2-E23.2 | Endokrinoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1064382 | desmopressiin, 0,2mg | H01BA02 | MINIRIN, tablett, 30TK | Ferring Lääkkeet Oy | 100 | E23.2-E23.2 | Pediaater, Endokrinoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1064348 | desmopressiin, 10mcg 1annust | H01BA02 | MINIRIN, ninasprei, lahus, 2.5ml 1TK | Ferring Lääkkeet Oy | 100 | E23.2-E23.2 | Endokrinoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1225594 | desmopressiin, 120mcg | H01BA02 | MINIRIN, suukaudne lüofilisaat, 30TK | Ferring Lääkkeet Oy | 100 | E23.2-E23.2 | Endokrinoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1225561 | desmopressiin, 60mcg | H01BA02 | MINIRIN, suukaudne lüofilisaat, 30TK | Ferring Lääkkeet Oy | 100 | E23.2-E23.2 | Endokrinoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1064360 | desmopressiin, 0,1mg | H01BA02 | MINIRIN, tablett, 30TK | Ferring Lääkkeet Oy | 50 | | | | | | |

| | | | | | 100 | E23.2-E23.2 | Pediaater, Endokrinoloog | esmane | | | |

| 1064382 | desmopressiin, 0,2mg | H01BA02 | MINIRIN, tablett, 30TK | Ferring Lääkkeet Oy | 50 | | | | | | |

| | | | | | 100 | E23.2-E23.2 | Pediaater, Endokrinoloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1064348 | desmopressiin, 10mcg 1annust | H01BA02 | MINIRIN, ninasprei, lahus, 2.5ml 1TK | Ferring Lääkkeet Oy | 100 | E23.2-E23.2 | Pediaater, Endokrinoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1225594 | desmopressiin, 120mcg | H01BA02 | MINIRIN, suukaudne lüofilisaat, 30TK | Ferring Lääkkeet Oy | 100 | E23.2-E23.2 | Pediaater, Endokrinoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1225561 | desmopressiin, 60mcg | H01BA02 | MINIRIN, suukaudne lüofilisaat, 30TK | Ferring Lääkkeet Oy | 50 | | | | | | |

| | | | | | 100 | E23.2-E23.2 | Pediaater, Endokrinoloog | esmane | | | |

| 1063303 | desogestreel, 75mcg | G03AC09 | CERAZETTE, õhukese polümeerikattega tablett, 84TK | N.V. ORGANON | 50 | | | | | | |

| 1062908 | desogestreel+etünüülö stradiool, 0,15mg+0,02mg | G03AA09 | MERCILON, tablett, 63TK | N.V. ORGANON | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1062920 | desogestreel+etünüülö stradiool, 0,15mg+0,02mg | G03AA09 | NOVYNETTE, õhukese polümeerikattega tablett, 63TK | Gedeon Richter Plc. | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1062908 | desogestreel+etünüülö stradiool, 0,15mg+0,02mg | G03AA09 | MERCILON, tablett, 63TK | N.V. ORGANON | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1062920 | desogestreel+etünüülö stradiool, 0,15mg+0,02mg | G03AA09 | NOVYNETTE, õhukese polümeerikattega tablett, 63TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1062863 | desogestreel+etünüülö stradiool, 0,15mg+0,03mg | G03AA09 | MARVELON, tablett, 63TK | N.V. ORGANON | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1062931 | desogestreel+etünüülö stradiool, 0,15mg+0,03mg | G03AA09 | REGULON, õhukese polümeerikattega tablett, 63TK | Gedeon Richter Plc. | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1161458 | desogestreel+etünüülö stradiool, 25mcg+40mcg/125mc g+30mcg | G03AB05 | GRACIAL, tablett, 21TK / 45TK | N.V. ORGANON | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1161458 | desogestreel+etünüülö stradiool, 25mcg+40mcg/125mc g+30mcg | G03AB05 | GRACIAL, tablett, 21TK / 45TK | N.V. ORGANON | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1208045 | detemir-insuliin, 100ühik 1ml | A10AE05 | LEVEMIR FLEXPEN, süstelahus pen-süstlis, 3ml 5TK | Novo Nordisk A/S | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

@@ -658,29 +657,29 @@

| | | | | | 50 | | | | | | |

| 1222209 | digoksiin, 0,25mg | C01AA05 | DIGOXIN NYCOMED 0,25 MG, tablett, 60TK | Nycomed Sefa AS | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| 1222197 | digoksiin, 62,5mcg | C01AA05 | DIGOXIN NYCOMED 62,5 MCG, tablett, 60TK | Nycomed Sefa AS | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| 1222197 | digoksiin, 62,5mcg | C01AA05 | DIGOXIN NYCOMED 62,5 MCG, tablett, 60TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| 1361786 | dihüdrokodeiin, 60mg | N02AA08 | DHC CONTINUS, toimeainet prolongeeritult vabastav tablett, 10TK | MUNDIPHARMA Ges.m.b.H. | 50 | | | | | | |

| 1361797 | dihüdrokodeiin, 90mg | N02AA08 | DHC CONTINUS, toimeainet prolongeeritult vabastav tablett, 10TK | MUNDIPHARMA Ges.m.b.H. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1012307 | diklofenak, 100mg | M01AB05 | DICLAC 100 MG, toimeainet prolongeeritult vabastav tablett, 20TK | Sandoz d.d. | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1012307 | diklofenak, 100mg | M01AB05 | DICLAC 100 MG, toimeainet prolongeeritult vabastav tablett, 20TK | Sandoz d.d. | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1016109 | diklofenak, 100mg | M01AB05 | DICLOBERL RETARD, toimeainet prolongeeritult vabastav kõvakapsel, 50TK | Berlin-Chemie AG (Menarini Group) | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| 1016109 | diklofenak, 100mg | M01AB05 | DICLOBERL RETARD, toimeainet prolongeeritult vabastav kõvakapsel, 50TK | Berlin-Chemie AG (Menarini Group) | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1032589 | diklofenak, 100mg | M01AB05 | DICLOMELAN RETARD 100 MG, toimeainet prolongeeritult vabastav tablett, 30TK | G.L. Pharma GmbH | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1032613 | diklofenak, 100mg | M01AB05 | DICLOMELAN, rektaalsuposiit, 6TK | G.L. Pharma GmbH | 75 | M15-M19 | | | 63,00 | | |

| 1032589 | diklofenak, 100mg | M01AB05 | DICLOMELAN RETARD 100 MG, toimeainet prolongeeritult vabastav tablett, 30TK | G.L. Pharma GmbH | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 50 | | | | | | |

| 1032613 | diklofenak, 100mg | M01AB05 | DICLOMELAN, rektaalsuposiit, 6TK | G.L. Pharma GmbH | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| 1078163 | diklofenak, 100mg | M01AB05 | DICLAC 100 MG, toimeainet prolongeeritult vabastav tablett, 50TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

@@ -688,86 +687,86 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1134166 | diklofenak, 100mg | M01AB05 | DICLOBERL RETARD, toimeainet prolongeeritult vabastav kõvakapsel, 20TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| 1134166 | diklofenak, 100mg | M01AB05 | DICLOBERL RETARD, toimeainet prolongeeritult vabastav kõvakapsel, 20TK | Berlin-Chemie AG (Menarini Group) | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 50 | | | | | | |

| 1017133 | diklofenak, 100mg | M01AB05 | DICLOFENAC-RATIOPHARM 100 MG, rektaalsuposiit, 10TK | ratiopharm GmbH | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| 1039632 | diklofenak, 100mg | M01AB05 | OLFEN DEPOCAPS, toimeainet prolongeeritult vabastav kõvakapsel, 20TK | MEPHA Lda. | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| 1040320 | diklofenak, 100mg | M01AB05 | DICLAC 100, rektaalsuposiit, 10TK | Sandoz d.d. | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1072730 | diklofenak, 100mg | M01AB05 | VOLTAREN RETARD, toimeainet prolongeeritult vabastav tablett, 30TK | Novartis Finland OY | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1071920 | diklofenak, 150mg | M01AB05 | DICLAC ID 150 MG, toimeainet modifitseeritult vabastav tablett, 20TK | Sandoz d.d. | 100 | C00-D48 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 50 | | | | | | |

| 1071942 | diklofenak, 150mg | M01AB05 | DICLAC ID 150 MG, toimeainet modifitseeritult vabastav tablett, 100TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| 1017133 | diklofenak, 100mg | M01AB05 | DICLOFENAC-RATIOPHARM 100 MG, rektaalsuposiit, 10TK | ratiopharm GmbH | 100 | C00-D48 | | | | | |

| 1072279 | diklofenak, 150mg | M01AB05 | DICLOFENAC-RATIOPHARM UNO, toimeainet modifitseeritult vabastav tablett, 20TK | ratiopharm GmbH | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 50 | | | | | | |

| 1039632 | diklofenak, 100mg | M01AB05 | OLFEN DEPOCAPS, toimeainet prolongeeritult vabastav kõvakapsel, 20TK | MEPHA Lda. | 50 | | | | | | |

| 1072280 | diklofenak, 150mg | M01AB05 | DICLOFENAC-RATIOPHARM UNO, toimeainet modifitseeritult vabastav tablett, 50TK | ratiopharm GmbH | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1040320 | diklofenak, 100mg | M01AB05 | DICLAC 100, rektaalsuposiit, 10TK | Sandoz d.d. | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 50 | | | | | | |

| 1024715 | diklofenak, 20mg 1g | M02AA15 | ORTOFEN, salv, 30g 1TK | Grindeks | 50 | | | | | | |

| 1032590 | diklofenak, 50mg | M01AB05 | DICLOMELAN 50 MG, gastroresistentne tablett, 10TK | G.L. Pharma GmbH | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1072730 | diklofenak, 100mg | M01AB05 | VOLTAREN RETARD, toimeainet prolongeeritult vabastav tablett, 30TK | Novartis Finland OY | 75 | M15-M19 | | | 63,00 | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1001372 | diklofenak, 50mg | M01AB05 | DICLOFENAC- RATIOPHARM 50MG, gastroresistentne tablett, 20TK | ratiopharm GmbH | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| 1002520 | diklofenak, 50mg | M01AB05 | CATAFLAM, kaetud tablett, 20TK | Novartis Finland OY | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| 1007356 | diklofenak, 50mg | M01AB05 | DICLOFENAC-RATIOPHARM 50MG, rektaalsuposiit, 10TK | ratiopharm GmbH | 100 | C00-D48 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1071920 | diklofenak, 150mg | M01AB05 | DICLAC ID 150 MG, toimeainet modifitseeritult vabastav tablett, 20TK | Sandoz d.d. | 50 | | | | | | |

| 1072213 | diklofenak, 50mg | M01AB05 | DICLOFENAC- RATIOPHARM 50MG, gastroresistentne tablett, 50TK | ratiopharm GmbH | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| 1073999 | diklofenak, 50mg 1g | M02AA15 | DICLAC 5%, geel, 100g 1TK | Sandoz d.d. | 50 | | | | | | |

| 1012048 | diklofenak, 75mg | M01AB05 | OLFEN DEPOTABS, toimeainet prolongeeritult vabastav tablett, 30TK | MEPHA Lda. | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1071964 | diklofenak, 75mg | M01AB05 | DICLAC ID 75 MG, toimeainet modifitseeritult vabastav tablett, 20TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| 1071942 | diklofenak, 150mg | M01AB05 | DICLAC ID 150 MG, toimeainet modifitseeritult vabastav tablett, 100TK | Sandoz d.d. | 75 | M15-M19 | | | 63,00 | | |

| 1071986 | diklofenak, 75mg | M01AB05 | DICLAC ID 75 MG, toimeainet modifitseeritult vabastav tablett, 100TK | Sandoz d.d. | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| 1072279 | diklofenak, 150mg | M01AB05 | DICLOFENAC-RATIOPHARM UNO, toimeainet modifitseeritult vabastav tablett, 20TK | ratiopharm GmbH | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1072280 | diklofenak, 150mg | M01AB05 | DICLOFENAC-RATIOPHARM UNO, toimeainet modifitseeritult vabastav tablett, 50TK | ratiopharm GmbH | 100 | C00-D48 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| 1024715 | diklofenak, 20mg 1g | M02AA15 | ORTOFEN, salv, 30g 1TK | Grindeks | 50 | | | | | | |

| 1032590 | diklofenak, 50mg | M01AB05 | DICLOMELAN 50 MG, gastroresistentne tablett, 10TK | G.L. Pharma GmbH | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1001372 | diklofenak, 50mg | M01AB05 | DICLOFENAC- RATIOPHARM 50MG, gastroresistentne tablett, 20TK | ratiopharm GmbH | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| 1002520 | diklofenak, 50mg | M01AB05 | CATAFLAM, kaetud tablett, 20TK | Novartis Finland OY | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| 1007356 | diklofenak, 50mg | M01AB05 | DICLOFENAC-RATIOPHARM 50MG, rektaalsuposiit, 10TK | ratiopharm GmbH | 100 | C00-D48 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| 1072213 | diklofenak, 50mg | M01AB05 | DICLOFENAC- RATIOPHARM 50MG, gastroresistentne tablett, 50TK | ratiopharm GmbH | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1073999 | diklofenak, 50mg 1g | M02AA15 | DICLAC 5%, geel, 100g 1TK | Sandoz d.d. | 50 | | | | | | |

| 1012048 | diklofenak, 75mg | M01AB05 | OLFEN DEPOTABS, toimeainet prolongeeritult vabastav tablett, 30TK | MEPHA Lda. | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1071964 | diklofenak, 75mg | M01AB05 | DICLAC ID 75 MG, toimeainet modifitseeritult vabastav tablett, 20TK | Sandoz d.d. | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| 1071986 | diklofenak, 75mg | M01AB05 | DICLAC ID 75 MG, toimeainet modifitseeritult vabastav tablett, 100TK | Sandoz d.d. | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| 1088399 | diklofenak+misoprosto ol, 50mg+0,2mg | M01AB80 | ARTHROTEC, gastroresistentne tablett, 60TK | Pfizer Enterprises SARL | 50 | | | | | | |

| 1088399 | diklofenak+ misoprostool, 50mg+0,2mg | M01AB80 | ARTHROTEC, gastroresistentne tablett, 60TK | Pfizer Enterprises SARL | 50 | | | | | | |

| 1014556 | diltiaseem, 180mg | C08DB01 | ALTIAZEM RR, toimeainet prolongeeritult vabastav kõvakapsel, 20TK | Instituto Luso Farmaco d Italia S.p.A. | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| 1031634 | diltiaseem, 180mg | C08DB01 | DILTIAZEM LANNACHER, toimeainet prolongeeritult vabastav tablett, 30TK | LANNACHER HEILMITTEL GmbH | 100 | I27.0-I27.0 | | | | | |

@@ -775,8 +774,8 @@

| 1031645 | diltiaseem, 90mg | C08DB01 | DILTIAZEM LANNACHER, toimeainet prolongeeritult vabastav tablett, 20TK | LANNACHER HEILMITTEL GmbH | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| 1028203 | doksasosiin, 1mg | C02CA04 | CARDURA, tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1028214 | doksasosiin, 2mg | C02CA04 | CARDURA, tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1083585 | doksasosiin, 2mg | C02CA04 | ZOXON 2, tablett, 30TK | Nycomed GmbH | 50 | | | | | | |

| 1028214 | doksasosiin, 2mg | C02CA04 | CARDURA, tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1071391 | doksasosiin, 2mg | C02CA04 | KAMIREN, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1011610 | doksasosiin, 4mg | C02CA04 | ZOXON 4, tablett, 30TK | Nycomed GmbH | 50 | | | | | | |

| 1028225 | doksasosiin, 4mg | C02CA04 | CARDURA, tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

@@ -811,14 +810,14 @@

| 1165711 | drospirenoon+ östradiool, 2mg+1mg | G03FA17 | ANGELIQ, õhukese polümeerikattega tablett, 28TK | Bayer Schering Pharma AG | 50 | | | | | | |

| 1220487 | drospirenoon+etünüülö stradiool, 3mg+0,02mg | G03AA12 | YASMINELLE, õhukese polümeerikattega tablett, 21TK | Bayer Schering Pharma AG | 50 | | | | | | |

| 1316090 | drospirenoon+etünüülö stradiool, 3mg+0,02mg | G03AA12 | YAZ, õhukese polümeerikattega tablett, 28TK | Bayer Schering Pharma AG | 50 | | | | | | |

| 1043536 | drospirenoon+etünüülö stradiool, 3mg+0,03mg | G03AA12 | YARINA, õhukese polümeerikattega tablett, 21TK | Bayer Schering Pharma AG | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1043536 | drospirenoon+etünüülö stradiool, 3mg+0,03mg | G03AA12 | YARINA, õhukese polümeerikattega tablett, 21TK | Bayer Schering Pharma AG | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1062885 | drotaveriin, 40mg | A03AD02 | NO-SPA, tablett, 100TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| 1195624 | duloksetiin, 30mg | N06AX21 | CYMBALTA, gastroresistentne kõvakapsel, 28TK | Eli Lilly Nederland B.V. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1155440 | dutasteriid, 0,5mg | G04CB02 | AVODART, pehmekapsel, 30TK | GlaxoSmithKline Eesti OÜ | 50 | | | | | | |

| 1054752 | düdrogesteroon, 10mg | G03DB01 | DUPHASTON, õhukese polümeerikattega tablett, 20TK | Abbott Healthcare Products B.V. | 50 | | | | | | |

@@ -831,130 +830,130 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1039036 | ekonasool, 50mg | G01AF05 | GYNO-PEVARYL, vaginaalsuposiit, 15TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1395772 | eksemestaan, 25mg | L02BG06 | EXEMESTANE TEVA 25MG, õhukese polümeerikattega tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 100 | C50-C50 | Onkoloog | | | | |

| 1011148 | eksemestaan, 25mg | L02BG06 | AROMASIN, kaetud tablett, 30TK | Pfizer Enterprises SARL | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1395772 | eksemestaan, 25mg | L02BG06 | EXEMESTANE TEVA 25MG, õhukese polümeerikattega tablett, 30TK | Teva Pharma B.V. | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1074215 | enalapriil, 10mg | C09AA02 | RENITEC 10 MG, tablett, 28TK | Merck Sharp & Dohme OÜ | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1010013 | enalapriil, 10mg | C09AA02 | ENALAPRIL-RATIOPHARM 10MG, tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1133929 | enalapriil, 10mg | C09AA02 | ENAP, tablett, 60TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1010013 | enalapriil, 10mg | C09AA02 | ENALAPRIL-RATIOPHARM 10MG, tablett, 30TK | ratiopharm GmbH | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1010620 | enalapriil, 10mg | C09AA02 | ENAHEXAL 10 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1013599 | enalapriil, 10mg | C09AA02 | BERLIPRIL 10 MG, tablett, 30TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1087501 | enalapriil, 10mg | C09AA02 | EDNYT, tablett, 30TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1133929 | enalapriil, 10mg | C09AA02 | ENAP, tablett, 60TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1013599 | enalapriil, 10mg | C09AA02 | BERLIPRIL 10 MG, tablett, 30TK | Berlin-Chemie AG (Menarini Group) | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1087501 | enalapriil, 10mg | C09AA02 | EDNYT, tablett, 30TK | Gedeon Richter Plc. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1359974 | enalapriil, 10mg | C09AA02 | ENALAPRIL VITABALANS, tablett, 30TK | VITABALANS OY | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1074259 | enalapriil, 20mg | C09AA02 | RENITEC FORTE, tablett, 28TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1371080 | enalapriil, 20mg | C09AA02 | RENITEC FORTE, tablett, 98TK | Merck Sharp & Dohme OÜ | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1010024 | enalapriil, 20mg | C09AA02 | ENALAPRIL-RATIOPHARM 20MG, tablett, 30TK | ratiopharm GmbH | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1010631 | enalapriil, 20mg | C09AA02 | ENAHEXAL 20 MG, tablett, 30TK | HEXAL AG | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1013601 | enalapriil, 20mg | C09AA02 | BERLIPRIL 20 MG, tablett, 30TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1087512 | enalapriil, 20mg | C09AA02 | EDNYT, tablett, 30TK | Gedeon Richter Plc. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1074259 | enalapriil, 20mg | C09AA02 | RENITEC FORTE, tablett, 28TK | Merck Sharp & Dohme OÜ | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1133952 | enalapriil, 20mg | C09AA02 | ENAP, tablett, 60TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1371080 | enalapriil, 20mg | C09AA02 | RENITEC FORTE, tablett, 98TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1010024 | enalapriil, 20mg | C09AA02 | ENALAPRIL-RATIOPHARM 20MG, tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1010631 | enalapriil, 20mg | C09AA02 | ENAHEXAL 20 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1013601 | enalapriil, 20mg | C09AA02 | BERLIPRIL 20 MG, tablett, 30TK | Berlin-Chemie AG (Menarini Group) | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1087512 | enalapriil, 20mg | C09AA02 | EDNYT, tablett, 30TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1360033 | enalapriil, 20mg | C09AA02 | ENALAPRIL VITABALANS, tablett, 30TK | VITABALANS OY | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1074226 | enalapriil, 5mg | C09AA02 | RENITEC 5 MG, tablett, 28TK | Merck Sharp & Dohme OÜ | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1010002 | enalapriil, 5mg | C09AA02 | ENALAPRIL-RATIOPHARM 5MG, tablett, 30TK | ratiopharm GmbH | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1010619 | enalapriil, 5mg | C09AA02 | ENAHEXAL 5 MG, tablett, 30TK | HEXAL AG | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1017470 | enalapriil, 5mg | C09AA02 | BERLIPRIL 5 MG, tablett, 30TK | Berlin-Chemie AG (Menarini Group) | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1074226 | enalapriil, 5mg | C09AA02 | RENITEC 5 MG, tablett, 28TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1133895 | enalapriil, 5mg | C09AA02 | ENAP, tablett, 60TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1010002 | enalapriil, 5mg | C09AA02 | ENALAPRIL-RATIOPHARM 5MG, tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1010619 | enalapriil, 5mg | C09AA02 | ENAHEXAL 5 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1017470 | enalapriil, 5mg | C09AA02 | BERLIPRIL 5 MG, tablett, 30TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1074080 | enalapriil, 5mg | C09AA02 | BERLIPRIL 5 MG, tablett, 50TK | Berlin-Chemie AG (Menarini Group) | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1074091 | enalapriil, 5mg | C09AA02 | BERLIPRIL 5 MG, tablett, 100TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1074091 | enalapriil, 5mg | C09AA02 | BERLIPRIL 5 MG, tablett, 100TK | Berlin-Chemie AG (Menarini Group) | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1087499 | enalapriil, 5mg | C09AA02 | EDNYT, tablett, 30TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1133895 | enalapriil, 5mg | C09AA02 | ENAP, tablett, 60TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1359918 | enalapriil, 5mg | C09AA02 | ENALAPRIL VITABALANS, tablett, 30TK | VITABALANS OY | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1129159 | enalapriil+ hüdroklorotiasiid, 20mg+12,5mg | C09BA02 | ENAHEXAL COMP 20 MG/12,5 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1147564 | enalapriil+hüdrokloroti asiid, 10mg+12,5mg | C09BA02 | ENAP-HL, tablett, 30TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1147575 | enalapriil+hüdrokloroti asiid, 10mg+12,5mg | C09BA02 | ENAP-HL, tablett, 60TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1359918 | enalapriil, 5mg | C09AA02 | ENALAPRIL VITABALANS, tablett, 30TK | VITABALANS OY | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1129159 | enalapriil+ hüdroklorotiasiid, 20mg+12,5mg | C09BA02 | ENAHEXAL COMP 20 MG/12,5 MG, tablett, 30TK | HEXAL AG | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1147564 | enalapriil+hüdrokloroti asiid, 10mg+12,5mg | C09BA02 | ENAP-HL, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1147575 | enalapriil+hüdrokloroti asiid, 10mg+12,5mg | C09BA02 | ENAP-HL, tablett, 60TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1074899 | enalapriil+hüdrokloroti asiid, 10mg+25mg | C09BA02 | CO-RENITEC, tablett, 30TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1147597 | enalapriil+hüdrokloroti asiid, 10mg+25mg | C09BA02 | ENAP-H, tablett, 30TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1147609 | enalapriil+hüdrokloroti asiid, 10mg+25mg | C09BA02 | ENAP-H, tablett, 60TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1129160 | enalapriil+hüdrokloroti asiid, 10mg+25mg | C09BA02 | ENAHEXAL COMP 10 MG/25 MG, tablett, 20TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1147597 | enalapriil+hüdrokloroti asiid, 10mg+25mg | C09BA02 | ENAP-H, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1147609 | enalapriil+hüdrokloroti asiid, 10mg+25mg | C09BA02 | ENAP-H, tablett, 60TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1074888 | enalapriil+hüdrokloroti asiid, 20mg+12,5mg | C09BA02 | CO-RENITEC, tablett, 28TK | Merck Sharp & Dohme OÜ | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1151389 | enalapriil+hüdrokloroti asiid, 20mg+12,5mg | C09BA02 | ENAP-HL, tablett, 30TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1074901 | enalapriil+hüdrokloroti asiid, 20mg+6mg | C09BA02 | RENITEC PLUS, tablett, 28TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1151389 | enalapriil+hüdrokloroti asiid, 20mg+12,5mg | C09BA02 | ENAP-HL, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1074901 | enalapriil+hüdrokloroti asiid, 20mg+6mg | C09BA02 | RENITEC PLUS, tablett, 28TK | Merck Sharp & Dohme OÜ | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1081101 | eprosartaan, 600mg | C09CA02 | TEVETEN, õhukese polümeerikattega tablett, 28TK | Abbott Healthcare Products B.V. | 50 | | | | | | |

| 1163720 | erütromütsiin, 10mg 1ml | D10AF02 | AKNEFUG-EL, nahalahus, 50ml 1TK | Dr. August Wolff GmbH & Co. KG Arzneimittel | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1162965 | esetimiib, 10mg | C10AX09 | EZETROL, tablett, 28TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 75 | Z45-Z45, I21-I22, Z95-Z95, E13-E14, I25.2-I25.2, E10-E11 | | | | | kombinatsioonis atorvastatiini või rosuvastatiiniga, kui vaatamata nimetatud ravimi optimaalse annuse kasutamisele on kolesterooli sisaldus veres 4,5 mmol/l |

| | | | | | 50 | | | | | | |

| 1422335 | esetimiib, 10mg | C10AX09 | EZOLETA, tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1087949 | esomeprasool, 20mg | A02BC05 | NEXIUM, gastroresistentne tablett, 14TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1087950 | esomeprasool, 20mg | A02BC05 | NEXIUM, gastroresistentne tablett, 28TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1087972 | esomeprasool, 40mg | A02BC05 | NEXIUM, gastroresistentne tablett, 14TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1087972 | esomeprasool, 40mg | A02BC05 | NEXIUM, gastroresistentne tablett, 14TK | AstraZeneca AB | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1087983 | esomeprasool, 40mg | A02BC05 | NEXIUM, gastroresistentne tablett, 28TK | AstraZeneca AB | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1102521 | estsitalopraam, 10mg | N06AB10 | CIPRALEX, õhukese polümeerikattega tablett, 14TK | H. LUNDBECK A/S | 50 | | | | | | |

| 1102543 | estsitalopraam, 10mg | N06AB10 | CIPRALEX, õhukese polümeerikattega tablett, 28TK | H. LUNDBECK A/S | 50 | | | | | | |

| 1321951 | estsitalopraam, 10mg | N06AB10 | NEPANIL, õhukese polümeerikattega tablett, 28TK | Gedeon Richter Plc. | 50 | | | | | | |

| 1322952 | estsitalopraam, 10mg | N06AB10 | CIRASET 10 MG, õhukese polümeerikattega tablett, 28TK | Sandoz d.d. | 50 | | | | | | |

| 1324471 | estsitalopraam, 10mg | N06AB10 | NORESTAL, õhukese polümeerikattega tablett, 28TK | UAB Norameda | 50 | | | | | | |

| 1331648 | estsitalopraam, 10mg | N06AB10 | ESCITALOPRAM TEVA, õhukese polümeerikattega tablett, 28TK | Teva Pharma B.V. | 50 | | | | | | |

| 1336676 | estsitalopraam, 10mg | N06AB10 | ESLOREX 10 MG, õhukese polümeerikattega tablett, 30TK | Zentiva, k.s. | 50 | | | | | | |

| 1336687 | estsitalopraam, 10mg | N06AB10 | ESLOREX 10 MG, õhukese polümeerikattega tablett, 60TK | Zentiva, k.s. | 50 | | | | | | |

| 1336935 | estsitalopraam, 10mg | N06AB10 | ESCITALOPRAM- RATIOPHARM 10MG, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| 1102521 | estsitalopraam, 10mg | N06AB10 | CIPRALEX, õhukese polümeerikattega tablett, 14TK | H. LUNDBECK A/S | 50 | | | | | | |

| 1102543 | estsitalopraam, 10mg | N06AB10 | CIPRALEX, õhukese polümeerikattega tablett, 28TK | H. LUNDBECK A/S | 50 | | | | | | |

| 1324471 | estsitalopraam, 10mg | N06AB10 | NORESTAL, õhukese polümeerikattega tablett, 28TK | UAB Norameda | 50 | | | | | | |

| 1331648 | estsitalopraam, 10mg | N06AB10 | ESCITALOPRAM TEVA, õhukese polümeerikattega tablett, 28TK | Teva Pharma B.V. | 50 | | | | | | |

| 1400218 | estsitalopraam, 10mg | N06AB10 | ELICEA 10MG, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1102598 | estsitalopraam, 20mg | N06AB10 | CIPRALEX, õhukese polümeerikattega tablett, 28TK | H. LUNDBECK A/S | 50 | | | | | | |

| 1337059 | estsitalopraam, 20mg | N06AB10 | ESCITALOPRAM- RATIOPHARM 20 MG, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| 1324617 | estsitalopraam, 20mg | N06AB10 | NORESTAL, õhukese polümeerikattega tablett, 28TK | UAB Norameda | 50 | | | | | | |

| 1331907 | estsitalopraam, 20mg | N06AB10 | ESCITALOPRAM TEVA, õhukese polümeerikattega tablett, 28TK | Teva Pharma B.V. | 50 | | | | | | |

| 1337059 | estsitalopraam, 20mg | N06AB10 | ESCITALOPRAM- RATIOPHARM 20 MG, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| 1400320 | estsitalopraam, 20mg | N06AB10 | ELICEA 20MG, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1138621 | etonogestreel+etünüül östradiool, 11,7mg+2,7mg | G02BB01 | NUVARING, vaginaalravivahend, 1TK | N.V. Organon | 50 | | | | | | |

| 1036213 | etoposiid, 100mg | L01CB01 | VEPESID, kapsel, 10TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 100 | C00-D48 | Hematoloog, Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1036213 | etoposiid, 100mg | L01CB01 | VEPESID, kapsel, 10TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Onkoloog, Hematoloog | | | | |

| 1085352 | etorikoksiib, 120mg | M01AH05 | ARCOXIA, õhukese polümeerikattega tablett, 14TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| 1127843 | etorikoksiib, 120mg | M01AH05 | ARCOXIA, õhukese polümeerikattega tablett, 7TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| 1085318 | etorikoksiib, 60mg | M01AH05 | ARCOXIA, õhukese polümeerikattega tablett, 14TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

@@ -965,24 +964,24 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1038361 | famotidiin, 20mg | A02BA03 | FAMOSAN, õhukese polümeerikattega tablett, 20TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| 1019708 | felodipiin, 10mg | C08CA02 | PLENDIL, toimeainet prolongeeritult vabastav tablett, 30TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1012330 | felodipiin, 10mg | C08CA02 | PRESID, toimeainet prolongeeritult vabastav tablett, 30TK | TEVA Czech Industries s.r.o. | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1174474 | felodipiin, 10mg | C08CA02 | FELODIPIN HEXAL, toimeainet prolongeeritult vabastav tablett, 30TK | HEXAL AG | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1028135 | felodipiin, 2,5mg | C08CA02 | PLENDIL, toimeainet prolongeeritult vabastav tablett, 30TK | AstraZeneca AB | 50 | | | | | | |

| 1019708 | felodipiin, 10mg | C08CA02 | PLENDIL, toimeainet prolongeeritult vabastav tablett, 30TK | AstraZeneca AB | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1174474 | felodipiin, 10mg | C08CA02 | FELODIPIN HEXAL, toimeainet prolongeeritult vabastav tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1012318 | felodipiin, 2,5mg | C08CA02 | PRESID, toimeainet prolongeeritult vabastav tablett, 30TK | TEVA Czech Industries s.r.o. | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1028135 | felodipiin, 2,5mg | C08CA02 | PLENDIL, toimeainet prolongeeritult vabastav tablett, 30TK | AstraZeneca AB | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1012329 | felodipiin, 5mg | C08CA02 | PRESID, toimeainet prolongeeritult vabastav tablett, 30TK | TEVA Czech Industries s.r.o. | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1019696 | felodipiin, 5mg | C08CA02 | PLENDIL, toimeainet prolongeeritult vabastav tablett, 30TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1012329 | felodipiin, 5mg | C08CA02 | PRESID, toimeainet prolongeeritult vabastav tablett, 30TK | TEVA Czech Industries s.r.o. | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1174373 | felodipiin, 5mg | C08CA02 | FELODIPIN HEXAL, toimeainet prolongeeritult vabastav tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1029495 | fenobarbitaal, 100mg | N03AA02 | PHENAEMAL 0,1, tablett, 50TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| 1029495 | fenobarbitaal, 100mg | N03AA02 | PHENAEMAL 0,1, tablett, 50TK | Desitin Arzneimittel GmbH | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1026593 | fenofibraat, 200mg | C10AB05 | LIPANTHYL, kapsel, 30TK | Laboratoires Fournier S.A. | 50 | | | | | | |

| 1020340 | fenoksümetüülpenitsillii n, 1000000TÜ | J01CE02 | OSPEN, õhukese polümeerikattega tablett, 12TK | Sandoz GmbH | 50 | | | | | | |

| | | | | | 75 | J13-J15 | | | | 16,00 | |

@@ -993,24 +992,24 @@

| | | | | | 75 | J13-J15 | | | | 16,00 | |

| 1105951 | fenoksümetüülpenitsillii n, 400000TÜ 5ml | J01CE02 | OSPEN, suukaudne suspensioon, 60ml 1TK | Sandoz GmbH | 75 | J13-J15 | | | | 16,00 | |

| | | | | | 50 | | | | | | |

| 1020272 | fenoksümetüülpenitsillii n, 500000TÜ | J01CE02 | OSPEN, õhukese polümeerikattega tablett, 12TK | Sandoz GmbH | 50 | | | | | | |

| | | | | | 75 | J13-J15 | | | | 16,00 | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| 1020272 | fenoksümetüülpenitsillii n, 500000TÜ | J01CE02 | OSPEN, õhukese polümeerikattega tablett, 12TK | Sandoz GmbH | 75 | J13-J15 | | | | 16,00 | |

| | | | | | 50 | | | | | | |

| 1044223 | fenoterool, 100mcg 1annust | R03AC04 | BEROTEC N 100 MCG, inhalatsiooniaerosool, lahus, 200annust 1TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1009651 | fenoterool+ipratroopiu mbromiid, 50mcg+20mcg 1annust | R03AK80 | BERODUAL N, inhalatsiooniaerosool, lahus, 200annust 1TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| 1028168 | fentanüül, 100mcg 1h | N02AB03 | DUROGESIC, transdermaalne plaaster, 5TK | Johnson & Johnson UAB | 100 | C00-D48 | | | | | patsientidele, kelle valutustamiseks ei saa kasutada suukaudset morfiini kõrvaltoimete või ravimvormi sobimatuse tõttu või kui suukaudne morfiin ei taga valutustamist |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1223165 | fentanüül, 100mcg 1h | N02AB03 | MATRIFEN, transdermaalne plaaster, 5TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | patsientidele, kelle valutustamiseks ei saa kasutada suukaudset morfiini kõrvaltoimete või ravimvormi sobimatuse tõttu või kui suukaudne morfiin ei taga valutustamist |

| 1223165 | fentanüül, 100mcg 1h | N02AB03 | MATRIFEN, transdermaalne plaaster, 5TK | Nycomed Sefa AS | 100 | C00-D48 | | | | | patsientidele, kelle valutustamiseks ei saa kasutada suukaudset morfiini kõrvaltoimete või ravimvormi sobimatuse tõttu või kui suukaudne morfiin ei taga valutustamist |

| | | | | | 50 | | | | | | |

| 1254754 | fentanüül, 100mcg 1h | N02AB03 | FENTANYL SANDOZ, transdermaalne plaaster, 5TK | Sandoz d.d. | 100 | C00-D48 | | | | | patsientidele, kelle valutustamiseks ei saa kasutada suukaudset morfiini kõrvaltoimete või ravimvormi sobimatuse tõttu või kui suukaudne morfiin ei taga valutustamist |

| | | | | | 50 | | | | | | |

| 1178186 | fentanüül, 12mcg 1h | N02AB03 | DUROGESIC, transdermaalne plaaster, 5TK | Johnson & Johnson UAB | 100 | C00-D48 | | | | | patsientidele, kelle valutustamiseks ei saa kasutada suukaudset morfiini kõrvaltoimete või ravimvormi sobimatuse tõttu või kui suukaudne morfiin ei taga valutustamist |

@@ -1022,8 +1021,8 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1022218 | fentanüül, 25mcg 1h | N02AB03 | DUROGESIC, transdermaalne plaaster, 5TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1223132 | fentanüül, 25mcg 1h | N02AB03 | MATRIFEN, transdermaalne plaaster, 5TK | Nycomed Sefa AS | 50 | | | | | | |

| 1223132 | fentanüül, 25mcg 1h | N02AB03 | MATRIFEN, transdermaalne plaaster, 5TK | Nycomed Sefa AS | 100 | C00-D48 | | | | | patsientidele, kelle valutustamiseks ei saa kasutada suukaudset morfiini kõrvaltoimete või ravimvormi sobimatuse tõttu või kui suukaudne morfiin ei taga valutustamist |

| | | | | | 50 | | | | | | |

| 1254664 | fentanüül, 25mcg 1h | N02AB03 | FENTANYL SANDOZ, transdermaalne plaaster, 5TK | Sandoz d.d. | 100 | C00-D48 | | | | | patsientidele, kelle valutustamiseks ei saa kasutada suukaudset morfiini kõrvaltoimete või ravimvormi sobimatuse tõttu või kui suukaudne morfiin ei taga valutustamist |

| | | | | | 50 | | | | | | |

| 1028146 | fentanüül, 50mcg 1h | N02AB03 | DUROGESIC, transdermaalne plaaster, 5TK | Johnson & Johnson UAB | 100 | C00-D48 | | | | | patsientidele, kelle valutustamiseks ei saa kasutada suukaudset morfiini kõrvaltoimete või ravimvormi sobimatuse tõttu või kui suukaudne morfiin ei taga valutustamist |

@@ -1033,8 +1032,8 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1223143 | fentanüül, 50mcg 1h | N02AB03 | MATRIFEN, transdermaalne plaaster, 5TK | Nycomed Sefa AS | 50 | | | | | | |

| 1254697 | fentanüül, 50mcg 1h | N02AB03 | FENTANYL SANDOZ, transdermaalne plaaster, 5TK | Sandoz d.d. | 50 | | | | | | |

| 1254697 | fentanüül, 50mcg 1h | N02AB03 | FENTANYL SANDOZ, transdermaalne plaaster, 5TK | Sandoz d.d. | 100 | C00-D48 | | | | | patsientidele, kelle valutustamiseks ei saa kasutada suukaudset morfiini kõrvaltoimete või ravimvormi sobimatuse tõttu või kui suukaudne morfiin ei taga valutustamist |

| | | | | | 50 | | | | | | |

| 1129137 | fentanüül, 75mcg 1h | N02AB03 | DUROGESIC, transdermaalne plaaster, 5TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1223154 | fentanüül, 75mcg 1h | N02AB03 | MATRIFEN, transdermaalne plaaster, 5TK | Nycomed Sefa AS | 50 | | | | | | |

@@ -1048,33 +1047,33 @@

| 1013487 | finasteriid, 5mg | G04CB01 | PENESTER, õhukese polümeerikattega tablett, 30TK | Nycomed GmbH | 50 | | | | | | |

| 1346510 | finasteriid, 5mg | G04CB01 | FINASTERIDE PORTFARMA 5MG, õhukese polümeerikattega tablett, 30TK | Portfarma ehf | 50 | | | | | | |

| 1070637 | flekainiid, 100mg | C01BC04 | TAMBOCOR, tablett, 100TK | Meda AB | 50 | | | | | | |

| 1144774 | flukonasool, 100mg | J02AC01 | FLUCONAZOLE SANDOZ 100MG, kapsel, 7TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 100 | B48.8-B48.8, B48.2- B48.2, B37-B37, B44-B44 | | | | | kaasasündinud või omandatud immuunpuudulikkuseg a (pahaloomulise kasvaja raviga, organsiirdamise järgse seisundiga, HIV-tõve või aplastilise aneemiaga) seotud mükoosi raviks ja profülaktikaks |

| | | | | | 50 | | | | | | |

| 1009718 | flukonasool, 150mg | J02AC01 | MYCOSYST 150 MG, kõvakapsel, 1TK | Gedeon Richter Plc. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1395165 | flukonasool, 150mg | J02AC01 | FLUCONAZOLE PORTFARMA, kõvakapsel, 1TK | Portfarma ehf | 50 | | | | | | |

| 1082999 | flukonasool, 150mg | J02AC01 | MYCOSYST 150 MG, kõvakapsel, 2TK | Gedeon Richter Plc. | 50 | | | | | | |

| 1395176 | flukonasool, 150mg | J02AC01 | FLUCONAZOLE PORTFARMA, kõvakapsel, 2TK | Portfarma ehf | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1011733 | flukonasool, 150mg | J02AC01 | MYCOMAX, kõvakapsel, 1TK | Zentiva, k.s. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1140275 | flukonasool, 150mg | J02AC01 | FLUCONAZOL NYCOMED 150MG, kõvakapsel, 1TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1144831 | flukonasool, 150mg | J02AC01 | FLUCONAZOLE SANDOZ 150MG, kapsel, 1TK | Sandoz d.d. | 50 | | | | | | |

@@ -1084,47 +1083,47 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1144842 | flukonasool, 150mg | J02AC01 | FLUCONAZOLE SANDOZ 150MG, kapsel, 2TK | Sandoz d.d. | 50 | | | | | | |

| 1395660 | flukonasool, 50mg | J02AC01 | FLUCONAZOLE PORTFARMA, kõvakapsel, 7TK | Portfarma ehf | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1036932 | flukonasool, 50mg | J02AC01 | DIFLAZON, kõvakapsel, 7TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1144662 | flukonasool, 50mg | J02AC01 | FLUCONAZOLE SANDOZ 50MG, kapsel, 7TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1167971 | fluokortoloon+lidokaiin, 1mg+20mg 1g | C05AA84 | DOLOPROCT 1MG+20MG/G REKTAALKREEM, rektaalkreem, 15g 1TK | Intendis GmbH | 50 | | | | | | |

| 1167948 | fluokortoloon+lidokaiin, 1mg+40mg | C05AA84 | DOLOPROCT 1MG/40MG REKTAALSUPOSIIDID, rektaalsuposiit, 10TK | Intendis GmbH | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1107122 | fluoksetiin, 20mg | N06AB03 | FLUX, kõvakapsel, 28TK | Sandoz d.d. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1006175 | flupentiksool, 20mg 1ml | N05AF01 | FLUANXOL DEPOT, süstelahus, 1ml 1TK | H. LUNDBECK A/S | 50 | | | | | | |

| 1005972 | flupentiksool, 1mg | N05AF01 | FLUANXOL, kaetud tablett, 50TK | H. LUNDBECK A/S | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1107201 | flupirtiin, 100mg | N02BG07 | KATADOLON, kõvakapsel, 10TK | AWD. pharma GmbH & Co.KG | 50 | | | | | | |

| 1115244 | flupirtiin, 100mg | N02BG07 | KATADOLON, kõvakapsel, 30TK | AWD. pharma GmbH & Co.KG | 50 | | | | | | |

| 1115255 | flupirtiin, 100mg | N02BG07 | KATADOLON, kõvakapsel, 50TK | AWD. pharma GmbH & Co.KG | 50 | | | | | | |

| 1007840 | flutikasoon, 100mcg 1annust | R03BA05 | FLIXOTIDE DISKUS 100 MCG, inhalatsioonipulber, 60annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 18,00 | |

| 1007840 | flutikasoon, 100mcg 1annust | R03BA05 | FLIXOTIDE DISKUS 100 MCG, inhalatsioonipulber, 60annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 18,00 | |

| | | | | | 50 | | | | | | |

| 1007884 | flutikasoon, 250mcg 1annust | R03BA05 | FLIXOTIDE DISKUS 250 MCG, inhalatsioonipulber, 60annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 18,00 | |

| | | | | | 50 | | | | | | |

| 1007233 | flutikasoon, 50mcg 1annust | R01AD08 | FLIXONASE AQUEOUS NASAL SPRAY 50 MCG, ninasprei, suspensioon, 120annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| 1007862 | flutikasoon, 50mcg 1annust | R03BA05 | FLIXOTIDE DISKUS 50 MCG, inhalatsioonipulber, 60annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 18,00 | |

| | | | | | 50 | | | | | | |

| 1130690 | flutikasoon, 50mcg 1annust | R03BA05 | FLIXOTIDE INHALER, inhalatsiooniaerosool, suspensioon, 120annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 18,00 | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1007862 | flutikasoon, 50mcg 1annust | R03BA05 | FLIXOTIDE DISKUS 50 MCG, inhalatsioonipulber, 60annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 18,00 | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 18,00 | |

| 1004847 | flutikasoon, 50mcg 1g | D07AC17 | CUTIVATE OINTMENT, salv, 15g 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| 1343034 | flutikasoonfuroaat, 27,5mcg 1annust | R01AD12 | AVAMYS, ninasprei, suspensioon, 120annust 1TK | Glaxo Group Limited | 50 | | | | | | |

@@ -1132,150 +1131,152 @@

| 1011126 | fluvastatiin, 80mg | C10AA04 | LESCOL XL, toimeainet prolongeeritult vabastav tablett, 28TK | Novartis Finland OY | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1287187 | fluvastatiin, 80mg | C10AA04 | FLUVASTATIN ACTAVIS, toimeainet prolongeeritult vabastav tablett, 28TK | Actavis Group PTC ehf | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1287187 | fluvastatiin, 80mg | C10AA04 | FLUVASTATIN ACTAVIS, toimeainet prolongeeritult vabastav tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1039564 | fluvoksamiin, 100mg | N06AB08 | FEVARIN, õhukese polümeerikattega tablett, 30TK | Abbott Healthcare Products B.V. | 50 | | | | | | |

| 1070570 | fluvoksamiin, 50mg | N06AB08 | FEVARIN, õhukese polümeerikattega tablett, 50TK | Abbott Healthcare Products B.V. | 50 | | | | | | |

| 1115503 | fluvoksamiin, 50mg | N06AB08 | FEVARIN, õhukese polümeerikattega tablett, 20TK | Abbott Healthcare Products B.V. | 50 | | | | | | |

| 1087152 | formoterool, 12mcg | R03AC13 | FORADIL AEROLIZER, inhalatsioonipulber kõvakapslis, 60TK | Novartis Finland OY | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1178939 | formoterool, 12mcg 1annust | R03AC13 | DIFFUMAX EASYHALER, inhalatsioonipulber, 120annust 1TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1178939 | formoterool, 12mcg 1annust | R03AC13 | DIFFUMAX EASYHALER, inhalatsioonipulber, 120annust 1TK | Menarini International Operations Luxembourg S.A. | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1034064 | formoterool, 4,5mcg 1annust | R03AC13 | OXIS TURBUHALER, inhalatsioonipulber, 60annust 1TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| 1034075 | formoterool, 9mcg 1annust | R03AC13 | OXIS TURBUHALER, inhalatsioonipulber, 60annust 1TK | AstraZeneca AB | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1314256 | formoterool+beklometa soon, 6mcg+100mcg 1annust | R03AK07 | FOSTER, inhalatsiooniaerosool, lahus, 180annust 1TK | Torrex Chiesi Pharma GmbH | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1068443 | formoterool+budesonii d, 4,5mcg+160mcg 1annust | R03AK83 | SYMBICORT TURBUHALER, inhalatsioonipulber, 120annust 1TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| 1314256 | formoterool+beklometa soon, 6mcg+100mcg 1annust | R03AK07 | FOSTER, inhalatsiooniaerosool, lahus, 180annust 1TK | Torrex Chiesi Pharma GmbH | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| 1068443 | formoterool+budesonii d, 4,5mcg+160mcg 1annust | R03AK83 | SYMBICORT TURBUHALER, inhalatsioonipulber, 120annust 1TK | AstraZeneca AB | 75 | J43-J44 | Pulmonoloog | | | | vastavalt GOLD 2006. a ravijuhisele III-IV staadiumi haigusega patsientidele,kellel on esinenud vähemalt 3 süsteemse glükokortikoidiga ravitud haiguse ägenemist viimase 3 aasta jooksul |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| 1072505 | formoterool+budesonii d, 4,5mcg+80mcg 1annust | R03AK83 | SYMBICORT TURBUHALER, inhalatsioonipulber, 120annust 1TK | AstraZeneca AB | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1156250 | formoterool+budesonii d, 9mcg+320mcg 1annust | R03AK83 | SYMBICORT TURBUHALER, inhalatsioonipulber, 60annust 1TK | AstraZeneca AB | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J43-J44 | Pulmonoloog | | | | vastavalt GOLD 2006. a ravijuhisele III-IV staadiumi haigusega patsientidele,kellel on esinenud vähemalt 3 süsteemse glükokortikoidiga ravitud haiguse ägenemist viimase 3 aasta jooksul |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| 1072505 | formoterool+budesonii d, 4,5mcg+80mcg 1annust | R03AK83 | SYMBICORT TURBUHALER, inhalatsioonipulber, 120annust 1TK | AstraZeneca AB | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1156250 | formoterool+budesonii d, 9mcg+320mcg 1annust | R03AK83 | SYMBICORT TURBUHALER, inhalatsioonipulber, 60annust 1TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| 1193767 | fosinopriil, 10mg | C09AA09 | FOSINOPRIL ACTAVIS, tablett, 28TK | Actavis Nordic A/S | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1027145 | fosinopriil, 10mg | C09AA09 | MONOPRIL, tablett, 28TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1193891 | fosinopriil, 20mg | C09AA09 | FOSINOPRIL ACTAVIS, tablett, 28TK | Actavis Nordic A/S | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1027336 | fosinopriil, 20mg | C09AA09 | MONOPRIL, tablett, 28TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1107021 | fosinopriil+hüdrokloroti asiid, 20mg+12,5mg | C09BA09 | MONOZIDE, tablett, 28TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1193767 | fosinopriil, 10mg | C09AA09 | FOSINOPRIL ACTAVIS, tablett, 28TK | Actavis Nordic A/S | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1027145 | fosinopriil, 10mg | C09AA09 | MONOPRIL, tablett, 28TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1193891 | fosinopriil, 20mg | C09AA09 | FOSINOPRIL ACTAVIS, tablett, 28TK | Actavis Nordic A/S | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1027336 | fosinopriil, 20mg | C09AA09 | MONOPRIL, tablett, 28TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1107021 | fosinopriil+hüdrokloroti asiid, 20mg+12,5mg | C09BA09 | MONOZIDE, tablett, 28TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1250581 | fosinopriil+hüdrokloroti asiid, 20mg+12,5mg | C09BA09 | FOSINOPRIL HCT ACTAVIS, tablett, 30TK | Actavis Group Hf | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1161548 | frovatriptaan, 2,5mg | N02CC07 | MIGARD, õhukese polümeerikattega tablett, 2TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1000258 | furosemiid, 40mg | C03CA01 | FUROSEMID NYCOMED 40 mg, tablett, 20TK | Nycomed Sefa AS | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| 1000258 | furosemiid, 40mg | C03CA01 | FUROSEMID NYCOMED 40 mg, tablett, 20TK | Nycomed Sefa AS | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| 1060399 | furosemiid, 40mg | C03CA01 | FUROSEMID NYCOMED 40 mg, tablett, 100TK | Nycomed Sefa AS | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| 1039362 | furosemiid, 60mg | C03CA01 | LASIX RETARD, toimeainet prolongeeritult vabastav kõvakapsel, 30TK | Sanofi-Aventis Estonia OÜ | 75 | I50-I50 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1060399 | furosemiid, 40mg | C03CA01 | FUROSEMID NYCOMED 40 mg, tablett, 100TK | Nycomed Sefa AS | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1039362 | furosemiid, 60mg | C03CA01 | LASIX RETARD, toimeainet prolongeeritult vabastav kõvakapsel, 30TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| 1212758 | fusafungiin, 0,125mg 1annust | R02AB03 | BIOPAROX, nina- /suuõõnesprei, lahus, 10ml 1TK | Les Laboratoires Servier | 50 | | | | | | |

| 1018606 | fusidiinhape, 10mg 1g | S01AA13 | FUCITHALMIC, silmatilgad, suspensioon, 5g 1TK | Leo Pharmaceutical Products | 50 | | | | | | |

| 1007727 | fusidiinhape, 20mg 1g | D06AX01 | FUCIDIN 20 mg/g salv, salv, 15g 1TK | Leo Pharmaceutical Products | 50 | | | | | | |

| 1007750 | fusidiinhape, 20mg 1g | D06AX01 | FUCIDIN 20 mg/g kreem, kreem, 15g 1TK | Leo Pharmaceutical Products | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1032815 | gabapentiin, 300mg | N03AX12 | NEURONTIN, kõvakapsel, 50TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 75 | G63.2-G63.2 | Endokrinoloog, Neuroloog | esmane | | | kui eelistatud ravi tritsüklilise antidepressandiga on vastunäidustatud, põhjustab ravi katkestama sundivaid kõrvaltoimeid või ei ole vähemasti 3-kuulise kasutamise järel andnud piisavat raviefekti, ravimi esmase väljakirjutamise õigus valuravi arstil |

| | | | | | 75 | G63.2-G63.2 | Neuroloog, Endokrinoloog | esmane | | | kui eelistatud ravi tritsüklilise antidepressandiga on vastunäidustatud, põhjustab ravi katkestama sundivaid kõrvaltoimeid või ei ole vähemasti 3-kuulise kasutamise järel andnud piisavat raviefekti, ravimi esmase väljakirjutamise õigus valuravi arstil |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1328857 | gabapentiin, 300mg | N03AX12 | GABAPENTIN ACTAVIS, kõvakapsel, 50TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1126033 | gabapentiin, 300mg | N03AX12 | GABAGAMMA 300MG, kõvakapsel, 20TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| 1126055 | gabapentiin, 300mg | N03AX12 | GABAGAMMA 300MG, kõvakapsel, 50TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| 1125931 | gabapentiin, 400mg | N03AX12 | GABAGAMMA 400MG, kõvakapsel, 20TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| 1125953 | gabapentiin, 400mg | N03AX12 | GABAGAMMA 400MG, kõvakapsel, 50TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| 1012059 | ganireliks, 0,25mg 0,5ml | H01CC01 | ORGALUTRAN, süstelahus, 0.5ml 1TK | N.V. ORGANON | 50 | | | | | | |

| 1115716 | gestodeen+etünüülöstr adiool, 0,075mg+0,02mg | G03AA10 | LINDYNETTE 20, kaetud tablett, 63TK | Gedeon Richter Plc. | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1035098 | gestodeen+etünüülöstr adiool, 0,075mg+0,02mg | G03AA10 | LOGEST, kaetud tablett, 21TK | Bayer Schering Pharma AG | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1115716 | gestodeen+etünüülöstr adiool, 0,075mg+0,02mg | G03AA10 | LINDYNETTE 20, kaetud tablett, 63TK | Gedeon Richter Plc. | 50 | | | | | | |

| 1115693 | gestodeen+etünüülöstr adiool, 0,075mg+0,03mg | G03AA10 | LINDYNETTE 30, kaetud tablett, 63TK | Gedeon Richter Plc. | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1023624 | gestodeen+etünüülöstr adiool, 0,075mg+0,03mg | G03AA10 | FEMODEN, kaetud tablett, 21TK | Bayer Schering Pharma AG | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1012149 | gestodeen+etünüülöstr adiool, 60mcg+15mcg | G03AA10 | MIRELLE, õhukese polümeerikattega tablett, 28TK | Bayer Schering Pharma AG | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1027718 | gestodeen+etünüülöstr adiool, 75mcg+20mcg | G03AA10 | HARMONET, kaetud tablett, 21TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1115693 | gestodeen+etünüülöstr adiool, 0,075mg+0,03mg | G03AA10 | LINDYNETTE 30, kaetud tablett, 63TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1027718 | gestodeen+etünüülöstr adiool, 75mcg+20mcg | G03AA10 | HARMONET, kaetud tablett, 21TK | Pfizer Europe MA EEIG | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1062953 | gestodeen+etünüülöstr adiool, 75mcg+20mcg | G03AA10 | HARMONET, kaetud tablett, 63TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1364048 | gestodeen+etünüülöstr adiool, 75mcg+20mcg | G03AA10 | GESYTIL 75/20 MIKROGRAMMI, kaetud tablett, 21TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1364048 | gestodeen+etünüülöstr adiool, 75mcg+20mcg | G03AA10 | GESYTIL 75/20 MIKROGRAMMI, kaetud tablett, 21TK | ratiopharm GmbH | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1364105 | gestodeen+etünüülöstr adiool, 75mcg+20mcg | G03AA10 | GESYTIL 75/20 MIKROGRAMMI, kaetud tablett, 63TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1005309 | gestodeen+etünüülöstr adiool, 75mcg+30mcg | G03AA10 | MINULET, kaetud tablett, 21TK | Pfizer Europe MA EEIG | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1062986 | gestodeen+etünüülöstr adiool, 75mcg+30mcg | G03AA10 | MINULET, kaetud tablett, 63TK | Pfizer Europe MA EEIG | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1005309 | gestodeen+etünüülöstr adiool, 75mcg+30mcg | G03AA10 | MINULET, kaetud tablett, 21TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1062986 | gestodeen+etünüülöstr adiool, 75mcg+30mcg | G03AA10 | MINULET, kaetud tablett, 63TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1364127 | gestodeen+etünüülöstr adiool, 75mcg+30mcg | G03AA10 | GESYTIL 75/30 MIKROGRAMMI, kaetud tablett, 21TK | ratiopharm GmbH | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1364138 | gestodeen+etünüülöstr adiool, 75mcg+30mcg | G03AA10 | GESYTIL 75/30 MIKROGRAMMI, kaetud tablett, 63TK | ratiopharm GmbH | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1061334 | glargiin-insuliin, 100ühik 1ml | A10AE04 | LANTUS, süstelahus kolbampullis, 3ml 5TK | Sanofi-Aventis Deutschland GmbH | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1265790 | glargiin-insuliin, 100ühik 1ml | A10AE04 | LANTUS SOLOSTAR, süstelahus pen-süstlis, 3ml 5TK | Sanofi-Aventis Deutschland GmbH | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1241244 | glatirameeratsetaat, 20mg 1ml | L03AX13 | COPAXONE, süstelahus süstlis, 1ml 28TK | Teva Pharmaceuticals Ltd | 50 | | | | | | |

| 1161740 | gliklasiid, 30mg | A10BB09 | DIAPREL MR, toimeainet modifitseeritult vabastav tablett, 60TK | Les Laboratoires Servier | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1364138 | gestodeen+etünüülöstr adiool, 75mcg+30mcg | G03AA10 | GESYTIL 75/30 MIKROGRAMMI, kaetud tablett, 63TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1061334 | glargiin-insuliin, 100ühik 1ml | A10AE04 | LANTUS, süstelahus kolbampullis, 3ml 5TK | Sanofi-Aventis Deutschland GmbH | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1265790 | glargiin-insuliin, 100ühik 1ml | A10AE04 | LANTUS SOLOSTAR, süstelahus pen-süstlis, 3ml 5TK | Sanofi-Aventis Deutschland GmbH | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1161740 | gliklasiid, 30mg | A10BB09 | DIAPREL MR, toimeainet modifitseeritult vabastav tablett, 60TK | Les Laboratoires Servier | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1261066 | gliklasiid, 30mg | A10BB09 | GLICLADA 30 MG, toimeainet modifitseeritult vabastav tablett, 60TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1029439 | gliklasiid, 80mg | A10BB09 | DIABREZIDE, tablett, 40TK | L.Molteni & C.dei F.lli Alitti Societa di Esercizio S.p.A. | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1029439 | gliklasiid, 80mg | A10BB09 | DIABREZIDE, tablett, 40TK | L.Molteni & C.dei F.lli Alitti Societa di Esercizio S.p.A. | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1046405 | gliklasiid, 80mg | A10BB09 | DIAPREL, tablett, 60TK | Les Laboratoires Servier | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1084957 | glimepiriid, 1mg | A10BB12 | AMARYL, tablett, 30TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1176948 | glimepiriid, 1mg | A10BB12 | OLTAR 1MG, tablett, 30TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| 1176948 | glimepiriid, 1mg | A10BB12 | OLTAR 1MG, tablett, 30TK | Berlin-Chemie AG (Menarini Group) | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1191709 | glimepiriid, 2mg | A10BB12 | MEGLIMID, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1191709 | glimepiriid, 2mg | A10BB12 | MEGLIMID, tablett, 30TK | KRKA d.d., Novo Mesto | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1110328 | glimepiriid, 2mg | A10BB12 | AMARYL, tablett, 30TK | Sanofi-Aventis Estonia OÜ | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1177039 | glimepiriid, 2mg | A10BB12 | OLTAR 2 MG, tablett, 30TK | Berlin-Chemie AG (Menarini Group) | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1191787 | glimepiriid, 3mg | A10BB12 | MEGLIMID, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1177039 | glimepiriid, 2mg | A10BB12 | OLTAR 2 MG, tablett, 30TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1110339 | glimepiriid, 3mg | A10BB12 | AMARYL, tablett, 30TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| 1191787 | glimepiriid, 3mg | A10BB12 | MEGLIMID, tablett, 30TK | KRKA d.d., Novo Mesto | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1110339 | glimepiriid, 3mg | A10BB12 | AMARYL, tablett, 30TK | Sanofi-Aventis Estonia OÜ | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1177129 | glimepiriid, 3mg | A10BB12 | OLTAR 3 MG, tablett, 30TK | Berlin-Chemie AG (Menarini Group) | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1191844 | glimepiriid, 4mg | A10BB12 | MEGLIMID, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1177129 | glimepiriid, 3mg | A10BB12 | OLTAR 3 MG, tablett, 30TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| 1125391 | glimepiriid, 4mg | A10BB12 | AMARYL, tablett, 30TK | Sanofi-Aventis Estonia OÜ | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1395121 | glimepiriid, 6mg | A10BB12 | AMARYL, tablett, 30TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1191844 | glimepiriid, 4mg | A10BB12 | MEGLIMID, tablett, 30TK | KRKA d.d., Novo Mesto | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1125391 | glimepiriid, 4mg | A10BB12 | AMARYL, tablett, 30TK | Sanofi-Aventis Estonia OÜ | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1029338 | glipisiid, 10mg | A10BB07 | GLIBENESE GITS, toimeainet prolongeeritult vabastav tablett, 30TK | Pfizer Europe MA EEIG | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1029349 | glipisiid, 5mg | A10BB07 | GLIBENESE GITS, toimeainet prolongeeritult vabastav tablett, 30TK | Pfizer Europe MA EEIG | 75 | E14-E14, E11-E11 | | | | | |

@@ -1284,19 +1285,19 @@

| | | | | | 50 | | | | | | |

| 1294398 | glulisiin-insuliin, 100ühik 1ml | A10AB06 | APIDRA SOLOSTAR, süstelahus pen-süstlis, 3ml 5TK | Sanofi-Aventis Deutschland GmbH | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1316551 | glulisiin-insuliin, 100ühik 1ml | A10AB06 | APIDRA OPTICLIK, süstelahus kolbampullis, 3ml 5TK | Sanofi-Aventis Deutschland GmbH | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1165878 | glükagoon, 1mg | H04AA01 | GLUCAGEN 1MG HYPOKIT, süstelahuse pulber ja lahusti, 1TK | Novo Nordisk A/S | 50 | | | | | | |

| 1326653 | glükoosamiin, 1178mg | M01AX05 | GLUCOSAMIN- RATIOPHARM 1178 MG, suukaudse lahuse pulber, 20TK | ratiopharm GmbH | 50 | | | | | | |

| 1183687 | glükoosamiin, 400mg | M01AX05 | GLUCOSAMINE PHARMA NORD, kõvakapsel, 90TK | PHARMA NORD ApS | 50 | | | | | | |

| 1183698 | glükoosamiin, 400mg | M01AX05 | GLUCOSAMINE PHARMA NORD, kõvakapsel, 270TK | PHARMA NORD ApS | 50 | | | | | | |

| 1137068 | glükoosamiin, 400mg | M01AX05 | GLUCADOL, õhukese polümeerikattega tablett, 60TK | Nycomed Sefa AS | 50 | | | | | | |

| 1220094 | glükoosamiin, 400mg | M01AX05 | GLUCADOL, õhukese polümeerikattega tablett, 180TK | Nycomed Sefa AS | 50 | | | | | | |

| 1002621 | gosereliin, 3,6mg | L02AE03 | ZOLADEX, implantaat, 1TK | AstraZeneca UK Limited | 50 | | | | | | |

| | | | | | 75 | N80-N80 | Günekoloog | | | | III-IV astme endometrioosi põdevatele patsientidele |

| 1002621 | gosereliin, 3,6mg | L02AE03 | ZOLADEX, implantaat, 1TK | AstraZeneca UK Limited | 75 | N80-N80 | Günekoloog | | | | III-IV astme endometrioosi põdevatele patsientidele |

| | | | | | 50 | | | | | | |

| 1023950 | granisetroon, 1mg | A04AA02 | KYTRIL, õhukese polümeerikattega tablett, 10TK | Roche Eesti OÜ | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | suukaudsest keemiaravist põhjustatud iivelduse ja oksendamise profülaktikaks ja raviks juhul, kui metoklopramiid ei ole esmase valikuna soovitatud või see on osutunud ebaefektiivseks |

@@ -1311,15 +1312,15 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1014679 | haloperidool, 5mg | N05AD01 | HALOPERIDOL-RICHTER, tablett, 50TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 100 | F33.2-F33.3, F18.4- F18.7, F60.3-F60.3, F11.4-F11.7, F13.4- F13.7, F14.4-F14.7, F17.4-F17.7, F16.4- F16.7, F19.4-F19.7, F70-F79, F00-F09, F20-F29, F32.2- F33.2, F15.4-F15.7, F30-F31, F12.4- F12.7, F10.4-F10.7 | Psühhiaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1054055 | hõbesulfadiasiin, 10mg 1g | D06BA01 | SULFARGIN, salv, 50g 1TK | Grindeks | 50 | | | | | | |

| 1015434 | hüdroklorotiasiid, 100mg | C03AA03 | HYPOTHIAZID, tablett, 20TK | Sanofi-Aventis Estonia OÜ | 100 | I27.0-I27.0 | | | | | |

| 1015434 | hüdroklorotiasiid, 100mg | C03AA03 | HYPOTHIAZID, tablett, 20TK | Sanofi-Aventis Estonia OÜ | 75 | I15-I15, I10-I13, O10-O16, I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1015478 | hüdroklorotiasiid, 25mg | C03AA03 | HYPOTHIAZID, tablett, 20TK | Sanofi-Aventis Estonia OÜ | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, O10-O16, I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| 1015478 | hüdroklorotiasiid, 25mg | C03AA03 | HYPOTHIAZID, tablett, 20TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, O10-O16, I50-I50 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1030172 | hüdroklorotiasiid+ triamtereen, 12,5mg+25mg | C03EA80 | TRIAMPUR COMPOSITUM, tablett, 50TK | AWD. pharma GmbH & Co.KG | 50 | | | | | | |

| 1008841 | hüdroklorotiasiid+amilo riid, 50mg+5mg | C03EA81 | MODURETIC, tablett, 30TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| 1137013 | hüdrokortisoon, 10mg 1g | D07AA02 | HYDROCORTISONE DAK, salv, 30g 1TK | Nycomed Sefa AS | 50 | | | | | | |

@@ -1329,65 +1330,65 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1035403 | hüdrokortisoon+kloorh eksidiin, 10mg+10mg 1g | D07BA80 | SIBICORT, kreem, 20g 1TK | Orion Corporation | 50 | | | | | | |

| 1036022 | hüdroksükarbamiid, 500mg | L01XX05 | HYDREA, kõvakapsel, 100TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Onkoloog, Hematoloog | | | | |

| 1036022 | hüdroksükarbamiid, 500mg | L01XX05 | HYDREA, kõvakapsel, 100TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 100 | C00-D48 | Hematoloog, Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1213209 | ibandroonhape, 150mg | M05BA06 | BONVIVA, õhukese polümeerikattega tablett, 1TK | Roche Registration Limited | 50 | | | | | | |

| | | | | | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| 1373116 | ibandroonhape, 150mg | M05BA06 | OSSICA, õhukese polümeerikattega tablett, 1TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| 1073012 | ibuprofeen, 400mg | M01AE01 | IBUMAX, õhukese polümeerikattega tablett, 100TK | VITABALANS OY | 50 | | | | | | |

| 1073012 | ibuprofeen, 400mg | M01AE01 | IBUMAX, õhukese polümeerikattega tablett, 100TK | VITABALANS OY | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1073078 | ibuprofeen, 400mg | M01AE01 | IBUMETIN, õhukese polümeerikattega tablett, 50TK | Nycomed Sefa AS | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| 1073089 | ibuprofeen, 400mg | M01AE01 | IBUMETIN, õhukese polümeerikattega tablett, 100TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| 1032714 | ibuprofeen, 600mg | M01AE01 | IBUPROFEN LANNACHER, õhukese polümeerikattega tablett, 30TK | LANNACHER HEILMITTEL GmbH | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1073102 | ibuprofeen, 600mg | M01AE01 | IBUMETIN, õhukese polümeerikattega tablett, 50TK | Nycomed Sefa AS | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 50 | | | | | | |

| 1073113 | ibuprofeen, 600mg | M01AE01 | IBUMETIN, õhukese polümeerikattega tablett, 100TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1073078 | ibuprofeen, 400mg | M01AE01 | IBUMETIN, õhukese polümeerikattega tablett, 50TK | Nycomed Sefa AS | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| 1073089 | ibuprofeen, 400mg | M01AE01 | IBUMETIN, õhukese polümeerikattega tablett, 100TK | Nycomed Sefa AS | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| 1032714 | ibuprofeen, 600mg | M01AE01 | IBUPROFEN LANNACHER, õhukese polümeerikattega tablett, 30TK | LANNACHER HEILMITTEL GmbH | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1085194 | ibuprofeen, 600mg | M01AE01 | IBUMAX, õhukese polümeerikattega tablett, 30TK | VITABALANS OY | 50 | | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1073102 | ibuprofeen, 600mg | M01AE01 | IBUMETIN, õhukese polümeerikattega tablett, 50TK | Nycomed Sefa AS | 50 | | | | | | |

| 1085206 | ibuprofeen, 600mg | M01AE01 | IBUMAX, õhukese polümeerikattega tablett, 100TK | VITABALANS OY | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| 1073113 | ibuprofeen, 600mg | M01AE01 | IBUMETIN, õhukese polümeerikattega tablett, 100TK | Nycomed Sefa AS | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1085194 | ibuprofeen, 600mg | M01AE01 | IBUMAX, õhukese polümeerikattega tablett, 30TK | VITABALANS OY | 100 | C00-D48 | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 50 | | | | | | |

| 1085206 | ibuprofeen, 600mg | M01AE01 | IBUMAX, õhukese polümeerikattega tablett, 100TK | VITABALANS OY | 50 | | | | | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| 1291890 | iloprost, 10mcg 1ml | B01AC11 | VENTAVIS, nebuliseeritav lahus, 1ml 30TK | Bayer Schering Pharma AG | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | Pediaater, Kardioloog, Pulmonoloog, Reumatoloog | | | | NYHA III-IV kl idiopaatilise, süsteemse sidekoehaiguse või kaasasündinud südamerikkega seotud pulmonaalse arteriaalse hüpertensiooni raviks patsientidele konsiiliumi (vähemalt 3 vastava eriala spetsialisti) otsuse alusel, kui sildenafiil on vastunäidustatud, osutunud ebaefektiivseks või põhjustanud olulisi kõrvaltoimeid |

| | | | | | 100 | I27.0-I27.0 | Kardioloog, Reumatoloog, Pediaater, Pulmonoloog | | | | NYHA III-IV kl idiopaatilise, süsteemse sidekoehaiguse või kaasasündinud südamerikkega seotud pulmonaalse arteriaalse hüpertensiooni raviks patsientidele konsiiliumi (vähemalt 3 vastava eriala spetsialisti) otsuse alusel, kui sildenafiil on vastunäidustatud, osutunud ebaefektiivseks või põhjustanud olulisi kõrvaltoimeid |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1291902 | iloprost, 1Omcg 1ml | B01AC11 | VENTAVIS, nebuliseeritav lahus, 1ml 168TK | Bayer Schering Pharma AG | 50 | | | | | | |

| | | | | | 100 | 127.0-1 27.0 | Pediaater, Reumatoloog, Kardioloog, Pulmonoloog | | | | NYHA III-IV kl idiopaat ilise, susteemse sidek oehaiguse voi kaasasundinud sudamerikkega seotud pulmonaalse arteriaalse hupertensiooni raviks patsient idele kon siiliumi (vahemalt 3 vastava eriala spetsialisti) otsuse alusel, kui sildenafiil on vastunaidustatud, osutunud ebaefektiivseks voi pohjustanud olulisi korvaltoimeid |

| | | | | | 100 | 127.0-1 27.0 | Pulmonoloog, Reumatoloog, Kardioloog, Pediaater | | | | NYHA III-IV kl idiopaat ilise, susteemse sidek oehaiguse voi kaasasundinud sudamerikkega seotud pulmonaalse arteriaalse hupertensiooni raviks patsient idele kon siiliumi (vahemalt 3 vastava eriala spetsialisti) otsuse alusel, kui sildenafiil on vastunaidustatud, osutunud ebaefektiivseks voi pohjustanud olulisi korvaltoimeid |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1085712 | imatiniib, 100mg | L01XE01 | GLIVEC, kõvakapsel, 120TK | Novartis Europharm Limited | 50 | | | | | | |

| | | | | | 100 | C49.9-C49.9, C16- C20 | Onkoloog | | | | patsientidele, kellel ravi alustamine ja jätkamine imatiniibiga on hinnatud konsiiliumi (vähemalt 3 onkoloogi) poolt vastavaks järgmistele kriteeriumidele:diagno ositud KIT-positiivne mitteopereeritav või metastaseerunud pahaloomuline gastrointestinaalne stromaaltruumor ning mitte enam kui 3 ravikuu möödumisel on saavutatud täielik või osaline ravivastus või haigus püsib stabiilsena |

| | | | | | 100 | C92.1-C92.1 | Hematoloog | | | | patsiendile, kelle ravi alustamine ja jätkamine imatiniibiga on hinnatud konsiiliumi (vähemalt kolme hematoloogi) poolt vastavaks Eesti Hematoloogide Seltsi, Sotsiaalministeeriumi ja Eesti Haigekassa poolt tunnustatud ravijuhisele, soodustus ei laiene patsientidele, kelle ravi imatiniibiga on ravimitootja vastutusel alustatud ja tagatud enne 1.07.2006. a. |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

@@ -1398,7 +1399,7 @@

| 7002313 | imikute toitesegu, | | MILUPA APTAMIL FMS, pulber, 200 g | N.V. Nutricia | 75 | P05-P05, E42-E42, P07-P07, P27.1- P27.1 | | | | 0,58 | |

| 7002650 | imikute toitesegu, | | APTAMIL PREMATIL, pulber, 600g N1 | N.V. Nutricia | 75 | P05-P05, E42-E42, P07-P07, P27.1- P27.1 | | | | 0,58 | |

| 7002863 | imikute toitesegu, | | FRISO PEP AC, pulber, 400g | Friesland Foods BV | 75 | K52.2-K52.2, L20.8- L20.8, K90.4-K90.4, L27.2-L27.2 | | | | 1,00 | |

| 7002874 | imikute toitesegu, | | FRISO PREMATURE, pulber, 400g | Friesland Foods BV | 75 | P05.0-P05.0, E42- E42, P07.0-P07.0, P27.1-P27.1 | | | | 0,58 | |

| 7002874 | imikute toitesegu, | | FRISO PREMATURE, pulber, 400g | Friesland Foods BV | 75 | P05-P05, E42-E42, P07-P07, P27.1- P27.1 | | | | 0,58 | |

| 7002885 | imikute toitesegu, | | FRISO PEP, pulber, 400g | Friesland Foods BV | 75 | K52.2-K52.2, L20.8- L20.8, K90.4-K90.4, L27.2-L27.2 | | | | 1,00 | |

| 1060322 | imikvimood, 5% | D06BB10 | ALDARA, kreem, 250mg 12TK | Meda AB | 50 | | | | | | |

@@ -1408,65 +1409,65 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1167780 | indapamiid, 1,5mg | C03BA11 | TERTENSIF SR, toimeainet prolongeeritult vabastav tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| 1167780 | indapamiid, 1,5mg | C03BA11 | TERTENSIF SR, toimeainet prolongeeritult vabastav tablett, 30TK | Les Laboratoires Servier | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, O10-O16, I50-I50 | | | | | |

| 1185230 | indapamiid, 1,5mg | C03BA11 | RAWEL SR, toimeainet prolongeeritult vabastav tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, O10-O16, I50-I50 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I15-I15, I10-I13, O10-O16, I50-I50 | | | | | |

| 1185230 | indapamiid, 1,5mg | C03BA11 | RAWEL SR, toimeainet prolongeeritult vabastav tablett, 30TK | KRKA d.d., Novo Mesto | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, O10-O16, I50-I50 | | | | | |

| 1379741 | indapamiid, 1,5mg | C03BA11 | INDAMAX, toimeainet prolongeeritult vabastav tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, O10-O16, I50-I50 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1038383 | indapamiid, 2,5mg | C03BA11 | PROINDAP, kõvakapsel, 30TK | PRO. MED. CS. PRAHA a.s. | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I15-I15, I10-I13, O10-O16, I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| 1019416 | indapamiid, 2,5mg | C03BA11 | TERTENSIF, õhukese polümeerikattega tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| 1038383 | indapamiid, 2,5mg | C03BA11 | PROINDAP, kõvakapsel, 30TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I15-I15, I10-I13, O10-O16, I50-I50 | | | | | |

| 1019416 | indapamiid, 2,5mg | C03BA11 | TERTENSIF, õhukese polümeerikattega tablett, 30TK | Les Laboratoires Servier | 75 | I15-I15, I10-I13, O10-O16, I50-I50 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| 1001697 | indometatsiin, 10mg 1g | M02AA23 | INDOMET-RATIOPHARM GEL, geel, 50g 1TK | ratiopharm GmbH | 50 | | | | | | |

| 1071841 | indometatsiin, 50mg | M01AB01 | INDOMET- RATIOPHARM 50MG, kõvakapsel, 50TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1071841 | indometatsiin, 50mg | M01AB01 | INDOMET- RATIOPHARM 50MG, kõvakapsel, 50TK | ratiopharm GmbH | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| | | | | | 75 | M30-M33, M05- M08, M35-M35, M45-M46 | | | | | |

| | | | | | 75 | M15-M19 | | | 63,00 | | |

| 1029204 | indometatsiin, 8mg 1ml | M02AA23 | ELMETACIN SPRAY, nahasprei, lahus, 50ml 1TK | UAB ''STADA- Nizhpharm-Baltija'' | 50 | | | | | | |

| 1105940 | ipratroopiumbromiid, 0,02mg 1annust | R03BB01 | ATROVENT N, inhalatsiooniaerosool, lahus, 200annust 1TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1057711 | ipratroopiumbromiid, 0,25mg 1ml | R03BB01 | ATROVENT, nebuliseeritav lahus, 20ml 1TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1060467 | irbesartaan, 150mg | C09CA04 | APROVEL, tablett, 28TK | Sanofi Pharma Bristol- Myers Squibb SNC | 50 | | | | | | |

| 1060490 | irbesartaan, 300mg | C09CA04 | APROVEL, tablett, 28TK | Sanofi Pharma Bristol- Myers Squibb SNC | 50 | | | | | | |

| 1000348 | isokonasool, 10mg 1g | D01AC05 | TRAVOGEN, kreem, 20g 1TK | Intendis GmbH | 50 | | | | | | |

| 1000416 | isokonasool+ diflukortoloon, 10mg+1mg 1g | D01AC80 | TRAVOCORT, kreem, 15g 1TK | Intendis GmbH | 50 | | | | | | |

| 1037371 | isosorbiitdinitraat, 20mg | C01DA08 | ISOKET 20, toimeainet prolongeeritult vabastav tablett, 50TK | SCHWARZ PHARMA AG | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1015074 | isosorbiitdinitraat, 20mg | C01DA08 | ISDN-RATIOPHARM 20 MG, toimeainet prolongeeritult vabastav kõvakapsel, 50TK | ratiopharm GmbH | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1037382 | isosorbiitdinitraat, 40mg | C01DA08 | ISOKET 40, toimeainet prolongeeritult vabastav tablett, 50TK | SCHWARZ PHARMA AG | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1015074 | isosorbiitdinitraat, 20mg | C01DA08 | ISDN-RATIOPHARM 20 MG, toimeainet prolongeeritult vabastav kõvakapsel, 50TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1037382 | isosorbiitdinitraat, 40mg | C01DA08 | ISOKET 40, toimeainet prolongeeritult vabastav tablett, 50TK | SCHWARZ PHARMA AG | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1008964 | isosorbiitdinitraat, 40mg | C01DA08 | ISDN-RATIOPHARM 40 MG, toimeainet prolongeeritult vabastav kõvakapsel, 50TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1005028 | isosorbiitdinitraat, 5mg | C01DA08 | ISDN-RATIOPHARM 5 MG, tablett, 50TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1003712 | isosorbiitmononitraat, 100mg | C01DA14 | MONO MACK DEPOT, toimeainet prolongeeritult vabastav tablett, 20TK | Pfizer Europe MA EEIG | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1037416 | isosorbiitmononitraat, 20mg | C01DA14 | ELANTAN, tablett, 50TK | UCB Pharma GmbH | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1006197 | isosorbiitmononitraat, 20mg | C01DA14 | MONO MACK 20 MG, tablett, 50TK | Pfizer Europe MA EEIG | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1043547 | isosorbiitmononitraat, 20mg | C01DA14 | MONOSAN 20 MG, tablett, 30TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| 1003712 | isosorbiitmononitraat, 100mg | C01DA14 | MONO MACK DEPOT, toimeainet prolongeeritult vabastav tablett, 20TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1037416 | isosorbiitmononitraat, 20mg | C01DA14 | ELANTAN, tablett, 50TK | UCB Pharma GmbH | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1006197 | isosorbiitmononitraat, 20mg | C01DA14 | MONO MACK 20 MG, tablett, 50TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1043547 | isosorbiitmononitraat, 20mg | C01DA14 | MONOSAN 20 MG, tablett, 30TK | PRO. MED. CS. PRAHA a.s. | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1146361 | isosorbiitmononitraat, 20mg | C01DA14 | ISOSORBIDE MONONITRATE VITABALANS, tablett, 30TK | VITABALANS OY | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1146372 | isosorbiitmononitraat, 20mg | C01DA14 | ISOSORBIDE MONONITRATE VITABALANS, tablett, 100TK | VITABALANS OY | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1146372 | isosorbiitmononitraat, 20mg | C01DA14 | ISOSORBIDE MONONITRATE VITABALANS, tablett, 100TK | VITABALANS OY | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1037405 | isosorbiitmononitraat, 40mg | C01DA14 | ELANTAN, tablett, 50TK | UCB Pharma GmbH | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1006221 | isosorbiitmononitraat, 40mg | C01DA14 | MONO MACK 40 MG, tablett, 50TK | Pfizer Europe MA EEIG | 75 | I20-I20 | | | | | |

@@ -1475,18 +1476,18 @@

| | | | | | 50 | | | | | | |

| 1101913 | isosorbiitmononitraat, 40mg | C01DA14 | OLICARD 40 MG, toimeainet prolongeeritult vabastav kõvakapsel, 50TK | Abbott Products GmbH | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1127573 | isosorbiitmononitraat, 40mg | C01DA14 | ISOMONIT 40 MG, tablett, 100TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1037427 | isosorbiitmononitraat, 50mg | C01DA14 | ELANTAN LONG, toimeainet modifitseeritult vabastav kõvakapsel, 20TK | UCB Pharma GmbH | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1127573 | isosorbiitmononitraat, 40mg | C01DA14 | ISOMONIT 40 MG, tablett, 100TK | HEXAL AG | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1037427 | isosorbiitmononitraat, 50mg | C01DA14 | ELANTAN LONG, toimeainet modifitseeritult vabastav kõvakapsel, 20TK | UCB Pharma GmbH | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1046786 | isosorbiitmononitraat, 60mg | C01DA14 | IMDUR, toimeainet prolongeeritult vabastav tablett, 30TK | AstraZeneca AB | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1101924 | isosorbiitmononitraat, 60mg | C01DA14 | OLICARD 60 MG, toimeainet prolongeeritult vabastav kõvakapsel, 50TK | Abbott Products GmbH | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1127584 | isosorbiitmononitraat, 60mg | C01DA14 | ISOMONIT 60 MG, toimeainet modifitseeritult vabastav tablett, 30TK | HEXAL AG | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1252741 | isosorbiitmononitraat, 60mg | C01DA14 | ISOMONIT 60 MG, toimeainet modifitseeritult vabastav tablett, 60TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I20-I20 | | | | | |

| 1252741 | isosorbiitmononitraat, 60mg | C01DA14 | ISOMONIT 60 MG, toimeainet modifitseeritult vabastav tablett, 60TK | HEXAL AG | 75 | I20-I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1004364 | isotretinoiin, 10mg | D10BA01 | ROACCUTANE 10 MG, pehmekapsel, 30TK | Roche Eesti OÜ | 75 | L70.1-L70.2 | Dermatoveneroloog | | | | |

| | | | | | 50 | | | | | | |

| 1112230 | isotretinoiin, 20mg | D10BA01 | ROACCUTANE 20 MG, pehmekapsel, 30TK | Roche Eesti OÜ | 75 | L70.1-L70.2 | Dermatoveneroloog | | | | |

@@ -1494,59 +1495,59 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1071548 | itrakonasool, 100mg | J02AC02 | ORUNGAL, kõvakapsel, 28TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1164035 | itrakonasool, 100mg | J02AC02 | PROKANAZOL, kõvakapsel, 4TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| 1164057 | itrakonasool, 100mg | J02AC02 | PROKANAZOL, kõvakapsel, 28TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1230488 | itrakonasool, 100mg | J02AC02 | ITRACONAZOL ACTAVIS, kõvakapsel, 28TK | Actavis Group Hf | 50 | | | | | | |

| 1219553 | ivabradiin, 5mg | C01EB17 | PROCORALAN, õhukese polümeerikattega tablett, 56TK | Les Laboratoires Servier | 50 | | | | | | |

| 1219485 | ivabradiin, 7,5mg | C01EB17 | PROCORALAN, õhukese polümeerikattega tablett, 56TK | Les Laboratoires Servier | 50 | | | | | | |

| 1018549 | kaltsipotriool, 50mcg 1g | D05AX02 | DAIVONEX, kreem, 30g 1TK | Leo Pharmaceutical Products | 50 | | | | | | |

| 1018549 | kaltsipotriool, 50mcg 1g | D05AX02 | DAIVONEX, kreem, 30g 1TK | Leo Pharmaceutical Products | 75 | L40-L40 | Dermatoveneroloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1018550 | kaltsipotriool, 50mcg 1ml | D05AX02 | DAIVONEX, nahalahus, 60ml 1TK | Leo Pharmaceutical Products | 50 | | | | | | |

| | | | | | 75 | L40-L40 | Dermatoveneroloog, Pediaater | esmane | | | |

| 1093340 | kaltsipotriool+beetamet asoon, 50mcg+0,5mg 1g | D05AX80 | DAIVOBET, salv, 30g 1TK | Leo Pharmaceutical Products | 75 | L40-L40 | Pediaater, Dermatoveneroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1408036 | kaltsipotriool+beetamet asoon, 50mcg+0,5mg 1g | D05AX80 | XAMIOL, geel, 30g 1TK | LEO Pharmaceutical Products Ltd. A/S | 50 | | | | | | |

| | | | | | 75 | L40-L40 | Pediaater, Dermatoveneroloog | esmane | | | |

| 1018550 | kaltsipotriool, 50mcg 1ml | D05AX02 | DAIVONEX, nahalahus, 60ml 1TK | Leo Pharmaceutical Products | 75 | L40-L40 | Pediaater, Dermatoveneroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1093340 | kaltsipotriool+beetamet asoon, 50mcg+0,5mg 1g | D05AX80 | DAIVOBET, salv, 30g 1TK | Leo Pharmaceutical Products | 50 | | | | | | |

| | | | | | 75 | L40-L40 | Dermatoveneroloog, Pediaater | esmane | | | |

| 1408036 | kaltsipotriool+beetamet asoon, 50mcg+0,5mg 1g | D05AX80 | XAMIOL, geel, 30g 1TK | LEO Pharmaceutical Products Ltd. A/S | 75 | L40-L40 | Pediaater, Dermatoveneroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1004599 | kaltsitriool, 0,25mcg | A11CC04 | ROCALTROL, pehmekapsel, 30TK | Roche Eesti OÜ | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1392016 | kaltsium+kolekaltsifero ol, 500mg+400TÜ | A12AX80 | CALCIGRAN FORTE, närimistablett, 120TK | Nycomed Sefa AS | 100 | N18-N18 | | | | | |

| | | | | | 75 | M80-M80 | | | | | kombinatsioonis bifosfonaadiga patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| 1044481 | kaltsiumatsetaat, 250mg | A12AA12 | PHOS-EX 250 MG, tablett, 180TK | Medans OY | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1392016 | kaltsium+kolekaltsifero ol, 500mg+400TÜ | A12AX80 | CALCIGRAN FORTE, närimistablett, 120TK | Nycomed Sefa AS | 75 | M80-M80 | | | | | kombinatsioonis bifosfonaadiga patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| | | | | | 100 | N18-N18 | | | | | |

| 1044481 | kaltsiumatsetaat, 250mg | A12AA12 | PHOS-EX 250 MG, tablett, 180TK | Medans OY | 100 | N18-N18 | | | | | |

| | | | | | 50 | | | | | | |

| 1046337 | kaltsiumkarbonaat, 1250mg | A12AA04 | CALCIGRAN SINE, närimistablett, 100TK | Nycomed Sefa AS | 100 | N18-N18 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | N18-N18 | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| 1065664 | kaltsiumnadropariin, 3800RÜ anti Xa 0.4ml | B01AB06 | FRAXIPARINE, süstelahus süstlis, 0.4ml 10TK | Glaxo Group Ltd | 50 | | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1124110 | kaltsiumnadropariin, 5700RÜ anti Xa 0.6ml | B01AB06 | FRAXIPARINE, süstelahus süstlis, 0.6ml 10TK | Glaxo Group Ltd | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| 1035908 | kandesartaan, 16mg | C09CA06 | ATACAND, tablett, 28TK | AstraZeneca AB | 50 | | | | | | |

| 1183867 | kandesartaan, 32mg | C09CA06 | ATACAND, tablett, 28TK | AstraZeneca AB | 50 | | | | | | |

| 1132591 | kandesartaan+hüdrokl orotiasiid, 16mg+12,5mg | C09DA06 | ATACAND PLUS, tablett, 28TK | AstraZeneca AB | 50 | | | | | | |

@@ -1561,53 +1562,53 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1023084 | kaptopriil, 50mg | C09AA01 | KAPTOPRIL KRKA, tablett, 20TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1077117 | karbamasepiin, 150mg | N03AF01 | TIMONIL 150 RETARD, toimeainet prolongeeritult vabastav tablett, 100TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| 1077117 | karbamasepiin, 150mg | N03AF01 | TIMONIL 150 RETARD, toimeainet prolongeeritult vabastav tablett, 100TK | Desitin Arzneimittel GmbH | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| | | | | | 50 | | | | | | |

| 1042311 | karbamasepiin, 200mg | N03AF01 | CARBALEX 200 MG, tablett, 50TK | G.L. Pharma GmbH | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | F18.4-F18.4, F14.4- F14.4, F33.2-F33.3, F00-F09, F32.2- F32.3, F10.4-F10.4, F19.4-F19.4, F11.4- F11.4, F30-F31, F70-F79, F20-F29, F60.3-F60.3, F17.4- F17.4, F13.4-F13.4, F15.4-F15.4, F12.4- F12.4, F16.4-F16.4 | Psühhiaater | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1008009 | karbamasepiin, 200mg | N03AF01 | TEGRETOL CR, toimeainet prolongeeritult vabastav tablett, 50TK | Novartis Finland OY | 75 | G50.0-G50.0 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1035942 | karbamasepiin, 200mg | N03AF01 | FINLEPSIN, toimeainet modifitseeritult vabastav tablett, 50TK | AWD. pharma GmbH & Co.KG | 100 | G40-G40 | Neuroloog | esmane | | | |

| 1008649 | karbamasepiin, 200mg | N03AF01 | CARBAMAZEPINE NYCOMED, tablett, 50TK | Nycomed Sefa AS | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| 1036055 | karbamasepiin, 200mg | N03AF01 | FINLEPSIN, tablett, 50TK | AWD. pharma GmbH & Co.KG | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1035942 | karbamasepiin, 200mg | N03AF01 | FINLEPSIN, toimeainet modifitseeritult vabastav tablett, 50TK | AWD. pharma GmbH & Co.KG | 50 | | | | | | |

| 1115592 | karbamasepiin, 300mg | N03AF01 | CARBALEX RETARD 300 MG, toimeainet prolongeeritult vabastav tablett, 50TK | G.L. Pharma GmbH | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| 1036055 | karbamasepiin, 200mg | N03AF01 | FINLEPSIN, tablett, 50TK | AWD. pharma GmbH & Co.KG | 75 | G50.0-G50.0 | | | | | |

| | | | | | 100 | F18.4-F18.7, F33.2- F33.3, F70-F79, F00-F09, F15.4- F15.7, F14.4-F14.7, F12.4-F12.7, F30- F31, F11.4-F11.7, F60.3-F60.3, F10.4- F10.7, F16.4-F16.7, F32.2-F32.3, F13.4- F13.7, F20-F29, F19.4-F19.7 | Psühhiaater | esmane | | | |

| 1077207 | karbamasepiin, 300mg | N03AF01 | TIMONIL 300 RETARD, toimeainet prolongeeritult vabastav tablett, 100TK | Desitin Arzneimittel GmbH | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1115592 | karbamasepiin, 300mg | N03AF01 | CARBALEX RETARD 300 MG, toimeainet prolongeeritult vabastav tablett, 50TK | G.L. Pharma GmbH | 75 | G50.0-G50.0 | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1042322 | karbamasepiin, 400mg | N03AF01 | CARBALEX 400 MG, tablett, 50TK | G.L. Pharma GmbH | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1042322 | karbamasepiin, 400mg | N03AF01 | CARBALEX 400 MG, tablett, 50TK | G.L. Pharma GmbH | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| | | | | | 50 | | | | | | |

| 1009358 | karbamasepiin, 400mg | N03AF01 | TEGRETOL CR, toimeainet prolongeeritult vabastav tablett, 30TK | Novartis Finland OY | 75 | G50.0-G50.0 | | | | | |

@@ -1616,68 +1617,68 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1035953 | karbamasepiin, 400mg | N03AF01 | FINLEPSIN, toimeainet modifitseeritult vabastav tablett, 50TK | AWD. pharma GmbH & Co.KG | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| | | | | | 50 | | | | | | |

| 1042333 | karbamasepiin, 600mg | N03AF01 | CARBALEX RETARD 600 MG, toimeainet prolongeeritult vabastav tablett, 50TK | G.L. Pharma GmbH | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1007716 | karbamasepiin, 600mg | N03AF01 | TIMONIL 600 RETARD, toimeainet prolongeeritult vabastav tablett, 50TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 75 | G50.0-G50.0 | | | | | |

| 1175846 | karvedilool, 12,5mg | C07AG02 | CARVETREND 12,50 MG, tablett, 30TK | Teva Pharma B.V. | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1110564 | karvedilool, 12,5mg | C07AG02 | CARVEDILOLHEXAL 12,5 MG, tablett, 30TK | HEXAL AG | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1157543 | karvedilool, 12,5mg | C07AG02 | CORYOL 12,5, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1110564 | karvedilool, 12,5mg | C07AG02 | CARVEDILOLHEXAL 12,5 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| 1167016 | karvedilool, 12,5mg | C07AG02 | CARVEDILOL GENERICON 12,5 MG, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| 1157543 | karvedilool, 12,5mg | C07AG02 | CORYOL 12,5, tablett, 30TK | KRKA d.d., Novo Mesto | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1175846 | karvedilool, 12,5mg | C07AG02 | CARVETREND 12,50 MG, tablett, 30TK | Teva Pharma B.V. | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1167016 | karvedilool, 12,5mg | C07AG02 | CARVEDILOL GENERICON 12,5 MG, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1318733 | karvedilool, 12,5mg | C07AG02 | AVEDOL, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| 1175880 | karvedilool, 25mg | C07AG02 | CARVETREND 25 MG, tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| 1029158 | karvedilool, 25mg | C07AG02 | DILATREND, tablett, 30TK | Roche Eesti OÜ | 50 | | | | | | |

| 1110520 | karvedilool, 25mg | C07AG02 | CARVEDILOLHEXAL 25 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1157644 | karvedilool, 25mg | C07AG02 | CORYOL 25, tablett, 30TK | KRKA d.d., Novo Mesto | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1175880 | karvedilool, 25mg | C07AG02 | CARVETREND 25 MG, tablett, 30TK | Teva Pharma B.V. | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1167094 | karvedilool, 25mg | C07AG02 | CARVEDILOL GENERICON 25 MG, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1318755 | karvedilool, 25mg | C07AG02 | AVEDOL, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| 1029158 | karvedilool, 25mg | C07AG02 | DILATREND, tablett, 30TK | Roche Eesti OÜ | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1110520 | karvedilool, 25mg | C07AG02 | CARVEDILOLHEXAL 25 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| 1157644 | karvedilool, 25mg | C07AG02 | CORYOL 25, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| 1167094 | karvedilool, 25mg | C07AG02 | CARVEDILOL GENERICON 25 MG, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 50 | | | | | | |

| 1029170 | karvedilool, 6,25mg | C07AG02 | DILATREND, tablett, 30TK | Roche Eesti OÜ | 50 | | | | | | |

| 1110609 | karvedilool, 6,25mg | C07AG02 | CARVEDILOLHEXAL 6,25 MG, tablett, 30TK | HEXAL AG | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1157442 | karvedilool, 6,25mg | C07AG02 | CORYOL 6,25, tablett, 30TK | KRKA d.d., Novo Mesto | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1166936 | karvedilool, 6,25mg | C07AG02 | CARVEDILOL GENERICON 6,25 MG, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1175790 | karvedilool, 6,25mg | C07AG02 | CARVETREND 6,25 MG, tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| 1318755 | karvedilool, 25mg | C07AG02 | AVEDOL, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1029170 | karvedilool, 6,25mg | C07AG02 | DILATREND, tablett, 30TK | Roche Eesti OÜ | 50 | | | | | | |

| 1175790 | karvedilool, 6,25mg | C07AG02 | CARVETREND 6,25 MG, tablett, 30TK | Teva Pharma B.V. | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1110609 | karvedilool, 6,25mg | C07AG02 | CARVEDILOLHEXAL 6,25 MG, tablett, 30TK | HEXAL AG | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1157442 | karvedilool, 6,25mg | C07AG02 | CORYOL 6,25, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| 1166936 | karvedilool, 6,25mg | C07AG02 | CARVEDILOL GENERICON 6,25 MG, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| 1318711 | karvedilool, 6,25mg | C07AG02 | AVEDOL, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| 1112342 | keskmise toimeajaga humaaninsuliin, 100RÜ 1ml | A10AC01 | PROTAPHANE FLEXPEN, süstesuspensioon pen-süstlis, 3ml 5TK | Novo Nordisk A/S | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1115615 | keskmise toimeajaga humaaninsuliin, 100RÜ 1ml | A10AC01 | HUMULIN N, süstesuspensioon kolbampullis, 3ml 5TK | Eli Lilly Holdings Limited | 50 | | | | | | |

| 1318711 | karvedilool, 6,25mg | C07AG02 | AVEDOL, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1112342 | keskmise toimeajaga humaaninsuliin, 100RÜ 1ml | A10AC01 | PROTAPHANE FLEXPEN, süstesuspensioon pen-süstlis, 3ml 5TK | Novo Nordisk A/S | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1115637 | keskmise toimeajaga humaaninsuliin, 100RÜ 1ml | A10AC01 | HUMULIN N KWIKPEN, süstesuspensioon pen-süstlis, 3ml 5TK | Eli Lilly Holdings Limited | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1030026 | ketokonasool, 200mg | J02AB02 | ORONAZOL, tablett, 20TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1115615 | keskmise toimeajaga humaaninsuliin, 100RÜ 1ml | A10AC01 | HUMULIN N, süstesuspensioon kolbampullis, 3ml 5TK | Eli Lilly Holdings Limited | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1115637 | keskmise toimeajaga humaaninsuliin, 100RÜ 1ml | A10AC01 | HUMULIN N PEN, süstesuspensioon pen-süstlis, 3ml 5TK | Eli Lilly Holdings Limited | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1071357 | ketokonasool, 200mg | J02AB02 | NIZORAL, tablett, 30TK | Johnson & Johnson UAB | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| 1071357 | ketokonasool, 200mg | J02AB02 | NIZORAL, tablett, 30TK | Johnson & Johnson UAB | 100 | Z94-Z94, T86-T86 | | | | | |

| 1030026 | ketokonasool, 200mg | J02AB02 | ORONAZOL, tablett, 20TK | KRKA d.d., Novo Mesto | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| 1018189 | ketokonasool, 20mg 1g | D01AC08 | NIZORAL, kreem, 15g 1TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1073461 | ketoprofeen, 100mg | M01AE03 | KETO, õhukese polümeerikattega tablett, 30TK | VITABALANS OY | 50 | | | | | | |

@@ -1695,10 +1696,10 @@

| 1032736 | klaritromütsiin, 25mg 1ml | J01FA09 | KLACID 125 mg/5 ml, suukaudse suspensiooni graanulid, 60ml 1TK | Abbott Laboratories Baltics SIA | 50 | | | | | | |

| 1068881 | klaritromütsiin, 25mg 1ml | J01FA09 | KLACID 125 mg/5 ml, suukaudse suspensiooni graanulid, 100ml 1TK | Abbott Laboratories Baltics SIA | 50 | | | | | | |

| 1028876 | klaritromütsiin, 500mg | J01FA09 | FROMILID, õhukese polümeerikattega tablett, 14TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1032758 | klaritromütsiin, 500mg | J01FA09 | KLACID SR 500 MG, toimeainet modifitseeritult vabastav tablett, 5TK | Abbott Laboratories Baltics SIA | 50 | | | | | | |

| 1068904 | klaritromütsiin, 500mg | J01FA09 | KLACID SR 500 MG, toimeainet modifitseeritult vabastav tablett, 7TK | Abbott Laboratories Baltics SIA | 50 | | | | | | |

| 1141276 | klaritromütsiin, 500mg | J01FA09 | FROMILID UNO, toimeainet modifitseeritult vabastav tablett, 5TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1141287 | klaritromütsiin, 500mg | J01FA09 | FROMILID UNO, toimeainet modifitseeritult vabastav tablett, 7TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1032758 | klaritromütsiin, 500mg | J01FA09 | KLACID SR 500 MG, toimeainet modifitseeritult vabastav tablett, 5TK | Abbott Laboratories Baltics SIA | 50 | | | | | | |

| 1068904 | klaritromütsiin, 500mg | J01FA09 | KLACID SR 500 MG, toimeainet modifitseeritult vabastav tablett, 7TK | Abbott Laboratories Baltics SIA | 50 | | | | | | |

| 1108718 | klaritromütsiin, 500mg | J01FA09 | LEKOKLAR 500 MG, õhukese polümeerikattega tablett, 14TK | Sandoz d.d. | 50 | | | | | | |

| 1110238 | klaritromütsiin, 500mg | J01FA09 | KLERIMED 500MG, õhukese polümeerikattega tablett, 14TK | Medochemie Ltd | 50 | | | | | | |

| 1166677 | klaritromütsiin, 500mg | J01FA09 | KLABAX, õhukese polümeerikattega tablett, 14TK | Ranbaxy (UK) Limited | 50 | | | | | | |

@@ -1724,65 +1725,65 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1004544 | klonasepaam, 2mg | N03AE01 | RIVOTRIL, tablett, 30TK | Roche Eesti OÜ | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1007345 | kloorambutsiil, 2mg | L01AA02 | LEUKERAN, õhukese polümeerikattega tablett, 25TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 100 | C00-D48 | Hematoloog, Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1004544 | klonasepaam, 2mg | N03AE01 | RIVOTRIL, tablett, 30TK | Roche Eesti OÜ | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| 1007345 | kloorambutsiil, 2mg | L01AA02 | LEUKERAN, õhukese polümeerikattega tablett, 25TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Hematoloog, Onkoloog | | | | |

| 1044357 | klooramfenikool, 5mg 1ml | S01AA01 | OFTAN AKVAKOL, silmatilgad, lahus, 10ml 1TK | SANTEN OY | 50 | | | | | | |

| 1012880 | kloormadinoon+ etünüülöstradiool, 2mg+30mcg | G03AA15 | BELARA, õhukese polümeerikattega tablett, 21TK | Grünenthal GmbH | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1094509 | kloormadinoon+ etünüülöstradiool, 2mg+30mcg | G03AA15 | BELARA, õhukese polümeerikattega tablett, 63TK | Grünenthal GmbH | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1006063 | kloorprotikseen, 25mg | N05AF03 | TRUXAL, õhukese polümeerikattega tablett, 100TK | H. LUNDBECK A/S | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1006096 | kloorprotikseen, 50mg | N05AF03 | TRUXAL, õhukese polümeerikattega tablett, 50TK | H. LUNDBECK A/S | 50 | | | | | | |

| 1358153 | klopidogreel, 75mg | B01AC04 | CLOPIMEF, õhukese polümeerikattega tablett, 28TK | MEPHA Lda. | 50 | | | | | | |

| 1094509 | kloormadinoon+ etünüülöstradiool, 2mg+30mcg | G03AA15 | BELARA, õhukese polümeerikattega tablett, 63TK | Grünenthal GmbH | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1357961 | klopidogreel, 75mg | B01AC04 | PLAVOCORIN, õhukese polümeerikattega tablett, 28TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1359884 | klopidogreel, 75mg | B01AC04 | CLOPIGAMMA, õhukese polümeerikattega tablett, 28TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1367197 | klopidogreel, 75mg | B01AC04 | CLOPIDOGREL SANOSWISS 75MG, õhukese polümeerikattega tablett, 28TK | UAB SanoSwiss | 50 | | | | | | |

| 1040588 | klopidogreel, 75mg | B01AC04 | PLAVIX, õhukese polümeerikattega tablett, 28TK | Sanofi Pharma Bristol- Myers Squibb SNC | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1065743 | klopidogreel, 75mg | B01AC04 | PLAVIX, õhukese polümeerikattega tablett, 84TK | Sanofi Pharma Bristol- Myers Squibb SNC | 50 | | | | | | |

| 1357141 | klopidogreel, 75mg | B01AC04 | TROMBEX 75 MG, õhukese polümeerikattega tablett, 30TK | Zentiva, k.s. | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1358298 | klopidogreel, 75mg | B01AC04 | CLOPIDOGREL- RATIOPHARM 75 MG, õhukese polümeerikattega tablett, 28TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1359884 | klopidogreel, 75mg | B01AC04 | CLOPIGAMMA, õhukese polümeerikattega tablett, 28TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| 1367074 | klopidogreel, 75mg | B01AC04 | NOFARDOM, õhukese polümeerikattega tablett, 28TK | UAB Norameda | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1437465 | klopidogreel, 75mg | B01AC04 | ZYLLT, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1433630 | klopidogreel, 75mg | B01AC04 | CLOPIDOGREL TEVA, õhukese polümeerikattega tablett, 28TK | Teva Pharma B.V. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1004724 | klosapiin, 100mg | N05AH02 | LEPONEX, tablett, 50TK | Novartis Finland OY | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1004724 | klosapiin, 100mg | N05AH02 | LEPONEX, tablett, 50TK | Novartis Finland OY | 100 | F32.2-F32.3, F70- F79, F11.4-F11.7, F18.4-F18.7, F20- F29, F12.4-F12.7, F16.4-F16.7, F19.4- F19.7, F33.2-F33.3, F14.4-F14.7, F00- F09, F60.3-F60.3, F13.4-F13.7, F10.4- F10.7, F17.4-F17.7, F15.4-F15.7, F30- F31 | | | | | |

| | | | | | 50 | | | | | | |

| 1004768 | klosapiin, 25mg | N05AH02 | LEPONEX, tablett, 50TK | Novartis Finland OY | 100 | F32.2-F32.3, F70- F79, F11.4-F11.7, F18.4-F18.7, F20- F29, F12.4-F12.7, F16.4-F16.7, F19.4- F19.7, F33.2-F33.3, F14.4-F14.7, F00- F09, F60.3-F60.3, F13.4-F13.7, F10.4- F10.7, F17.4-F17.7, F15.4-F15.7, F30- F31 | | | | | |

| | | | | | 50 | | | | | | |

| 1033692 | klotrimasool, 1%/100mg | G01AF02 | CANIFUG CREMOLUM 100 KOMBI, vaginaalsuposiit+vaginaalkree m, 20g 1TK / 6TK | Dr. August Wolff GmbH & Co. KG Arzneimittel | 50 | | | | | | |

| 1033692 | klotrimasool, 1%/100mg | G01AF02 | CANIFUG CREMOLUM, vaginaalsuposiit+vaginaalkree m, 20g 1TK / 6TK | Dr. August Wolff GmbH & Co. KG Arzneimittel | 50 | | | | | | |

| 1033726 | klotrimasool, 100mg | G01AF02 | CANIFUG CREMOLUM, vaginaalsuposiit, 6TK | Dr. August Wolff GmbH & Co. KG Arzneimittel | 50 | | | | | | |

| 1045123 | klotrimasool, 100mg | G01AF02 | KLOTRIMASOOL GSK, vaginaaltablett, 6TK | GlaxoSmithKline Pharmaceuticals S.A. | 50 | | | | | | |

| 1033726 | klotrimasool, 100mg | G01AF02 | CANIFUG CREMOLUM 100, vaginaalsuposiit, 6TK | Dr. August Wolff GmbH & Co. KG Arzneimittel | 50 | | | | | | |

| 1033737 | klotrimasool, 200mg | G01AF02 | CANIFUG CREMOLUM 200, vaginaalsuposiit, 3TK | Dr. August Wolff GmbH & Co. KG Arzneimittel | 50 | | | | | | |

| 1033737 | klotrimasool, 200mg | G01AF02 | CANIFUG CREMOLUM, vaginaalsuposiit, 3TK | Dr. August Wolff GmbH & Co. KG Arzneimittel | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

@@ -1793,17 +1794,17 @@

| 1001631 | kromoglütsiinhape, 40mg 1ml | S01GX01 | LECROLYN, silmatilgad, lahus, 5ml 1TK | SANTEN OY | 50 | | | | | | |

| 1120644 | kvetiapiin, 100mg | N05AH04 | SEROQUEL, õhukese polümeerikattega tablett, 60TK | AstraZeneca UK Limited | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1241345 | kvetiapiin, 100mg | N05AH04 | KETIPINOR, õhukese polümeerikattega tablett, 30TK | Orion Corporation | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1241356 | kvetiapiin, 100mg | N05AH04 | KETIPINOR, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1241345 | kvetiapiin, 100mg | N05AH04 | KETIPINOR, õhukese polümeerikattega tablett, 30TK | Orion Corporation | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1241356 | kvetiapiin, 100mg | N05AH04 | KETIPINOR, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1265420 | kvetiapiin, 100mg | N05AH04 | HEDONIN 100 MG, õhukese polümeerikattega tablett, 60TK | LANNACHER HEILMITTEL GmbH | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1369942 | kvetiapiin, 100mg | N05AH04 | QUETIAPINE POLPHARMA, õhukese polümeerikattega tablett, 60TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1369942 | kvetiapiin, 100mg | N05AH04 | QUETIAPINE POLPHARMA, õhukese polümeerikattega tablett, 60TK | Pharmaceutical Works Polpharma S.A. | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1115086 | kvetiapiin, 200mg | N05AH04 | SEROQUEL, õhukese polümeerikattega tablett, 60TK | AstraZeneca UK Limited | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1241378 | kvetiapiin, 200mg | N05AH04 | KETIPINOR, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

@@ -1819,25 +1820,25 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1301847 | kvetiapiin, 200mg | N05AH04 | QUETIAPINE TEVA, õhukese polümeerikattega tablett, 60TK | Teva Pharma B.V. | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1370001 | kvetiapiin, 200mg | N05AH04 | QUETIAPINE POLPHARMA, õhukese polümeerikattega tablett, 60TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| 1370001 | kvetiapiin, 200mg | N05AH04 | QUETIAPINE POLPHARMA, õhukese polümeerikattega tablett, 60TK | Pharmaceutical Works Polpharma S.A. | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1241334 | kvetiapiin, 25mg | N05AH04 | KETIPINOR, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1369931 | kvetiapiin, 25mg | N05AH04 | QUETIAPINE POLPHARMA, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1377503 | kvetiapiin, 25mg | N05AH04 | QUETIAPINE TEVA, õhukese polümeerikattega tablett, 30TK | Teva Pharma B.V. | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1274587 | kvetiapiin, 300mg | N05AH04 | SEROQUEL XR, toimeainet prolongeeritult vabastav tablett, 60TK | AstraZeneca UK Limited | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1301937 | kvetiapiin, 300mg | N05AH04 | QUETIAPINE TEVA, õhukese polümeerikattega tablett, 60TK | Teva Pharma B.V. | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1363531 | kvetiapiin, 300mg | N05AH04 | KETIPINOR, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1370023 | kvetiapiin, 300mg | N05AH04 | QUETIAPINE POLPHARMA, õhukese polümeerikattega tablett, 60TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1241334 | kvetiapiin, 25mg | N05AH04 | KETIPINOR, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1377503 | kvetiapiin, 25mg | N05AH04 | QUETIAPINE TEVA, õhukese polümeerikattega tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1370023 | kvetiapiin, 300mg | N05AH04 | QUETIAPINE POLPHARMA, õhukese polümeerikattega tablett, 60TK | Pharmaceutical Works Polpharma S.A. | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1274611 | kvetiapiin, 400mg | N05AH04 | SEROQUEL XR, toimeainet prolongeeritult vabastav tablett, 60TK | AstraZeneca UK Limited | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1288289 | kvetiapiin, 50mg | N05AH04 | SEROQUEL XR, toimeainet prolongeeritult vabastav tablett, 60TK | AstraZeneca UK Limited | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

@@ -1847,27 +1848,27 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1415506 | kvinapriil, 20mg | C09AA06 | QUINAPRIL POLPHARMA 20 MG, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1415517 | kvinapriil, 40mg | C09AA06 | QUINAPRIL POLPHARMA 40 MG, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1415506 | kvinapriil, 20mg | C09AA06 | QUINAPRIL POLPHARMA 20 MG, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1415517 | kvinapriil, 40mg | C09AA06 | QUINAPRIL POLPHARMA 40 MG, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1031094 | kvinapriil+ hüdroklorotiasiid, 10mg+12,5mg | C09BA06 | ACCUZIDE, õhukese polümeerikattega tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1030105 | kvinapriil+ hüdroklorotiasiid, 20mg+12,5mg | C09BA06 | ACCUZIDE 20, õhukese polümeerikattega tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1007828 | labetalool, 100mg | C07AG01 | TRANDATE, õhukese polümeerikattega tablett, 50TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 75 | O10-O16 | | | | | |

| 1007828 | labetalool, 100mg | C07AG01 | TRANDATE, õhukese polümeerikattega tablett, 50TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | O10-O16 | | | | | |

| | | | | | 50 | | | | | | |

| 1043042 | lamivudiin, 100mg | J05AF05 | ZEFFIX, õhukese polümeerikattega tablett, 28TK | Glaxo Group Ltd | 50 | | | | | | |

| 1122691 | lamotrigiin, 100mg | N03AX09 | LAMICTAL 100MG, närimis- /dispergeeruv tablett, 30TK | Glaxo Group Ltd | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1153897 | lamotrigiin, 25mg | N03AX09 | LAMICTAL 25MG, närimis- /dispergeeruv tablett, 30TK | Glaxo Group Ltd | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1394210 | lamotrigiin, 25mg | N03AX09 | LAMICTAL 25MG, närimis- /dispergeeruv tablett, 28TK | Glaxo Group Ltd | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1379088 | lamotrigiin, 50mg | N03AX09 | LAMICTAL 50MG, närimis- /dispergeeruv tablett, 28TK | Glaxo Group Ltd | 50 | | | | | | |

@@ -1875,23 +1876,23 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1394018 | lamotrigiin, 5mg | N03AX09 | LAMICTAL 5MG, närimis- /dispergeeruv tablett, 28TK | Glaxo Group Ltd | 50 | | | | | | |

| 1141434 | lamotrigiin, 5mg | N03AX09 | LAMICTAL 5MG, närimis- /dispergeeruv tablett, 30TK | Glaxo Group Ltd | 50 | | | | | | |

| 1235056 | lantaan, 750mg | V03AE03 | FOSRENOL, närimistablett, 90TK | Shire Pharmaceutical Contracts Limited | 100 | N18-N18 | Pediaater, Nefroloog | | | | juhul, kui kaltsiumipõhine fosforisiduja on vastunäidustatud (seerumi kaltsiumisisaldus >2,54 mmol/l) |

| | | | | | 50 | | | | | | |

| 1235056 | lantaan, 750mg | V03AE03 | FOSRENOL, närimistablett, 90TK | Shire Pharmaceutical Contracts Limited | 100 | N18-N18 | Nefroloog, Pediaater | | | | juhul, kui kaltsiumipõhine fosforisiduja on vastunäidustatud (seerumi kaltsiumisisaldus >2,54 mmol/l) |

| | | | | | 50 | | | | | | |

| 1041196 | latanoprost, 50mcg 1ml | S01EE01 | XALATAN, silmatilgad, lahus, 2.5ml 1TK | Pfizer Enterprises SARL | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| 1165733 | latanoprost, 50mcg 1ml | S01EE01 | GLAUMAX, silmatilgad, lahus, 2.5ml 1TK | Kevelt AS | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1165733 | latanoprost, 50mcg 1ml | S01EE01 | GLAUMAX, silmatilgad, lahus, 2.5ml 1TK | Kevelt AS | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| 1300071 | latanoprost, 50mcg 1ml | S01EE01 | XALOPTIC, silmatilgad, lahus, 2.5ml 1TK | Pharmaceutical Works Polpharma S.A. | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1316438 | latanoprost, 50mcg 1ml | S01EE01 | LATANOPROST- RATIOPHARM, silmatilgad, lahus, 2.5ml 1TK | ratiopharm GmbH | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1316438 | latanoprost, 50mcg 1ml | S01EE01 | LATANOPROST- RATIOPHARM, silmatilgad, lahus, 2.5ml 1TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| 1377873 | latanoprost, 50mcg 1ml | S01EE01 | UNILAT, silmatilgad, lahus, 2.5ml 1TK | Unimed Pharma spol. s.r.o. (Ltd.) | 50 | | | | | | |

| | | | | | 100 | H40-H42 | Oftalmoloog | esmane | | | |

@@ -1899,8 +1900,8 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1073001 | latsidipiin, 4mg | C08CA09 | LACIPIL, õhukese polümeerikattega tablett, 28TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1073023 | latsidipiin, 4mg | C08CA09 | LACIPIL, õhukese polümeerikattega tablett, 56TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1073023 | latsidipiin, 4mg | C08CA09 | LACIPIL, õhukese polümeerikattega tablett, 56TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1122567 | latsidipiin, 6mg | C08CA09 | LACIPIL 6MG, õhukese polümeerikattega tablett, 28TK | GlaxoSmithKline SpA | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1122578 | latsidipiin, 6mg | C08CA09 | LACIPIL 6MG, õhukese polümeerikattega tablett, 56TK | GlaxoSmithKline SpA | 75 | I10-I13, I15-I15 | | | | | |

@@ -1915,111 +1916,111 @@

| 1299540 | lenalidomiid, 5mg | L04AX04 | REVLIMID, kõvakapsel, 21TK | Celgene Europe Ltd | 100 | C90-C90 | Hematoloog | | | | kuni haiguse progresseerumiseni patsiendile, kelle ravi alustamise lenalidomiidiga on hinnanud konsiilium (vähemalt 3 hematoloogi) vastavaks järgmistele kriteeriumidele: ravi bortesomiibiga on vastunäidustatud või osutunud ebaefektiivseks või on haigus pärast bortesomiibravi taastekkinud ning patsient on heas üldseisundis (funktsionaalne klass 0-2 ECOG järgi). Soodustus ei laiene patsientidele, kelle ravi lenalidomiidiga on ravimitootja vastutusel alustatud ja tagatud enne 1. oktoobrit 2010. a. |

| 1474950 | lerkanidipiin, 10mg | C08CA13 | LERCAPIN, õhukese polümeerikattega tablett, 90TK | Menarini International Operations Luxembourg S.A. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1474994 | lerkanidipiin, 20mg | C08CA13 | LERCAPIN, õhukese polümeerikattega tablett, 90TK | Menarini International Operations Luxembourg S.A. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1474994 | lerkanidipiin, 20mg | C08CA13 | LERCAPIN, õhukese polümeerikattega tablett, 90TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1289213 | letrosool, 2,5mg | L02BG04 | LETROZOL-RATIOPHARM, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1302398 | letrosool, 2,5mg | L02BG04 | LETROZOLE SANOSWISS 2,5 MG, õhukese polümeerikattega tablett, 30TK | UAB SanoSwiss | 50 | | | | | | |

| | | | | | 100 | C50-C50 | Onkoloog | | | | |

| 1302792 | letrosool, 2,5mg | L02BG04 | LETROZOLE POLPHARMA 2,5 MG, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| | | | | | 100 | C50-C50 | Onkoloog | | | | |

| 1034334 | letrosool, 2,5mg | L02BG04 | FEMARA, õhukese polümeerikattega tablett, 30TK | Novartis Finland OY | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1302398 | letrosool, 2,5mg | L02BG04 | LETROZOLE SANOSWISS 2,5 MG, õhukese polümeerikattega tablett, 30TK | UAB SanoSwiss | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1302488 | letrosool, 2,5mg | L02BG04 | LETROZOLE GENERICON, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 50 | | | | | | |

| | | | | | 100 | C50-C50 | Onkoloog | | | | |

| 1302792 | letrosool, 2,5mg | L02BG04 | LETROZOLE POLPHARMA 2,5 MG, õhukese polümeerikattega tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 100 | C50-C50 | Onkoloog | | | | |

| 1302488 | letrosool, 2,5mg | L02BG04 | LETROZOLE GENERICON, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 100 | C50-C50 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1007176 | levamisool, 150mg | P02CE01 | DECARIS, tablett, 1TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1198975 | levetiratsetaam, 1000mg | N03AX14 | KEPPRA, õhukese polümeerikattega tablett, 30TK | UCB Pharma SA | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1198829 | levetiratsetaam, 500mg | N03AX14 | KEPPRA, õhukese polümeerikattega tablett, 30TK | UCB Pharma SA | 50 | | | | | | |

| 1085161 | levodopa+ benserasiid, 100mg+25mg | N04BA80 | MADOPAR HBS, toimeainet prolongeeritult vabastav kõvakapsel, 100TK | Roche Eesti OÜ | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1077049 | levodopa+benserasiid, 100mg+25mg | N04BA80 | MADOPAR, dispergeeruv tablett, 100TK | Roche Eesti OÜ | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1082922 | levodopa+benserasiid, 100mg+25mg | N04BA80 | MADOPAR, kõvakapsel, 100TK | Roche Eesti OÜ | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1077049 | levodopa+benserasiid, 100mg+25mg | N04BA80 | MADOPAR, dispergeeruv tablett, 100TK | Roche Eesti OÜ | 50 | | | | | | |

| 1085161 | levodopa+benserasiid, 100mg+25mg | N04BA80 | MADOPAR HBS, toimeainet prolongeeritult vabastav kõvakapsel, 100TK | Roche Eesti OÜ | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1082922 | levodopa+benserasiid, 100mg+25mg | N04BA80 | MADOPAR, kõvakapsel, 100TK | Roche Eesti OÜ | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1002014 | levodopa+benserasiid, 200mg+50mg | N04BA80 | MADOPAR, tablett, 100TK | Roche Eesti OÜ | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1082517 | levodopa+karbidopa, 100mg+25mg | N04BA81 | SINEMET 25/100, tablett, 30TK | Merck Sharp & Dohme OÜ | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1006894 | levodopa+karbidopa, 200mg+50mg | N04BA81 | SINEMET CR 50/200 MG, toimeainet prolongeeritult vabastav tablett, 100TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1006894 | levodopa+karbidopa, 200mg+50mg | N04BA81 | SINEMET CR 50/200 MG, toimeainet prolongeeritult vabastav tablett, 100TK | Merck Sharp & Dohme OÜ | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1006861 | levodopa+karbidopa, 250mg+25mg | N04BA81 | SINEMET 25/250, tablett, 100TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1172854 | levodopa+karbidopa+e ntakapoon, 100mg+25mg+200mg | N04BA03 | STALEVO, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1172854 | levodopa+karbidopa+e ntakapoon, 100mg+25mg+200mg | N04BA03 | STALEVO, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1172898 | levodopa+karbidopa+e ntakapoon, 150mg+37,5mg+200m g | N04BA03 | STALEVO, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1368020 | levodopa+karbidopa+e ntakapoon, 200mg+50mg+200mg | N04BA03 | STALEVO, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1472228 | levodopa+karbidopa+e ntakapoon, 75mg+18,75mg+200m g | N04BA03 | STALEVO, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1368020 | levodopa+karbidopa+e ntakapoon, 200mg+50mg+200mg | N04BA03 | STALEVO, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1472228 | levodopa+karbidopa+e ntakapoon, 75mg+18,75mg+200m g | N04BA03 | STALEVO, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1009493 | levonorgestreel, 20mcg 24h | G02BA03 | MIRENA, intrauteriinne ravivahend, 1TK | Bayer Schering Pharma AG | 50 | | | | | | |

| 1014815 | levonorgestreel+etünü ülöstradiool, 75mcg+40mcg/50mcg +30mcg/125mcg+30m cg | G03AB03 | TRI-REGOL, kaetud tablett, 15TK / 18TK / 30TK | Gedeon Richter Plc. | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| 1014815 | levonorgestreel+etünü ülöstradiool, 75mcg+40mcg/50mcg +30mcg/125mcg+30m cg | G03AB03 | TRI-REGOL, kaetud tablett, 15TK / 18TK / 30TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1223064 | levotsetirisiin, 0,5mg 1ml | R06AE09 | XYZAL, suukaudne lahus, 200ml 1TK | UCB Pharma OY Finland | 50 | | | | | | |

| 1138126 | levotsetirisiin, 5mg | R06AE09 | XYZAL, õhukese polümeerikattega tablett, 7TK | UCB Pharma OY Finland | 50 | | | | | | |

| 1138137 | levotsetirisiin, 5mg | R06AE09 | XYZAL, õhukese polümeerikattega tablett, 28TK | UCB Pharma OY Finland | 50 | | | | | | |

| 1359312 | levotsetirisiin, 5mg | R06AE09 | LEVOCETIRIZINE ACTAVIS, õhukese polümeerikattega tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1359525 | levotsetirisiin, 5mg | R06AE09 | LEVOCETIRIZINE- RATIOPHARM, õhukese polümeerikattega tablett, 28TK | ratiopharm GmbH | 50 | | | | | | |

| 1013858 | linesoliid, 600mg | J01XX08 | ZYVOXID, õhukese polümeerikattega tablett, 10TK | Pfizer Enterprises SARL | 50 | | | | | | |

| 1044469 | lipaas+amülaas+prote aas, 10000TÜ+8000TÜ+60 0TÜ | A09AA02 | KREON 10 000 U, gastroresistentne kõvakapsel, 20TK | Abbott Products GmbH | 100 | E84-E84 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1063763 | lipaas+amülaas+prote aas, 10000TÜ+8000TÜ+60 0TÜ | A09AA02 | KREON 10 000 U, gastroresistentne kõvakapsel, 50TK | Abbott Products GmbH | 50 | | | | | | |

| 1044469 | lipaas+amülaas+prote aas, 10000TÜ+8000TÜ+60 0TÜ | A09AA02 | KREON 10 000 U, gastroresistentne kõvakapsel, 20TK | Abbott Products GmbH | 50 | | | | | | |

| | | | | | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| 1063763 | lipaas+amülaas+prote aas, 10000TÜ+8000TÜ+60 0TÜ | A09AA02 | KREON 10 000 U, gastroresistentne kõvakapsel, 50TK | Abbott Products GmbH | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1063774 | lipaas+amülaas+prote aas, 10000TÜ+8000TÜ+60 0TÜ | A09AA02 | KREON 10 000 U, gastroresistentne kõvakapsel, 100TK | Abbott Products GmbH | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1020205 | lipaas+amülaas+prote aas, 10000ühik+9000ühik+ 500ühik | A09AA02 | PANGROL 10000, gastroresistentne kõvakapsel, 20TK | Berlin-Chemie AG (Menarini Group) | 100 | E84-E84 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1060434 | lipaas+amülaas+prote aas, 20000ühik+12000ühik +900ühik | A09AA02 | MEZYM 20 000, gastroresistentne tablett, 100TK | Berlin-Chemie AG (Menarini Group) | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1044470 | lipaas+amülaas+prote aas, 25000TÜ+18000TÜ+1 000TÜ | A09AA02 | KREON 25 000 U, gastroresistentne kõvakapsel, 20TK | Abbott Products GmbH | 50 | | | | | | |

| | | | | | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| 1063707 | lipaas+amülaas+prote aas, 25000TÜ+18000TÜ+1 000TÜ | A09AA02 | KREON 25 000 U, gastroresistentne kõvakapsel, 50TK | Abbott Products GmbH | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1063729 | lipaas+amülaas+prote aas, 25000TÜ+18000TÜ+1 000TÜ | A09AA02 | KREON 25 000 U, gastroresistentne kõvakapsel, 100TK | Abbott Products GmbH | 50 | | | | | | |

| | | | | | 100 | E84-E84 | Pediaater, Pulmonoloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1063774 | lipaas+amülaas+prote aas, 10000TÜ+8000TÜ+60 0TÜ | A09AA02 | KREON 10 000 U, gastroresistentne kõvakapsel, 100TK | Abbott Products GmbH | 100 | E84-E84 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1020205 | lipaas+amülaas+prote aas, 10000ühik+9000ühik+ 500ühik | A09AA02 | PANGROL 10000, gastroresistentne kõvakapsel, 20TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| 1020182 | lipaas+amülaas+prote aas, 25000ühik+22500ühik +1250ühik | A09AA02 | PANGROL 25000, gastroresistentne kõvakapsel, 20TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| | | | | | 100 | E84-E84 | Pediaater, Pulmonoloog | esmane | | | |

| 1060434 | lipaas+amülaas+prote aas, 20000ühik+12000ühik +900ühik | A09AA02 | MEZYM 20 000, gastroresistentne tablett, 100TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| | | | | | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| 1044470 | lipaas+amülaas+prote aas, 25000TÜ+18000TÜ+1 000TÜ | A09AA02 | KREON 25 000 U, gastroresistentne kõvakapsel, 20TK | Abbott Products GmbH | 100 | E84-E84 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1063729 | lipaas+amülaas+prote aas, 25000TÜ+18000TÜ+1 000TÜ | A09AA02 | KREON 25 000 U, gastroresistentne kõvakapsel, 100TK | Abbott Products GmbH | 100 | E84-E84 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1020182 | lipaas+amülaas+prote aas, 25000ühik+22500ühik +1250ühik | A09AA02 | PANGROL 25000, gastroresistentne kõvakapsel, 20TK | Berlin-Chemie AG (Menarini Group) | 100 | E84-E84 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1030565 | lisinopriil, 10mg | C09AA03 | DIROTON, tablett, 28TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1030565 | lisinopriil, 10mg | C09AA03 | DIROTON, tablett, 28TK | Gedeon Richter Plc. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1030576 | lisinopriil, 20mg | C09AA03 | DIROTON, tablett, 28TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1300598 | lisinopriil+amlodipiin, 10mg+5mg | C09BB03 | DIRONORM, tablett, 30TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1012420 | lispro-insuliin, 100ühik 1ml | A10AD04 | HUMALOG MIX50, süstesuspensioon kolbampullis, 3ml 5TK | Eli Lilly Netherland B.V. | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1040409 | lispro-insuliin, 100ühik 1ml | A10AB04 | HUMALOG PEN, süstelahus, 3ml 5TK | Eli Lilly Netherland B.V. | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1300598 | lisinopriil+amlodipiin, 10mg+5mg | C09BB03 | DIRONORM, tablett, 30TK | Gedeon Richter Plc. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1012420 | lispro-insuliin, 100ühik 1ml | A10AD04 | HUMALOG MIX50, süstesuspensioon kolbampullis, 3ml 5TK | Eli Lilly Netherland B.V. | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1040409 | lispro-insuliin, 100ühik 1ml | A10AB04 | HUMALOG PEN, süstelahus, 3ml 5TK | Eli Lilly Netherland B.V. | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1043008 | lispro-insuliin, 100ühik 1ml | A10AD04 | HUMALOG MIX25, süstesuspensioon kolbampullis, 3ml 5TK | Eli Lilly Netherland B.V. | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1043019 | lispro-insuliin, 100ühik 1ml | A10AD04 | HUMALOG MIX25 PEN, süstesuspensioon, 3ml 5TK | Eli Lilly Netherland B.V. | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1111284 | lispro-insuliin, 100ühik 1ml | A10AB04 | HUMALOG, süstelahus kolbampullis, 3ml 5TK | Eli Lilly Netherland B.V. | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1364510 | lispro-insuliin, 100ühik 1ml | A10AB04 | HUMALOG KWIKPEN, süstelahus, 3ml 5TK | Eli Lilly Netherland B.V. | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1111284 | lispro-insuliin, 100ühik 1ml | A10AB04 | HUMALOG, süstelahus kolbampullis, 3ml 5TK | Eli Lilly Netherland B.V. | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1364510 | lispro-insuliin, 100ühik 1ml | A10AB04 | HUMALOG KWIKPEN, süstelahus, 3ml 5TK | Eli Lilly Netherland B.V. | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1364532 | lispro-insuliin, 100ühik 1ml | A10AD04 | HUMALOG MIX25 KWIKPEN, süstesuspensioon, 3ml 5TK | Eli Lilly Netherland B.V. | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1364554 | lispro-insuliin, 100ühik 1ml | A10AD04 | HUMALOG MIX50 KWIKPEN, süstesuspensioon, 3ml 5TK | Eli Lilly Netherland B.V. | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1364554 | lispro-insuliin, 100ühik 1ml | A10AD04 | HUMALOG MIX50 KWIKPEN, süstesuspensioon, 3ml 5TK | Eli Lilly Netherland B.V. | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1063482 | loperamiid, 2mg | A07DA03 | IMODIUM, kõvakapsel, 20TK | McNeil Products Ltd. | 50 | | | | | | |

@@ -2033,71 +2034,71 @@

| 1024209 | lornoksikaam, 4mg | M01AC05 | XEFO, õhukese polümeerikattega tablett, 20TK | Nycomed Sefa AS | 50 | | | | | | |

| 1134638 | lornoksikaam, 8mg | M01AC05 | XEFO RAPID, õhukese polümeerikattega tablett, 20TK | Nycomed Sefa AS | 50 | | | | | | |

| 1147339 | lornoksikaam, 8mg | M01AC05 | XEFO RAPID, õhukese polümeerikattega tablett, 10TK | Nycomed Sefa AS | 50 | | | | | | |

| 1207167 | losartaan, 100mg | C09CA01 | LOZAP 100, õhukese polümeerikattega tablett, 30TK | Zentiva a.s. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1210688 | losartaan, 100mg | C09CA01 | LOZAP 100, õhukese polümeerikattega tablett, 60TK | Zentiva a.s. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1268962 | losartaan, 100mg | C09CA01 | LORISTA, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1297414 | losartaan, 100mg | C09CA01 | LOSARTAN ACTAVIS, õhukese polümeerikattega tablett, 30TK | Actavis Group Hf | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1207167 | losartaan, 100mg | C09CA01 | LOZAP 100, õhukese polümeerikattega tablett, 30TK | Zentiva a.s. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1210688 | losartaan, 100mg | C09CA01 | LOZAP 100, õhukese polümeerikattega tablett, 60TK | Zentiva a.s. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1268962 | losartaan, 100mg | C09CA01 | LORISTA, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1297414 | losartaan, 100mg | C09CA01 | LOSARTAN ACTAVIS, õhukese polümeerikattega tablett, 30TK | Actavis Group Hf | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1207134 | losartaan, 50mg | C09CA01 | LOZAP 50, õhukese polümeerikattega tablett, 30TK | Zentiva a.s. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1210701 | losartaan, 50mg | C09CA01 | LOZAP 50, õhukese polümeerikattega tablett, 60TK | Zentiva a.s. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1013735 | losartaan, 50mg | C09CA01 | LORISTA, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1210701 | losartaan, 50mg | C09CA01 | LOZAP 50, õhukese polümeerikattega tablett, 60TK | Zentiva a.s. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1013735 | losartaan, 50mg | C09CA01 | LORISTA, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1297391 | losartaan, 50mg | C09CA01 | LOSARTAN ACTAVIS, õhukese polümeerikattega tablett, 30TK | Actavis Group Hf | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1166059 | losartaan+hüdrokloroti asiid, 50mg+12,5mg | C09DA01 | LORISTA H, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1166059 | losartaan+hüdrokloroti asiid, 50mg+12,5mg | C09DA01 | LORISTA H, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1217809 | losartaan+hüdrokloroti asiid, 50mg+12,5mg | C09DA01 | LOZAP H, õhukese polümeerikattega tablett, 30TK | Zentiva, k.s. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1185195 | loteprednool, 0,5% | S01BA14 | LOTEMAX, silmatilgad, suspensioon, 5ml 1TK | DR. GERHARD MANN CHEM.-PHARM. FABRIK GmbH | 50 | | | | | | |

| 1029417 | lühikese toimeajaga humaaninsuliin, 100RÜ 1ml | A10AB01 | HUMULIN R, süstelahus kolbampullis, 3ml 5TK | Eli Lilly Holdings Limited | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| | | | | | 50 | | | | | | |

| 1029417 | lühikese toimeajaga humaaninsuliin, 100RÜ 1ml | A10AB01 | HUMULIN R, süstelahus kolbampullis, 3ml 5TK | Eli Lilly Holdings Limited | 50 | | | | | | |

| | | | | | 100 | O24-O24, E13-E14, E10-E11, P70.2- P70.2, E89.1-E89.1 | | | | | |

| 1007222 | mebendasool, 100mg | P02CA01 | VERMOX 100 MG, tablett, 6TK | Gedeon Richter Plc. | 50 | | | | | | |

| 1136696 | mebeveriin, 200mg | A03AA04 | DUSPATALIN, toimeainet prolongeeritult vabastav kõvakapsel, 30TK | Abbott Healthcare Products B.V. | 50 | | | | | | |

| 1009044 | medroksüprogesteroon , 10mg | G03DA02 | PROVERA, tablett, 40TK | Pfizer Enterprises SARL | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | D18.1-D18.1 | Onkoloog, Pulmonoloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | D18.1-D18.1 | Pulmonoloog, Onkoloog | | | | |

| 1013195 | medroksüprogesteroon , 500mg | L02AB02 | FARLUTAL, tablett, 30TK | Pfizer Enterprises SARL | 100 | C00-D48 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1013195 | medroksüprogesteroon , 500mg | L02AB02 | FARLUTAL, tablett, 30TK | Pfizer Enterprises SARL | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Onkoloog | | | | |

| 1009022 | medroksüprogesteroon , 5mg | G03DA02 | PROVERA, tablett, 24TK | Pfizer Enterprises SARL | 50 | | | | | | |

| 1004410 | melfalaan, 2mg | L01AA03 | ALKERAN, õhukese polümeerikattega tablett, 25TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 100 | C00-D48 | Onkoloog, Hematoloog | | | | |

| | | | | | 50 | | | | | | |

| 1004410 | melfalaan, 2mg | L01AA03 | ALKERAN, õhukese polümeerikattega tablett, 25TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Hematoloog, Onkoloog | | | | |

| 1149779 | meloksikaam, 15mg | M01AC06 | MEXOLAN 15 MG, tablett, 30TK | LANNACHER HEILMITTEL GmbH | 50 | | | | | | |

| 1192261 | meloksikaam, 15mg | M01AC06 | MELOXICAM SANDOZ 15 MG, tablett, 20TK | Sandoz d.d. | 50 | | | | | | |

| 1035021 | meloksikaam, 15mg | M01AC06 | MOVALIS, tablett, 20TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| 1140680 | meloksikaam, 15mg | M01AC06 | MELOX 15MG, tablett, 20TK | Medochemie Ltd | 50 | | | | | | |

| 1175936 | meloksikaam, 15mg | M01AC06 | RECOXA 15, tablett, 20TK | Zentiva, k.s. | 50 | | | | | | |

| 1189199 | meloksikaam, 15mg | M01AC06 | LORMED 15 MG, tablett, 20TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| 1192261 | meloksikaam, 15mg | M01AC06 | MELOXICAM SANDOZ 15 MG, tablett, 20TK | Sandoz d.d. | 50 | | | | | | |

| 1240254 | meloksikaam, 15mg | M01AC06 | RECOXA 15, tablett, 60TK | Zentiva, k.s. | 50 | | | | | | |

| 1360189 | meloksikaam, 15mg | M01AC06 | MELOXICAM-RATIOPHARM 15 MG, tablett, 20TK | ratiopharm GmbH | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1149746 | meloksikaam, 7,5mg | M01AC06 | MEXOLAN 7,5 MG, tablett, 30TK | LANNACHER HEILMITTEL GmbH | 50 | | | | | | |

| 1192227 | meloksikaam, 7,5mg | M01AC06 | MELOXICAM SANDOZ 7,5 MG, tablett, 50TK | Sandoz d.d. | 50 | | | | | | |

| 1035009 | meloksikaam, 7,5mg | M01AC06 | MOVALIS, tablett, 20TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| 1140679 | meloksikaam, 7,5mg | M01AC06 | MELOX 7,5MG, tablett, 30TK | Medochemie Ltd | 50 | | | | | | |

| 1146350 | meloksikaam, 7,5mg | M01AC06 | MOVALIS, tablett, 50TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| 1175914 | meloksikaam, 7,5mg | M01AC06 | RECOXA 7,5, tablett, 20TK | Zentiva, k.s. | 50 | | | | | | |

| 1189043 | meloksikaam, 7,5mg | M01AC06 | LORMED 7,5 MG, tablett, 20TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| 1189076 | meloksikaam, 7,5mg | M01AC06 | LORMED 7,5 MG, tablett, 50TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| 1192227 | meloksikaam, 7,5mg | M01AC06 | MELOXICAM SANDOZ 7,5 MG, tablett, 50TK | Sandoz d.d. | 50 | | | | | | |

| 1360134 | meloksikaam, 7,5mg | M01AC06 | MELOXICAM-RATIOPHARM 7,5 MG, tablett, 20TK | ratiopharm GmbH | 50 | | | | | | |

| 1360156 | meloksikaam, 7,5mg | M01AC06 | MELOXICAM-RATIOPHARM 7,5 MG, tablett, 50TK | ratiopharm GmbH | 50 | | | | | | |

| 1006007 | melperoon, 25mg | N05AD03 | BURONIL, kaetud tablett, 100TK | Lundbeck Pharmaceuticals Ireland Limited | 50 | | | | | | |

@@ -2109,43 +2110,43 @@

| 1123524 | memantiin, 10mg | N06DX01 | AXURA, õhukese polümeerikattega tablett, 28TK | Merz Pharmaceuticals GmbH | 50 | | | | | | |

| 1123535 | memantiin, 10mg | N06DX01 | AXURA, õhukese polümeerikattega tablett, 56TK | Merz Pharmaceuticals GmbH | 50 | | | | | | |

| 1004971 | merkaptopuriin, 50mg | L01BB02 | PURI-NETHOL, tablett, 25TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 100 | C00-D48 | Hematoloog, Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1004971 | merkaptopuriin, 50mg | L01BB02 | PURI-NETHOL, tablett, 25TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Hematoloog, Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| 1352810 | mesalasiin, 1g | A07EC02 | PENTASA 1G, toimeainet prolongeeritult vabastavad graanulid, 50TK | Ferring Lääkkeet Oy | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1044829 | mesalasiin, 500mg | A07EC02 | SALOFALK, rektaalsuposiit, 10TK | Dr. Falk Pharma GmbH | 50 | | | | | | |

| 1352854 | mesalasiin, 2g | A07EC02 | PENTASA 2G, toimeainet prolongeeritult vabastavad graanulid, 60TK | Ferring Lääkkeet Oy | 50 | | | | | | |

| 1146574 | mesalasiin, 400mg | A07EC02 | ASACOL 400MG, toimeainet modifitseeritult vabastav tablett, 100TK | Tillotts Pharma AB | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1184970 | mesalasiin, 800mg | A07EC02 | ASACOL 800 MG, toimeainet modifitseeritult vabastav tablett, 50TK | Tillotts Pharma AB | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1044829 | mesalasiin, 500mg | A07EC02 | SALOFALK, rektaalsuposiit, 10TK | Dr. Falk Pharma GmbH | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1146541 | mesalasiin, 500mg | A07EC02 | ASACOL, rektaalsuposiit, 20TK | Tillotts Pharma AB | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1034109 | metadoon, 1mg 1ml | N07BC02 | METADON DAK 1 MG/ML, suukaudne lahus, 1000ml 1TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1034109 | metadoon, 1mg 1ml | N07BC02 | METADON DAK 1 MG/ML, suukaudne lahus, 1000ml 1TK | Nycomed Sefa AS | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1034110 | metadoon, 20mg | N07BC02 | METADON DAK, tablett, 25TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1164798 | metformiin, 1000mg | A10BA02 | METFORAL 1000, õhukese polümeerikattega tablett, 120TK | Berlin-Chemie AG (Menarini Group) | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1164798 | metformiin, 1000mg | A10BA02 | METFORAL 1000, õhukese polümeerikattega tablett, 120TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1302949 | metformiin, 1000mg | A10BA02 | METFOGAMMA 1000, õhukese polümeerikattega tablett, 120TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1064719 | metformiin, 500mg | A10BA02 | METFORAL 500 MG, õhukese polümeerikattega tablett, 120TK | Berlin-Chemie AG (Menarini Group) | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1083169 | metformiin, 500mg | A10BA02 | METFORMIN-RATIOPHARM 500 MG, õhukese polümeerikattega tablett, 120TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1116380 | metformiin, 500mg | A10BA02 | METFOGAMMA 500, õhukese polümeerikattega tablett, 120TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1083169 | metformiin, 500mg | A10BA02 | METFORMIN-RATIOPHARM 500 MG, õhukese polümeerikattega tablett, 120TK | ratiopharm GmbH | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| 1116380 | metformiin, 500mg | A10BA02 | METFOGAMMA 500, õhukese polümeerikattega tablett, 120TK | WÖRWAG PHARMA GmbH & Co. KG | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

@@ -2155,97 +2156,97 @@

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1111262 | metformiin, 850mg | A10BA02 | METFOGAMMA 850, õhukese polümeerikattega tablett, 120TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1156609 | metformiin, 850mg | A10BA02 | METFORMIN SANDOZ 850 MG, õhukese polümeerikattega tablett, 120TK | Sandoz GmbH | 75 | E14-E14, E11-E11 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1156609 | metformiin, 850mg | A10BA02 | METFORMIN SANDOZ 850 MG, õhukese polümeerikattega tablett, 120TK | Sandoz GmbH | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | |

| 1361034 | metformiin+sitagliptiin, 1000mg+50mg | A10BD07 | JANUMET, õhukese polümeerikattega tablett, 56TK | Merck Sharp & Dohme Limited | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1000674 | metoklopramiid, 10mg | A03FA01 | CERUCAL, tablett, 50TK | AWD. pharma GmbH & Co.KG | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1000674 | metoklopramiid, 10mg | A03FA01 | CERUCAL, tablett, 50TK | AWD. pharma GmbH & Co.KG | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1000742 | metoklopramiid, 5mg 1ml | A03FA01 | CERUCAL, süstelahus, 2ml 10TK | AWD. Pharma GmbH & Co. KG | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1327643 | metoksüpolüetüleenglü kool-beetaepoetiin, 100mcg 0,3ml | B03XA03 | MIRCERA, süstelahus süstlis, 0.3ml 1TK | Roche Registration Limited | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1370472 | metoksüpolüetüleenglü kool-beetaepoetiin, 30mcg 0,3ml | B03XA03 | MIRCERA, süstelahus süstlis, 0.3ml 1TK | Roche Registration Limited | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1370551 | metoksüpolüetüleenglü kool-beetaepoetiin, 360mcg 0,6ml | B03XA03 | MIRCERA, süstelahus süstlis, 0.6ml 1TK | Roche Registration Limited | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1327621 | metoksüpolüetüleenglü kool-beetaepoetiin, 50mcg 0,3ml | B03XA03 | MIRCERA, süstelahus süstlis, 0.3ml 1TK | Roche Registration Limited | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1010811 | metoprolool, 100mg | C07AB02 | EMZOK, toimeainet prolongeeritult vabastav tablett, 30TK | TEVA Czech Industries s.r.o. | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1019720 | metoprolool, 100mg | C07AB02 | BETALOC ZOK 100, toimeainet prolongeeritult vabastav tablett, 30TK | AstraZeneca AB | 50 | | | | | | |

| 1327632 | metoksüpolüetüleenglü kool-beetaepoetiin, 75mcg 0,3ml | B03XA03 | MIRCERA, süstelahus süstlis, 0.3ml 1TK | Roche Registration Limited | 50 | | | | | | |

| 1010811 | metoprolool, 100mg | C07AB02 | EMZOK, toimeainet prolongeeritult vabastav tablett, 30TK | TEVA Czech Industries s.r.o. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| 1224278 | metoprolool, 100mg | C07AB02 | METOZOK, toimeainet prolongeeritult vabastav tablett, 30TK | Sandoz d.d. | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1282249 | metoprolool, 100mg | C07AB02 | METOPROLOL- RATIOPHARM RETARD 100 MG, toimeainet prolongeeritult vabastav tablett, 30TK | ratiopharm GmbH | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| 1282249 | metoprolool, 100mg | C07AB02 | METOPROLOL- RATIOPHARM RETARD 100 MG, toimeainet prolongeeritult vabastav tablett, 30TK | ratiopharm GmbH | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1019720 | metoprolool, 100mg | C07AB02 | BETALOC ZOK 100, toimeainet prolongeeritult vabastav tablett, 30TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1296592 | metoprolool, 100mg | C07AB02 | METOPROLOL POLPHARMA 100, toimeainet prolongeeritult vabastav tablett, 28TK | Pharmaceutical Works Polpharma S.A. | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1297043 | metoprolool, 100mg | C07AB02 | SPESIMAX, toimeainet prolongeeritult vabastav tablett, 30TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1297043 | metoprolool, 100mg | C07AB02 | SPESIMAX, toimeainet prolongeeritult vabastav tablett, 30TK | Nycomed Sefa AS | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1282452 | metoprolool, 200mg | C07AB02 | METOPROLOL- RATIOPHARM RETARD 200 MG, toimeainet prolongeeritult vabastav tablett, 30TK | ratiopharm GmbH | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1296705 | metoprolool, 200mg | C07AB02 | METOPROLOL POLPHARMA 200, toimeainet prolongeeritult vabastav tablett, 28TK | Pharmaceutical Works Polpharma S.A. | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1224201 | metoprolool, 25mg | C07AB02 | METOZOK, toimeainet prolongeeritult vabastav tablett, 30TK | Sandoz d.d. | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| 1083406 | metoprolool, 25mg | C07AB02 | BETALOC ZOK 25, toimeainet prolongeeritult vabastav tablett, 28TK | AstraZeneca AB | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1010800 | metoprolool, 50mg | C07AB02 | EMZOK, toimeainet prolongeeritult vabastav tablett, 30TK | TEVA Czech Industries s.r.o. | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| 1224245 | metoprolool, 50mg | C07AB02 | METOZOK, toimeainet prolongeeritult vabastav tablett, 30TK | Sandoz d.d. | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| 1282160 | metoprolool, 50mg | C07AB02 | METOPROLOL- RATIOPHARM RETARD 50 MG, toimeainet prolongeeritult vabastav tablett, 30TK | ratiopharm GmbH | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| 1009055 | metoprolool, 50mg | C07AB02 | METOPROLOL- RATIOPHARM 50 MG, tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| 1282452 | metoprolool, 200mg | C07AB02 | METOPROLOL- RATIOPHARM RETARD 200 MG, toimeainet prolongeeritult vabastav tablett, 30TK | ratiopharm GmbH | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1019719 | metoprolool, 50mg | C07AB02 | BETALOC ZOK 50, toimeainet prolongeeritult vabastav tablett, 30TK | AstraZeneca AB | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1296491 | metoprolool, 50mg | C07AB02 | METOPROLOL POLPHARMA 50, toimeainet prolongeeritult vabastav tablett, 28TK | Pharmaceutical Works Polpharma S.A. | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| 1296930 | metoprolool, 50mg | C07AB02 | SPESIMAX, toimeainet prolongeeritult vabastav tablett, 30TK | Nycomed Sefa AS | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1296705 | metoprolool, 200mg | C07AB02 | METOPROLOL POLPHARMA 200, toimeainet prolongeeritult vabastav tablett, 28TK | Pharmaceutical Works Polpharma S.A. | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| 1083406 | metoprolool, 25mg | C07AB02 | BETALOC ZOK 25, toimeainet prolongeeritult vabastav tablett, 28TK | AstraZeneca AB | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1224201 | metoprolool, 25mg | C07AB02 | METOZOK, toimeainet prolongeeritult vabastav tablett, 30TK | Sandoz d.d. | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1010800 | metoprolool, 50mg | C07AB02 | EMZOK, toimeainet prolongeeritult vabastav tablett, 30TK | TEVA Czech Industries s.r.o. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| 1009055 | metoprolool, 50mg | C07AB02 | METOPROLOL- RATIOPHARM 50 MG, tablett, 30TK | ratiopharm GmbH | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1019719 | metoprolool, 50mg | C07AB02 | BETALOC ZOK 50, toimeainet prolongeeritult vabastav tablett, 30TK | AstraZeneca AB | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| 1224245 | metoprolool, 50mg | C07AB02 | METOZOK, toimeainet prolongeeritult vabastav tablett, 30TK | Sandoz d.d. | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| 1282160 | metoprolool, 50mg | C07AB02 | METOPROLOL- RATIOPHARM RETARD 50 MG, toimeainet prolongeeritult vabastav tablett, 30TK | ratiopharm GmbH | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| 1296491 | metoprolool, 50mg | C07AB02 | METOPROLOL POLPHARMA 50, toimeainet prolongeeritult vabastav tablett, 28TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 75 | I50-I50 | Kardioloog, Pediaater | esmane | | | |

| 1296930 | metoprolool, 50mg | C07AB02 | SPESIMAX, toimeainet prolongeeritult vabastav tablett, 30TK | Nycomed Sefa AS | 75 | I15-I15, I10-I13, I20- I20 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | Pediaater, Kardioloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1001136 | metotreksaat, 2,5mg | L04AX03 | TREXAN, õhukese polümeerikattega tablett, 100TK | Orion Corporation | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Hematoloog, Onkoloog | | | | |

| | | | | | 50 | | | | | | |

@@ -2254,74 +2255,74 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1009099 | metüülprednisoloon, 16mg | H02AB04 | MEDROL, tablett, 50TK | Pfizer Enterprises SARL | 100 | G35-G35 | Pediaater, Neuroloog | esmane | | | |

| 1009099 | metüülprednisoloon, 16mg | H02AB04 | MEDROL, tablett, 50TK | Pfizer Enterprises SARL | 50 | | | | | | |

| | | | | | 75 | N00-N08 | Pediaater, Nefroloog | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 100 | G35-G35 | Neuroloog, Pediaater | esmane | | | |

| 1009190 | metüülprednisoloon, 40mg 1ml | H02AB04 | DEPO-MEDROL, süstesuspensioon, 1ml 1TK | Pfizer Enterprises SARL | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 75 | N00-N08 | Pediaater, Nefroloog | | | | |

| | | | | | 100 | G35-G35 | Pediaater, Neuroloog | esmane | | | |

| 1065495 | metüülprednisoloon, 40mg 1ml | H02AB04 | DEPO-MEDROL, süstesuspensioon, 2ml 1TK | Pfizer Enterprises SARL | 100 | G35-G35 | Neuroloog, Pediaater | esmane | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| 1009190 | metüülprednisoloon, 40mg 1ml | H02AB04 | DEPO-MEDROL, süstesuspensioon, 1ml 1TK | Pfizer Enterprises SARL | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 100 | G35-G35 | Pediaater, Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1065495 | metüülprednisoloon, 40mg 1ml | H02AB04 | DEPO-MEDROL, süstesuspensioon, 2ml 1TK | Pfizer Enterprises SARL | 100 | G35-G35 | Neuroloog, Pediaater | esmane | | | |

| | | | | | 75 | N00-N08 | Pediaater, Nefroloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1009077 | metüülprednisoloon, 4mg | H02AB04 | MEDROL, tablett, 30TK | Pfizer Enterprises SARL | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 100 | G35-G35 | Pediaater, Neuroloog | esmane | | | |

| 1065754 | metüülprednisoloon, 4mg | H02AB04 | MEDROL, tablett, 100TK | Pfizer Enterprises SARL | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | N00-N08 | Pediaater, Nefroloog | | | | |

| | | | | | 100 | G35-G35 | Neuroloog, Pediaater | esmane | | | |

| 1065754 | metüülprednisoloon, 4mg | H02AB04 | MEDROL, tablett, 100TK | Pfizer Enterprises SARL | 50 | | | | | | |

| | | | | | 100 | G35-G35 | Pediaater, Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1062009 | metüülprednisoloonats eponaat, 1mg 1g | D07AC14 | ADVANTAN, salv, 15g 1TK | Intendis GmbH | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 75 | N00-N08 | Pediaater, Nefroloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1133356 | metüülprednisoloonats eponaat, 1mg 1g | D07AC14 | ADVANTAN MILK, nahaemulsioon, 20g 1TK | Intendis GmbH | 50 | | | | | | |

| 1024579 | mikonasool, 20mg 1g | A01AB09 | DAKTARIN, suukaudne geel, 40g 1TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1013049 | milnatsipraan, 50mg | N06AX17 | IXEL, kõvakapsel, 56TK | Pierre Fabre Medicament | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1116841 | mirtasapiin, 15mg | N06AX11 | REMERON SOLTAB, suus dispergeeruv tablett, 30TK | N.V. ORGANON | 50 | | | | | | |

| 1314683 | mirtasapiin, 15mg | N06AX11 | MIRZATEN Q-TAB, suus dispergeeruv tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1243684 | mirtasapiin, 15mg | N06AX11 | MIRTAZAPIN ORION, suus dispergeeruv tablett, 30TK | Orion Corporation | 50 | | | | | | |

| 1273137 | mirtasapiin, 15mg | N06AX11 | MIRTAZAPIN ACTAVIS, suus dispergeeruv tablett, 30TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1314683 | mirtasapiin, 15mg | N06AX11 | MIRZATEN Q-TAB, suus dispergeeruv tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1301522 | mirtasapiin, 30mg | N06AX11 | MIRZATEN Q-TAB, suus dispergeeruv tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1116896 | mirtasapiin, 30mg | N06AX11 | REMERON SOLTAB, suus dispergeeruv tablett, 30TK | N.V. ORGANON | 50 | | | | | | |

| 1170166 | mirtasapiin, 30mg | N06AX11 | ESPRITAL 30, õhukese polümeerikattega tablett, 30TK | Zentiva, k.s. | 50 | | | | | | |

| 1243729 | mirtasapiin, 30mg | N06AX11 | MIRTAZAPIN ORION, suus dispergeeruv tablett, 30TK | Orion Corporation | 50 | | | | | | |

| 1273227 | mirtasapiin, 30mg | N06AX11 | MIRTAZAPIN ACTAVIS, suus dispergeeruv tablett, 30TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1301522 | mirtasapiin, 30mg | N06AX11 | MIRZATEN Q-TAB, suus dispergeeruv tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1170199 | mirtasapiin, 45mg | N06AX11 | ESPRITAL 45, õhukese polümeerikattega tablett, 30TK | Zentiva, k.s. | 50 | | | | | | |

| 1243741 | mirtasapiin, 45mg | N06AX11 | MIRTAZAPIN ORION, suus dispergeeruv tablett, 30TK | Orion Corporation | 50 | | | | | | |

| 1013779 | moksonidiin, 0,2mg | C02AC05 | PHYSIOTENS 0,2 MG, õhukese polümeerikattega tablett, 28TK | Abbott Products GmbH | 50 | | | | | | |

| 1145999 | moksonidiin, 0,2mg | C02AC05 | MOXONIDIN HEXAL 0,2 MG, õhukese polümeerikattega tablett, 30TK | HEXAL AG | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1155091 | moksonidiin, 0,2mg | C02AC05 | STADAPRESS, õhukese polümeerikattega tablett, 30TK | STADA ARZNEIMITTEL AG | 50 | | | | | | |

| 1013779 | moksonidiin, 0,2mg | C02AC05 | PHYSIOTENS 0,2 MG, õhukese polümeerikattega tablett, 28TK | Abbott Products GmbH | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1145999 | moksonidiin, 0,2mg | C02AC05 | MOXONIDIN HEXAL 0,2 MG, õhukese polümeerikattega tablett, 30TK | HEXAL AG | 50 | | | | | | |

| 1157778 | moksonidiin, 0,2mg | C02AC05 | MOXOGAMMA 0,2 MG, õhukese polümeerikattega tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| 1146079 | moksonidiin, 0,3mg | C02AC05 | MOXONIDIN HEXAL 0,3 MG, õhukese polümeerikattega tablett, 30TK | HEXAL AG | 50 | | | | | | |

| 1157857 | moksonidiin, 0,3mg | C02AC05 | MOXOGAMMA 0,3 MG, õhukese polümeerikattega tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| 1155259 | moksonidiin, 0,4mg | C02AC05 | STADAPRESS, õhukese polümeerikattega tablett, 30TK | STADA ARZNEIMITTEL AG | 50 | | | | | | |

| 1013791 | moksonidiin, 0,4mg | C02AC05 | PHYSIOTENS 0,4 MG, õhukese polümeerikattega tablett, 28TK | Abbott Products GmbH | 50 | | | | | | |

| 1146170 | moksonidiin, 0,4mg | C02AC05 | MOXONIDIN HEXAL 0,4 MG, õhukese polümeerikattega tablett, 30TK | HEXAL AG | 50 | | | | | | |

| 1155259 | moksonidiin, 0,4mg | C02AC05 | STADAPRESS, õhukese polümeerikattega tablett, 30TK | STADA ARZNEIMITTEL AG | 50 | | | | | | |

| 1157947 | moksonidiin, 0,4mg | C02AC05 | MOXOGAMMA 0,4 MG, õhukese polümeerikattega tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| 1028933 | mometasoon, 1mg 1g | D07AC13 | ELOCON, nahalahus, 20ml 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1028944 | mometasoon, 1mg 1g | D07AC13 | ELOCON, salv, 20g 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

@@ -2330,107 +2331,107 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1193509 | mometasoon+salitsüül hape, 1mg+50mg 1g | D07XC03 | ELOSALIC, salv, 45g 1TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1084531 | montelukast, 10mg | R03DC03 | SINGULAIR, õhukese polümeerikattega tablett, 28TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1351752 | montelukast, 10mg | R03DC03 | MOFENSTRA, õhukese polümeerikattega tablett, 28TK | Sandoz d.d. | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1274116 | montelukast, 10mg | R03DC03 | MONTELUKAST TEVA, õhukese polümeerikattega tablett, 28TK | Teva Pharma B.V. | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 11,00 | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1289987 | montelukast, 10mg | R03DC03 | MONKASTA, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1274116 | montelukast, 10mg | R03DC03 | MONTELUKAST TEVA, õhukese polümeerikattega tablett, 28TK | Teva Pharma B.V. | 50 | | | | | | |

| 1334090 | montelukast, 10mg | R03DC03 | MONTELUKAST- RATIOPHARM 10 MG, õhukese polümeerikattega tablett, 28TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1408317 | montelukast, 10mg | R03DC03 | SPIROKAST 10MG, õhukese polümeerikattega tablett, 28TK | Zentiva, k.s. | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1077364 | montelukast, 4mg | R03DC03 | SINGULAIR 4 MG, närimistablett, 28TK | Merck Sharp & Dohme OÜ | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1111082 | montelukast, 4mg | R03DC03 | SINGULAIR MINI 4MG, graanulid, 28TK | Merck Sharp & Dohme OÜ | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 11,00 | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1273722 | montelukast, 4mg | R03DC03 | MONTELUKAST TEVA, närimistablett, 28TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1289987 | montelukast, 10mg | R03DC03 | MONKASTA, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1289718 | montelukast, 4mg | R03DC03 | MONKASTA, närimistablett, 28TK | KRKA d.d., Novo Mesto | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 11,00 | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1333819 | montelukast, 4mg | R03DC03 | MONTELUKAST- RATIOPHARM 4MG, närimistablett, 28TK | ratiopharm GmbH | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1379550 | montelukast, 4mg | R03DC03 | MOFENSTRA, närimistablett, 28TK | Sandoz d.d. | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1077331 | montelukast, 5mg | R03DC03 | SINGULAIR, närimistablett, 28TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1334090 | montelukast, 10mg | R03DC03 | MONTELUKAST- RATIOPHARM 10 MG, õhukese polümeerikattega tablett, 28TK | ratiopharm GmbH | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1273845 | montelukast, 5mg | R03DC03 | MONTELUKAST TEVA, närimistablett, 28TK | Teva Pharma B.V. | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1289831 | montelukast, 5mg | R03DC03 | MONKASTA, närimistablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1408317 | montelukast, 10mg | R03DC03 | SPIROKAST 10MG, õhukese polümeerikattega tablett, 28TK | Zentiva, k.s. | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1333954 | montelukast, 5mg | R03DC03 | MONTELUKAST- RATIOPHARM 5MG, närimistablett, 28TK | ratiopharm GmbH | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1077364 | montelukast, 4mg | R03DC03 | SINGULAIR 4 MG, närimistablett, 28TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1111082 | montelukast, 4mg | R03DC03 | SINGULAIR MINI 4MG, graanulid, 28TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1379370 | montelukast, 5mg | R03DC03 | MOFENSTRA, närimistablett, 28TK | Sandoz d.d. | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1273722 | montelukast, 4mg | R03DC03 | MONTELUKAST TEVA, närimistablett, 28TK | Teva Pharma B.V. | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1289718 | montelukast, 4mg | R03DC03 | MONKASTA, närimistablett, 28TK | KRKA d.d., Novo Mesto | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1333819 | montelukast, 4mg | R03DC03 | MONTELUKAST- RATIOPHARM 4MG, närimistablett, 28TK | ratiopharm GmbH | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1379550 | montelukast, 4mg | R03DC03 | MOFENSTRA, närimistablett, 28TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1077331 | montelukast, 5mg | R03DC03 | SINGULAIR, närimistablett, 28TK | Merck Sharp & Dohme OÜ | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 11,00 | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1273845 | montelukast, 5mg | R03DC03 | MONTELUKAST TEVA, närimistablett, 28TK | Teva Pharma B.V. | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1289831 | montelukast, 5mg | R03DC03 | MONKASTA, närimistablett, 28TK | KRKA d.d., Novo Mesto | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1333954 | montelukast, 5mg | R03DC03 | MONTELUKAST- RATIOPHARM 5MG, närimistablett, 28TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | 11,00 | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1379370 | montelukast, 5mg | R03DC03 | MOFENSTRA, närimistablett, 28TK | Sandoz d.d. | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | 11,00 | | mõõduka ja raske bronhiaalastma korral lisaks püsiravile inhaleeritava kortikosteroidi ja pikatoimelise beeta-2- adrenomimeetikumiga, kui see ei taga piisavat kontrolli astma üle, või lisaks püsiravile inhaleeritava kortikosteroidiga, kui beeta-2- adrenomimeetikum on vastunäidustatud või põhjustab talumatuid kõrvaltoimeid |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | 11,00 | |

| | | | | | 50 | | | | | | |

| 1035740 | morfiin, 100mg | N02AA01 | VENDAL RETARD 100 MG, toimeainet prolongeeritult vabastav tablett, 30TK | LANNACHER HEILMITTEL GmbH | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1035717 | morfiin, 10mg | N02AA01 | VENDAL RETARD 10 MG, toimeainet prolongeeritult vabastav tablett, 30TK | LANNACHER HEILMITTEL GmbH | 100 | C00-D48 | | | | | |

@@ -2446,14 +2447,14 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1014051 | morfiin, 30mg | N02AA01 | DOLTARD, toimeainet prolongeeritult vabastav tablett, 20TK | Nycomed Sefa AS | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1035728 | morfiin, 30mg | N02AA01 | VENDAL RETARD 30 MG, toimeainet prolongeeritult vabastav tablett, 30TK | LANNACHER HEILMITTEL GmbH | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1014051 | morfiin, 30mg | N02AA01 | DOLTARD, toimeainet prolongeeritult vabastav tablett, 20TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1035728 | morfiin, 30mg | N02AA01 | VENDAL RETARD 30 MG, toimeainet prolongeeritult vabastav tablett, 30TK | LANNACHER HEILMITTEL GmbH | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1080289 | morfiin, 30mg | N02AA01 | MST CONTINUS 30 MG, suukaudse suspensiooni toimeainet prolongeeritult vabastavad graanulid, 30TK | MUNDIPHARMA Ges.m.b.H. | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1339422 | morfiin, 30mg | N02AA01 | MXL 30 MG, toimeainet prolongeeritult vabastav kõvakapsel, 30TK | MUNDIPHARMA Ges.m.b.H. | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1339422 | morfiin, 30mg | N02AA01 | MXL 30 MG, toimeainet prolongeeritult vabastav kõvakapsel, 30TK | MUNDIPHARMA Ges.m.b.H. | 100 | C00-D48 | | | | | |

| | | | | | 50 | | | | | | |

| 1014062 | morfiin, 60mg | N02AA01 | DOLTARD, toimeainet prolongeeritult vabastav tablett, 20TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| 1035739 | morfiin, 60mg | N02AA01 | VENDAL RETARD 60 MG, toimeainet prolongeeritult vabastav tablett, 30TK | LANNACHER HEILMITTEL GmbH | 50 | | | | | | |

@@ -2466,62 +2467,62 @@

| | | | | | 50 | | | | | | |

| 1164697 | mükofenoolhape, 360mg | L04AA06 | MYFORTIC, gastroresistentne tablett, 120TK | Novartis Finland OY | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| 1088344 | mükofenoolhape, 500mg | L04AA06 | CELLCEPT, õhukese polümeerikattega tablett, 50TK | Roche Registration Limited | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| 1088344 | mükofenoolhape, 500mg | L04AA06 | CELLCEPT, õhukese polümeerikattega tablett, 50TK | Roche Registration Limited | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| 1343270 | mükofenoolhape, 500mg | L04AA06 | MYFENAX, õhukese polümeerikattega tablett, 50TK | Teva Pharma B.V. | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| 1455230 | naatriumbemipariin, 25000RÜ anti Xa 1ml | B01AB12 | ZIBOR, süstelahus, 0.4ml 2TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| 1454879 | naatriumbemipariin, 25000RÜ anti Xa 1ml | B01AB12 | ZIBOR, süstelahus, 0.3ml 2TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| 1455230 | naatriumbemipariin, 25000RÜ anti Xa 1ml | B01AB12 | ZIBOR, süstelahus, 0.4ml 2TK | Menarini International Operations Luxembourg S.A. | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| 1003914 | naatriumdaltepariin, 12500RÜ anti Xa 1ml | B01AB04 | FRAGMIN, süstelahus, 0.2ml 10TK | Pfizer Enterprises SARL | 50 | | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1003969 | naatriumdaltepariin, 25000RÜ anti Xa 1ml | B01AB04 | FRAGMIN, süstelahus, 0.2ml 10TK | Pfizer Enterprises SARL | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| 1012587 | naatriumdaltepariin, 7500RÜ anti Xa 0.3ml | B01AB04 | FRAGMIN, süstelahus, 10TK | Pfizer Enterprises SARL | 50 | | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| 1065529 | naatriumenoksapariin, 10000RÜ 1ml | B01AB05 | CLEXANE, süstelahus, 0.2ml 10TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| 1003914 | naatriumdaltepariin, 12500RÜ anti Xa 1ml | B01AB04 | FRAGMIN, süstelahus, 0.2ml 10TK | Pfizer Enterprises SARL | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| 1065552 | naatriumenoksapariin, 10000RÜ 1ml | B01AB05 | CLEXANE, süstelahus, 0.6ml 2TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1003969 | naatriumdaltepariin, 25000RÜ anti Xa 1ml | B01AB04 | FRAGMIN, süstelahus, 0.2ml 10TK | Pfizer Enterprises SARL | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| 1065574 | naatriumenoksapariin, 10000RÜ 1ml | B01AB05 | CLEXANE, süstelahus, 0.8ml 2TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| 1012587 | naatriumdaltepariin, 7500RÜ anti Xa 0.3ml | B01AB04 | FRAGMIN, süstelahus, 10TK | Pfizer Enterprises SARL | 100 | O99.8-O99.8 | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1065596 | naatriumenoksapariin, 10000RÜ 1ml | B01AB05 | CLEXANE, süstelahus, 1ml 2TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| 1065541 | naatriumenoksapariin, 10000RÜ 1ml | B01AB05 | CLEXANE, süstelahus, 0.4ml 10TK | Sanofi-Aventis Estonia OÜ | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 100 | O99.8-O99.8 | | | | | |

| | | | | | 50 | | | | | | |

| 1201521 | naatriumfenüülbutüraat , 500mg | A16AX03 | AMMONAPS, tablett, 250TK | Swedish Orphan International AB | 100 | E72.2-E72.2 | | | | | konsiiliumi (vähemalt 2 pediaatri ühise) otsuse alusel järgmistel tingimustel: haigus kulgeb metaboolsete kriisidega vaatamata muule suukaudsele ravile; patsiendi prognoos paranemisele on hea (püsivat ajukahjustust või organpuudulikkust ei esine); ravi jätkatakse patsiendil, kellel 1 kuu kestnud ravi on andnud hea tulemuse (hüperammoneemilisi kriise ei ole esinenud või on nende sagedus oluliselt vähenenud) |

@@ -2529,8 +2530,8 @@

| 1201543 | naatriumfenüülbutüraat , 940mg 1g | A16AX03 | AMMONAPS, graanulid, 266g 1TK | Swedish Orphan International AB | 100 | E72.2-E72.2 | | | | | konsiiliumi (vähemalt 2 pediaatri ühise) otsuse alusel järgmistel tingimustel: haigus kulgeb metaboolsete kriisidega vaatamata muule suukaudsele ravile; patsiendi prognoos paranemisele on hea (püsivat ajukahjustust või organpuudulikkust ei esine); ravi jätkatakse patsiendil, kellel 1 kuu kestnud ravi on andnud hea tulemuse (hüperammoneemilisi kriise ei ole esinenud või on nende sagedus oluliselt vähenenud) |

| 1065822 | naatriumlevotüroksiin, 100mcg | H03AA01 | L-THYROXIN BERLIN- CHEMIE, tablett, 100TK | Berlin-Chemie AG (Menarini Group) | 100 | E89.0-E89.0, E03- E03, E89.3-E89.3 | | | | | |

| | | | | | 50 | | | | | | |

| 1065866 | naatriumlevotüroksiin, 50mcg | H03AA01 | L-THYROXIN BERLIN- CHEMIE, tablett, 100TK | Berlin-Chemie AG (Menarini Group) | 100 | E89.0-E89.0, E03- E03, E89.3-E89.3 | | | | | |

| | | | | | 50 | | | | | | |

| 1065866 | naatriumlevotüroksiin, 50mcg | H03AA01 | L-THYROXIN BERLIN- CHEMIE, tablett, 100TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| | | | | | 100 | E89.0-E89.0, E03- E03, E89.3-E89.3 | | | | | |

| 1035346 | naatriumsulfaat, veevaba+ kaaliumkloriid+ naatriumkloriid+ makrogool+ naatriumvesinikkarbon aat, 5,7g+0,75g+1,46g+64 g+1,68g | A06AD81 | FORTRANS, suukaudse lahuse pulber, 4TK | Ipsen Pharma | 50 | | | | | | |

@@ -2542,96 +2543,96 @@

| 1147913 | naftidrofurüül, 100mg | C04AX21 | ENELBIN 100 RETARD, toimeainet prolongeeritult vabastav tablett, 100TK | Zentiva, k.s. | 50 | | | | | | |

| 1061086 | naftifiin, 1% | D01AE22 | EXODERIL, kreem, 30g 1TK | Sandoz GmbH | 50 | | | | | | |

| 1036459 | naratriptaan, 2,5mg | N02CC02 | NARAMIG, õhukese polümeerikattega tablett, 2TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| 1247251 | nebivolool, 5mg | C07AB12 | NEBIVOLOL-TEVA, tablett, 28TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1247251 | nebivolool, 5mg | C07AB12 | NEBIVOLOL-TEVA, tablett, 28TK | Teva Pharma B.V. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1319071 | nebivolool, 5mg | C07AB12 | NEBIVOLOL PORTFARMA, tablett, 28TK | Portfarma ehf | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1072437 | nebivolool, 5mg | C07AB12 | NEBILET, tablett, 28TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1072437 | nebivolool, 5mg | C07AB12 | NEBILET, tablett, 28TK | Menarini International Operations Luxembourg S.A. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1247374 | nebivolool, 5mg | C07AB12 | NEBISPES, tablett, 28TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1247420 | nebivolool, 5mg | C07AB12 | NEBISPES, tablett, 90TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1247420 | nebivolool, 5mg | C07AB12 | NEBISPES, tablett, 90TK | Nycomed Sefa AS | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1259355 | nebivolool, 5mg | C07AB12 | NEBICARD 5MG, tablett, 60TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1269862 | nebivolool, 5mg | C07AB12 | NEBIVOLOL ACTAVIS, tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1269862 | nebivolool, 5mg | C07AB12 | NEBIVOLOL ACTAVIS, tablett, 28TK | Actavis Group PTC ehf | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1284386 | nebivolool, 5mg | C07AB12 | NEBIVOLOL ORION, tablett, 30TK | Orion Corporation | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1323885 | nebivolool, 5mg | C07AB12 | NEBITEN 5MG, tablett, 30TK | G.L. Pharma GmbH | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1323885 | nebivolool, 5mg | C07AB12 | NEBITEN 5MG, tablett, 30TK | G.L. Pharma GmbH | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1398001 | nebivolool, 5mg | C07AB12 | NEBIVOLOL-RATIOPHARM 5 MG, tablett, 28TK | ratiopharm GmbH | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1445149 | nebivolool, 5mg | C07AB12 | NEBILET, tablett, 90TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1072572 | nifedipiin, 10mg | C08CA05 | CORINFAR, toimeainet prolongeeritult vabastav tablett, 100TK | AWD. pharma GmbH & Co.KG | 50 | | | | | | |

| 1035706 | nifedipiin, 20mg | C08CA05 | NIFEDIPIN-RATIOPHARM 20, toimeainet prolongeeritult vabastav tablett, 30TK | ratiopharm GmbH | 75 | M34-M34 | Pediaater, Reumatoloog | esmane | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1005703 | nifedipiin, 20mg | C08CA05 | CORDIPIN RETARD, toimeainet prolongeeritult vabastav tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | M34-M34 | Pediaater, Reumatoloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 75 | M34-M34 | Reumatoloog, Pediaater | esmane | | | |

| 1034301 | nifedipiin, 20mg | C08CA05 | CORINFAR RETARD, toimeainet prolongeeritult vabastav tablett, 30TK | AWD. pharma GmbH & Co.KG | 50 | | | | | | |

| | | | | | 75 | M34-M34 | Pediaater, Reumatoloog | esmane | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1035706 | nifedipiin, 20mg | C08CA05 | NIFEDIPIN-RATIOPHARM 20, toimeainet prolongeeritult vabastav tablett, 30TK | ratiopharm GmbH | 75 | M34-M34 | Pediaater, Reumatoloog | esmane | | | |

| | | | | | 75 | M34-M34 | Pediaater, Reumatoloog | esmane | | | |

| 1042456 | nifedipiin, 20mg | C08CA05 | ADALAT OROS, toimeainet prolongeeritult vabastav tablett, 28TK | Bayer Schering Pharma AG | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 75 | M34-M34 | Pediaater, Reumatoloog | esmane | | | |

| 1072549 | nifedipiin, 20mg | C08CA05 | CORINFAR RETARD, toimeainet prolongeeritult vabastav tablett, 50TK | AWD. pharma GmbH & Co.KG | 75 | M34-M34 | Pediaater, Reumatoloog | esmane | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| 1072550 | nifedipiin, 20mg | C08CA05 | CORINFAR RETARD, toimeainet prolongeeritult vabastav tablett, 100TK | AWD. pharma GmbH & Co.KG | 75 | M34-M34 | Reumatoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1042456 | nifedipiin, 20mg | C08CA05 | ADALAT OROS, toimeainet prolongeeritult vabastav tablett, 28TK | Bayer Schering Pharma AG | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | M34-M34 | Pediaater, Reumatoloog | esmane | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| 1072549 | nifedipiin, 20mg | C08CA05 | CORINFAR RETARD, toimeainet prolongeeritult vabastav tablett, 50TK | AWD. pharma GmbH & Co.KG | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M34-M34 | Pediaater, Reumatoloog | esmane | | | |

| 1072550 | nifedipiin, 20mg | C08CA05 | CORINFAR RETARD, toimeainet prolongeeritult vabastav tablett, 100TK | AWD. pharma GmbH & Co.KG | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1006311 | nifedipiin, 30mg | C08CA05 | ADALAT OROS, toimeainet prolongeeritult vabastav tablett, 28TK | Bayer Schering Pharma AG | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 75 | M34-M34 | Pediaater, Reumatoloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1006311 | nifedipiin, 30mg | C08CA05 | ADALAT OROS, toimeainet prolongeeritult vabastav tablett, 28TK | Bayer Schering Pharma AG | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M34-M34 | Reumatoloog, Pediaater | esmane | | | |

| 1023422 | nifedipiin, 40mg | C08CA05 | CORDIPIN XL, toimeainet modifitseeritult vabastav tablett, 20TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1023422 | nifedipiin, 40mg | C08CA05 | CORDIPIN XL, toimeainet modifitseeritult vabastav tablett, 20TK | KRKA d.d., Novo Mesto | 75 | M34-M34 | Reumatoloog, Pediaater | esmane | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 50 | | | | | | |

| 1027886 | nifedipiin, 40mg | C08CA05 | NYCOPIN, toimeainet modifitseeritult vabastav tablett, 30TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 75 | M34-M34 | Pediaater, Reumatoloog | esmane | | | |

| 1027886 | nifedipiin, 40mg | C08CA05 | NYCOPIN, toimeainet modifitseeritult vabastav tablett, 30TK | Nycomed Sefa AS | 75 | M34-M34 | Reumatoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| 1398685 | nifedipiin, 40mg | C08CA05 | NYCOPIN, toimeainet modifitseeritult vabastav tablett, 28TK | Nycomed Sefa AS | 75 | M34-M34 | Reumatoloog, Pediaater | esmane | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1042467 | nifedipiin, 60mg | C08CA05 | ADALAT OROS, toimeainet prolongeeritult vabastav tablett, 28TK | Bayer Schering Pharma AG | 75 | M34-M34 | Reumatoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1042467 | nifedipiin, 60mg | C08CA05 | ADALAT OROS, toimeainet prolongeeritult vabastav tablett, 28TK | Bayer Schering Pharma AG | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I10-I13, I15-I15, I20- I20, O10-O16 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | M34-M34 | Reumatoloog, Pediaater | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1342190 | nilotiniib, 200mg | L01XE08 | TASIGNA, kõvakapsel, 112TK | Novartis Europharm Limited | 100 | C92.1-C92.1 | Hematoloog | | | | patsiendile, kelle ravi alustamine ja jätkamine nilotiniibiga on hinnatud konsiiliumi (vähemalt 3 hematoloogi) poolt vastavaks järgmistele kriteeriumidele: näidustatud on tsütogeneetilist vastust indutseeriv ravi, eelnev ravi imatiniibiga annuses 600 mg on ebaõnnestunud või osutunud talumatuks (imatiniibravi on põhjustanud III või IV astme kõrvaltoime või üle 3 kuu püsinud II astme kõrvaltoime CTC klassifikatsiooni järgi), nilotiniibravi foonil püsib hematoloogiline ravivastus (haigus ei progresseeru). Soodustus ei laiene patsientidele, kelle ravi nilotiniibiga on ravimitootja vastutusel alustatud ja tagatud enne 1. oktoobrit 2009. a. |

| | | | | | 50 | | | | | | |

| 1261842 | nitrendipiin, 10mg | C08CA08 | NITRESAN 10 MG, tablett, 50TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| 1261842 | nitrendipiin, 10mg | C08CA08 | NITRESAN 10 MG, tablett, 50TK | PRO. MED. CS. PRAHA a.s. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1014545 | nitrendipiin, 20mg | C08CA08 | LUSOPRESS, tablett, 28TK | Instituto Luso Farmaco d Italia S.p.A. | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1014545 | nitrendipiin, 20mg | C08CA08 | LUSOPRESS, tablett, 28TK | Instituto Luso Farmaco d Italia S.p.A. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1261886 | nitrendipiin, 20mg | C08CA08 | NITRESAN 20 MG, tablett, 50TK | PRO. MED. CS. PRAHA a.s. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1261886 | nitrendipiin, 20mg | C08CA08 | NITRESAN 20 MG, tablett, 50TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1003857 | nitrofurantoiin, 50mg | J01XE01 | NITROFURANTOIN NYCOMED, tablett, 20TK | Nycomed Sefa AS | 50 | | | | | | |

| 1131589 | norelgestromiin+ etünüülöstradiool, 6mg+0,6mg | G03AA13 | EVRA, transdermaalne plaaster, 3TK | Janssen-Cilag International N.V. | 50 | | | | | | |

| 1175464 | noretisteroon+ östradiool, 0,5mg+1mg | G03FA01 | ACTIVELLE, õhukese polümeerikattega tablett, 28TK | Novo Nordisk A/S | 50 | | | | | | |

@@ -2639,8 +2640,8 @@

| 1116560 | noretisteroon+ östradiool+ östradiool, 1mg+1mg/0+1mg | G03FB05 | NOVOFEM, õhukese polümeerikattega tablett, 12TK / 16TK | Novo Nordisk A/S | 50 | | | | | | |

| 1030464 | noretisteroon+östradio ol, 1mg+2mg | G03FA01 | KLIOGEST, õhukese polümeerikattega tablett, 28TK | Novo Nordisk A/S | 50 | | | | | | |

| 1005455 | norfloksatsiin, 400mg | J01MA06 | NOLICIN, õhukese polümeerikattega tablett, 20TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1020430 | norgestimaat+etünüülö stradiool, 0,25mg+0,035mg | G03AA11 | CILEST, tablett, 21TK | Johnson & Johnson UAB | 50 | | | | | | |

| | | | | | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| 1020430 | norgestimaat+etünüülö stradiool, 0,25mg+0,035mg | G03AA11 | CILEST, tablett, 21TK | Johnson & Johnson UAB | 75 | Z30-Z30 | | | | | sünnitamisele meditsiinilise vastunäidustuse korral |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

@@ -2652,23 +2653,23 @@

| 1089402 | ofloksatsiin, 200mg | J01MA01 | OFLOXIN 200, õhukese polümeerikattega tablett, 10TK | Zentiva, k.s. | 50 | | | | | | |

| 1009673 | okskarbasepiin, 300mg | N03AF02 | TRILEPTAL, õhukese polümeerikattega tablett, 50TK | Novartis Finland OY | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1036033 | okskarbasepiin, 600mg | N03AF02 | APYDAN 600 MG, tablett, 50TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| 1036044 | okskarbasepiin, 300mg | N03AF02 | APYDAN 300 MG, tablett, 50TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1009684 | okskarbasepiin, 600mg | N03AF02 | TRILEPTAL, õhukese polümeerikattega tablett, 50TK | Novartis Finland OY | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1028483 | oksübutüniin, 5mg | G04BD04 | DRIPTANE, tablett, 60TK | Laboratoires Fournier S.A. | 50 | | | | | | |

| | | | | | 75 | N31-N31 | Pediaater, Neuroloog, Uroloog | | | | |

| | | | | | 75 | N31-N31 | Uroloog, Neuroloog, Pediaater | | | | |

| 1080593 | oksükodoon, 10mg | N02AA05 | OXYCONTIN 10 MG, toimeainet prolongeeritult vabastav tablett, 56TK | MUNDIPHARMA Ges.m.b.H. | 100 | C00-D48 | | | | | patsientidele, kellel suukaudne morfiin põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1402568 | oksükodoon, 10mg | N02AA05 | OXYCONTIN 10 MG, toimeainet prolongeeritult vabastav tablett, 60TK | MUNDIPHARMA Ges.m.b.H. | 100 | C00-D48 | | | | | patsientidele, kellel suukaudne morfiin põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1080627 | oksükodoon, 20mg | N02AA05 | OXYCONTIN 20 MG, toimeainet prolongeeritult vabastav tablett, 56TK | MUNDIPHARMA Ges.m.b.H. | 50 | | | | | | |

| 1402568 | oksükodoon, 10mg | N02AA05 | OXYCONTIN 10 MG, toimeainet prolongeeritult vabastav tablett, 60TK | MUNDIPHARMA Ges.m.b.H. | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | patsientidele, kellel suukaudne morfiin põhjustab olulisi kõrvaltoimeid |

| 1080627 | oksükodoon, 20mg | N02AA05 | OXYCONTIN 20 MG, toimeainet prolongeeritult vabastav tablett, 56TK | MUNDIPHARMA Ges.m.b.H. | 100 | C00-D48 | | | | | patsientidele, kellel suukaudne morfiin põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1402580 | oksükodoon, 20mg | N02AA05 | OXYCONTIN 20 MG, toimeainet prolongeeritult vabastav tablett, 60TK | MUNDIPHARMA Ges.m.b.H. | 100 | C00-D48 | | | | | patsientidele, kellel suukaudne morfiin põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

@@ -2676,44 +2677,44 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1080650 | oksükodoon, 40mg | N02AA05 | OXYCONTIN 40 MG, toimeainet prolongeeritult vabastav tablett, 56TK | MUNDIPHARMA Ges.m.b.H. | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | patsientidele, kellel suukaudne morfiin põhjustab olulisi kõrvaltoimeid |

| 1402603 | oksükodoon, 40mg | N02AA05 | OXYCONTIN 40 MG, toimeainet prolongeeritult vabastav tablett, 60TK | MUNDIPHARMA Ges.m.b.H. | 100 | C00-D48 | | | | | patsientidele, kellel suukaudne morfiin põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1075542 | oksükodoon, 80mg | N02AA05 | OXYCONTIN 80 MG, toimeainet prolongeeritult vabastav tablett, 56TK | MUNDIPHARMA Ges.m.b.H. | 100 | C00-D48 | | | | | patsientidele, kellel suukaudne morfiin põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1402625 | oksükodoon, 80mg | N02AA05 | OXYCONTIN 80 MG, toimeainet prolongeeritult vabastav tablett, 60TK | MUNDIPHARMA Ges.m.b.H. | 50 | | | | | | |

| 1402603 | oksükodoon, 40mg | N02AA05 | OXYCONTIN 40 MG, toimeainet prolongeeritult vabastav tablett, 60TK | MUNDIPHARMA Ges.m.b.H. | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | patsientidele, kellel suukaudne morfiin põhjustab olulisi kõrvaltoimeid |

| 1289516 | olansapiin, 10mg | N05AH03 | OLANZAPINE ACTAVIS, suus dispergeeruv tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1075542 | oksükodoon, 80mg | N02AA05 | OXYCONTIN 80 MG, toimeainet prolongeeritult vabastav tablett, 56TK | MUNDIPHARMA Ges.m.b.H. | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | patsientidele, kellel suukaudne morfiin põhjustab olulisi kõrvaltoimeid |

| 1402625 | oksükodoon, 80mg | N02AA05 | OXYCONTIN 80 MG, toimeainet prolongeeritult vabastav tablett, 60TK | MUNDIPHARMA Ges.m.b.H. | 100 | C00-D48 | | | | | patsientidele, kellel suukaudne morfiin põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1289516 | olansapiin, 10mg | N05AH03 | OLANZAPINE ACTAVIS, suus dispergeeruv tablett, 28TK | Actavis Group PTC ehf | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1259096 | olansapiin, 10mg | N05AH03 | OLANZAPIN-RATIOPHARM, tablett, 28TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1259096 | olansapiin, 10mg | N05AH03 | OLANZAPIN-RATIOPHARM, tablett, 28TK | ratiopharm GmbH | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1259108 | olansapiin, 10mg | N05AH03 | OLANZAPIN-RATIOPHARM, tablett, 30TK | ratiopharm GmbH | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1267714 | olansapiin, 10mg | N05AH03 | OLANZAPIN ACTAVIS, õhukese polümeerikattega tablett, 28TK | Actavis Group PTC ehf | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1271810 | olansapiin, 10mg | N05AH03 | SOLAZIN, tablett, 28TK | Nycomed Sefa AS | 50 | | | | | | |

| 1267714 | olansapiin, 10mg | N05AH03 | OLANZAPIN ACTAVIS, õhukese polümeerikattega tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1271810 | olansapiin, 10mg | N05AH03 | SOLAZIN, tablett, 28TK | Nycomed Sefa AS | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1271821 | olansapiin, 10mg | N05AH03 | SOLAZIN, tablett, 56TK | Nycomed Sefa AS | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1271854 | olansapiin, 10mg | N05AH03 | ZOLAFREN, tablett, 28TK | Laboratorios Adamed Sp. z.o.o | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1271854 | olansapiin, 10mg | N05AH03 | ZOLAFREN, tablett, 28TK | Laboratorios Adamed Sp. z.o.o | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1326507 | olansapiin, 10mg | N05AH03 | ZALASTA, suus dispergeeruv tablett, 28TK | KRKA d.d., Novo Mesto | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1342820 | olansapiin, 10mg | N05AH03 | OLANZAPINE TEVA, suus dispergeeruv tablett, 28TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1342820 | olansapiin, 10mg | N05AH03 | OLANZAPINE TEVA, suus dispergeeruv tablett, 28TK | Teva Pharma B.V. | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1289572 | olansapiin, 15mg | N05AH03 | OLANZAPINE ACTAVIS, suus dispergeeruv tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1267905 | olansapiin, 15mg | N05AH03 | OLANZAPIN ACTAVIS, õhukese polümeerikattega tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1342886 | olansapiin, 15mg | N05AH03 | OLANZAPINE TEVA, suus dispergeeruv tablett, 28TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1289459 | olansapiin, 5mg | N05AH03 | OLANZAPINE ACTAVIS, suus dispergeeruv tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1342886 | olansapiin, 15mg | N05AH03 | OLANZAPINE TEVA, suus dispergeeruv tablett, 28TK | Teva Pharma B.V. | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1289459 | olansapiin, 5mg | N05AH03 | OLANZAPINE ACTAVIS, suus dispergeeruv tablett, 28TK | Actavis Group PTC ehf | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1267455 | olansapiin, 5mg | N05AH03 | OLANZAPIN ACTAVIS, õhukese polümeerikattega tablett, 28TK | Actavis Group PTC ehf | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

@@ -2721,15 +2722,15 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1271797 | olansapiin, 5mg | N05AH03 | SOLAZIN, tablett, 28TK | Nycomed Sefa AS | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1271832 | olansapiin, 5mg | N05AH03 | ZOLAFREN, tablett, 28TK | Laboratorios Adamed Sp. z.o.o | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1271832 | olansapiin, 5mg | N05AH03 | ZOLAFREN, tablett, 28TK | Laboratorios Adamed Sp. z.o.o | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1326406 | olansapiin, 5mg | N05AH03 | ZALASTA, suus dispergeeruv tablett, 28TK | KRKA d.d., Novo Mesto | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1342763 | olansapiin, 5mg | N05AH03 | OLANZAPINE TEVA, suus dispergeeruv tablett, 28TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1139060 | olmesartaanmedokso miil, 10mg | C09CA08 | MESAR 10MG, õhukese polümeerikattega tablett, 28TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| 1407664 | olmesartaanmedokso miil, 10mg | C09CA08 | OLIMESTRA, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1407664 | olmesartaanmedokso miil, 10mg | C09CA08 | OLIMESTRA, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1139105 | olmesartaanmedokso miil, 20mg | C09CA08 | MESAR 20MG, õhukese polümeerikattega tablett, 28TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

| 1407833 | olmesartaanmedokso miil, 20mg | C09CA08 | OLIMESTRA, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

@@ -2744,46 +2745,46 @@

| 1140220 | olopatadiin, 1mg 1ml | S01GX09 | OPATANOL, silmatilgad, lahus, 5ml 1TK | ALCON LABORATORIES (UK) Ltd. | 50 | | | | | | |

| 1101542 | omeprasool, 20mg | A02BC01 | LOSEPRAZOL, gastroresistentne kõvakapsel, 14TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1101564 | omeprasool, 20mg | A02BC01 | LOSEPRAZOL, gastroresistentne kõvakapsel, 28TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| 1101564 | omeprasool, 20mg | A02BC01 | LOSEPRAZOL, gastroresistentne kõvakapsel, 28TK | PRO. MED. CS. PRAHA a.s. | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1194476 | omeprasool, 20mg | A02BC01 | OMEPRAZOL SANDOZ 20 MG, gastroresistentne kõvakapsel, 14TK | Sandoz d.d. | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1194498 | omeprasool, 20mg | A02BC01 | OMEPRAZOL SANDOZ 20 MG, gastroresistentne kõvakapsel, 28TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1041613 | omeprasool, 20mg | A02BC01 | OMEPRAZOLE- RATIOPHARM, gastroresistentne kõvakapsel, 15TK | ratiopharm GmbH | 50 | | | | | | |

| 1269200 | omeprasool, 20mg | A02BC01 | OMEP 20MG, gastroresistentne kõvakapsel, 15TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1269222 | omeprasool, 20mg | A02BC01 | OMEP 20MG, gastroresistentne kõvakapsel, 30TK | Sandoz d.d. | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1269244 | omeprasool, 20mg | A02BC01 | OMEP 20MG, gastroresistentne kõvakapsel, 56TK | Sandoz d.d. | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1041613 | omeprasool, 20mg | A02BC01 | OMEPRAZOLE- RATIOPHARM, gastroresistentne kõvakapsel, 15TK | ratiopharm GmbH | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1062166 | omeprasool, 20mg | A02BC01 | OMEPRAZOLE- RATIOPHARM, gastroresistentne kõvakapsel, 30TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1062199 | omeprasool, 20mg | A02BC01 | GASEC GASTROCAPS 20 MG, gastroresistentne kõvakapsel, 14TK | MEPHA Lda. | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1062201 | omeprasool, 20mg | A02BC01 | GASEC GASTROCAPS 20 MG, gastroresistentne kõvakapsel, 28TK | MEPHA Lda. | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1131815 | omeprasool, 20mg | A02BC01 | ULTOP, gastroresistentne kõvakapsel, 14TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1062201 | omeprasool, 20mg | A02BC01 | GASEC GASTROCAPS 20 MG, gastroresistentne kõvakapsel, 28TK | MEPHA Lda. | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1194476 | omeprasool, 20mg | A02BC01 | OMEPRAZOL SANDOZ 20 MG, gastroresistentne kõvakapsel, 14TK | Sandoz d.d. | 50 | | | | | | |

| 1131815 | omeprasool, 20mg | A02BC01 | ULTOP, gastroresistentne kõvakapsel, 14TK | KRKA d.d., Novo Mesto | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1352393 | omeprasool, 20mg | A02BC01 | OMEPRAZOLE STADA 20 MG, gastroresistentne kõvakapsel, 30TK | STADA ARZNEIMITTEL AG | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1423077 | omeprasool, 20mg | A02BC01 | ULTOP, gastroresistentne kõvakapsel, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1194498 | omeprasool, 20mg | A02BC01 | OMEPRAZOL SANDOZ 20 MG, gastroresistentne kõvakapsel, 28TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1269200 | omeprasool, 20mg | A02BC01 | OMEP 20MG, gastroresistentne kõvakapsel, 15TK | Sandoz d.d. | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1269244 | omeprasool, 20mg | A02BC01 | OMEP 20MG, gastroresistentne kõvakapsel, 56TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1423077 | omeprasool, 20mg | A02BC01 | ULTOP, gastroresistentne kõvakapsel, 28TK | KRKA d.d., Novo Mesto | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1112814 | omeprasool, 40mg | A02BC01 | GASEC GASTROCAPS 40 MG, gastroresistentne kõvakapsel, 14TK | MEPHA Lda. | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1269301 | omeprasool, 40mg | A02BC01 | OMEP 40MG, gastroresistentne kõvakapsel, 15TK | Sandoz d.d. | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1269323 | omeprasool, 40mg | A02BC01 | OMEP 40MG, gastroresistentne kõvakapsel, 30TK | Sandoz d.d. | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1112814 | omeprasool, 40mg | A02BC01 | GASEC GASTROCAPS 40 MG, gastroresistentne kõvakapsel, 14TK | MEPHA Lda. | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1247150 | ondansetroon, 8mg | A04AA01 | ONDANSETRON BMM PHARMA, õhukese polümeerikattega tablett, 10TK | BMM Pharma AB | 50 | | | | | | |

@@ -2794,33 +2795,33 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1110643 | oseltamiviir, 75mg | J05AH02 | TAMIFLU, kõvakapsel, 10TK | Roche Registration Limited | 50 | | | | | | |

| 1043020 | pantoprasool, 20mg | A02BC02 | CONTROLOC 20 MG, gastroresistentne tablett, 14TK | Nycomed GmbH | 50 | | | | | | |

| 1043020 | pantoprasool, 20mg | A02BC02 | CONTROLOC 20 MG, gastroresistentne tablett, 14TK | Nycomed GmbH | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1277232 | pantoprasool, 20mg | A02BC02 | PANTOPRAZOLE ACTAVIS, gastroresistentne tablett, 28TK | Actavis Group PTC ehf | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1249758 | pantoprasool, 20mg | A02BC02 | NOLPAZA, gastroresistentne tablett, 14TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1249758 | pantoprasool, 20mg | A02BC02 | NOLPAZA, gastroresistentne tablett, 14TK | KRKA d.d., Novo Mesto | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1249770 | pantoprasool, 20mg | A02BC02 | NOLPAZA, gastroresistentne tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1249770 | pantoprasool, 20mg | A02BC02 | NOLPAZA, gastroresistentne tablett, 28TK | KRKA d.d., Novo Mesto | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1043031 | pantoprasool, 40mg | A02BC02 | CONTROLOC 40 MG, gastroresistentne tablett, 14TK | Nycomed GmbH | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1277232 | pantoprasool, 20mg | A02BC02 | PANTOPRAZOLE ACTAVIS, gastroresistentne tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1277344 | pantoprasool, 40mg | A02BC02 | PANTOPRAZOLE ACTAVIS, gastroresistentne tablett, 28TK | Actavis Group PTC ehf | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1043031 | pantoprasool, 40mg | A02BC02 | CONTROLOC 40 MG, gastroresistentne tablett, 14TK | Nycomed GmbH | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1249646 | pantoprasool, 40mg | A02BC02 | NOLPAZA, gastroresistentne tablett, 14TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1249668 | pantoprasool, 40mg | A02BC02 | NOLPAZA, gastroresistentne tablett, 28TK | KRKA d.d., Novo Mesto | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1277344 | pantoprasool, 40mg | A02BC02 | PANTOPRAZOLE ACTAVIS, gastroresistentne tablett, 28TK | Actavis Group PTC ehf | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1280449 | pantoprasool, 40mg | A02BC02 | PANTOPRAZOL - RATIOPHARM 40 MG, gastroresistentne tablett, 14TK | ratiopharm GmbH | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| | | | | | 50 | | | | | | |

| 1249668 | pantoprasool, 40mg | A02BC02 | NOLPAZA, gastroresistentne tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1280449 | pantoprasool, 40mg | A02BC02 | PANTOPRAZOL - RATIOPHARM 40 MG, gastroresistentne tablett, 14TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | K25-K27 | | | | | Helicobacter pylori infektsiooniga seotud peptilise haavandi ravi korral koos antibiootikumidega |

| 1110799 | paroksetiin, 20mg | N06AB05 | PAROXETIN HEXAL 20 MG, õhukese polümeerikattega tablett, 30TK | HEXAL AG | 50 | | | | | | |

| 1185072 | paroksetiin, 20mg | N06AB05 | PAROXETIN ACTAVIS 20 MG, õhukese polümeerikattega tablett, 30TK | Actavis Nordic A/S | 50 | | | | | | |

| 1244900 | paroksetiin, 20mg | N06AB05 | ARKETIS 20 MG, tablett, 30TK | Medochemie Ltd | 50 | | | | | | |

| 1351583 | paroksetiin, 20mg | N06AB05 | PAROXETINE ORION, õhukese polümeerikattega tablett, 30TK | Orion Corporation | 50 | | | | | | |

| 1060232 | paroksetiin, 20mg | N06AB05 | SEROXAT, õhukese polümeerikattega tablett, 30TK | SMITHKLINE BEECHAM plc | 50 | | | | | | |

| 1096837 | paroksetiin, 20mg | N06AB05 | REXETIN, õhukese polümeerikattega tablett, 30TK | Gedeon Richter Plc. | 50 | | | | | | |

| 1185072 | paroksetiin, 20mg | N06AB05 | PAROXETIN ACTAVIS 20 MG, õhukese polümeerikattega tablett, 30TK | Actavis Nordic A/S | 50 | | | | | | |

| 1244900 | paroksetiin, 20mg | N06AB05 | ARKETIS 20 MG, tablett, 30TK | Medochemie Ltd | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

@@ -2831,8 +2832,8 @@

| 1015018 | pentoksüfülliin, 400mg | C04AD03 | PENTILIN, toimeainet prolongeeritult vabastav tablett, 20TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1028854 | pentoksüfülliin, 600mg | C04AD03 | VASONIT RETARD, toimeainet prolongeeritult vabastav tablett, 20TK | G.L. Pharma GmbH | 50 | | | | | | |

| 1168422 | perindopriil, 10mg | C09AA04 | PRESTARIUM ARGININE 10MG, õhukese polümeerikattega tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| 1283970 | perindopriil, 4mg | C09AA04 | PERINDOBAX, tablett, 30TK | Ranbaxy (UK) Limited | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1283970 | perindopriil, 4mg | C09AA04 | PERINDOBAX, tablett, 30TK | Ranbaxy (UK) Limited | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1302860 | perindopriil, 4mg | C09AA04 | STOPRESS, tablett, 30TK | Pharmaceutical Works Polpharma S.A. | 50 | | | | | | |

| 1168310 | perindopriil, 5mg | C09AA04 | PRESTARIUM ARGININE 5MG, õhukese polümeerikattega tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| 1284016 | perindopriil, 8mg | C09AA04 | PERINDOBAX, tablett, 30TK | Ranbaxy (UK) Limited | 50 | | | | | | |

@@ -2841,17 +2842,17 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1229587 | perindopriil+ indapamiid, 2,5mg+0,625mg | C09BA04 | NOLIPREL ARGININE, õhukese polümeerikattega tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| 1407068 | perindopriil+ indapamiid, 2mg+0,625mg | C09BA04 | CO-PRENESSA, tablett, 30TK | Krka, d.d., Novo mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1407068 | perindopriil+ indapamiid, 2mg+0,625mg | C09BA04 | CO-PRENESSA, tablett, 30TK | Krka, d.d., Novo mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1042401 | perindopriil+ indapamiid, 2mg+0,625mg | C09BA04 | NOLIPREL, tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| 1407158 | perindopriil+ indapamiid, 4mg+1,25mg | C09BA04 | CO-PRENESSA, tablett, 30TK | Krka, d.d., Novo mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1407158 | perindopriil+ indapamiid, 4mg+1,25mg | C09BA04 | CO-PRENESSA, tablett, 30TK | Krka, d.d., Novo mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1042412 | perindopriil+ indapamiid, 4mg+1,25mg | C09BA04 | NOLIPREL FORTE, tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| 1229879 | perindopriil+ indapamiid, 5mg+1,25mg | C09BA04 | NOLIPREL FORTE ARGININE, õhukese polümeerikattega tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| 1001855 | pilokarpiinvesinikkloriid +timolool, 20mg+5mg 1ml | S01EB80 | FOTIL, silmatilgad, lahus, 5ml 1TK | SANTEN OY | 50 | | | | | | |

| | | | | | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| 1002025 | pilokarpiinvesinikkloriid +timolool, 40mg+5mg 1ml | S01EB80 | FOTIL FORTE, silmatilgad, lahus, 5ml 1TK | SANTEN OY | 50 | | | | | | |

| 1229587 | perindopriil+indapamiid , 2,5mg+0,625mg | C09BA04 | NOLIPREL ARGININE, õhukese polümeerikattega tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| 1229879 | perindopriil+indapamiid , 5mg+1,25mg | C09BA04 | NOLIPREL FORTE ARGININE, õhukese polümeerikattega tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| 1001855 | pilokarpiinvesinikkloriid + timolool, 20mg+5mg 1ml | S01EB80 | FOTIL, silmatilgad, lahus, 5ml 1TK | SANTEN OY | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1002025 | pilokarpiinvesinikkloriid + timolool, 40mg+5mg 1ml | S01EB80 | FOTIL FORTE, silmatilgad, lahus, 5ml 1TK | SANTEN OY | 50 | | | | | | |

| | | | | | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| 1104680 | pimekroliimus, 10mg 1g | D11AH02 | ELIDEL, kreem, 15g 1TK | Novartis Finland OY | 50 | | | | | | |

| 1013566 | pioglitasoon, 15mg | A10BG03 | ACTOS, tablett, 28TK | Takeda Global Research and Development Centre (Europe) Ltd | 50 | | | | | | |

@@ -2869,57 +2870,57 @@

| 1039890 | piroksikaam, 20mg | M01AC01 | BREXIN, suukaudse lahuse pulber, 20TK | UAB Norameda | 50 | | | | | | |

| 1094026 | podofüllotoksiin, 0,15% | D06BB04 | WARTEC, kreem, 5g 1TK | Stiefel Laboratories (Ireland) Ltd. | 50 | | | | | | |

| 1033681 | podofüllotoksiin, 5mg 1ml | D06BB04 | WARTEC, nahalahus, 3ml 1TK | Stiefel Laboratories (Ireland) Ltd. | 50 | | | | | | |

| 1271775 | polüstüreensulfonaat, 949mg 1g | V03AE01 | SORBISTERIT, suukaudse /rektaalsuspensiooni pulber, 500g 1TK | Fresenius Medical Care Nephrologica Deutschland GmbH | 100 | N18-N18 | | | | | |

| | | | | | 50 | | | | | | |

| 1339332 | pramipeksool, 0,088mg | N04BC05 | PRAMIPEXOLE ORION, tablett, 30TK | Orion Corporation | 50 | | | | | | |

| 1271775 | polüstüreensulfonaat, 949mg 1g | V03AE01 | SORBISTERIT, suukaudse /rektaalsuspensiooni pulber, 500g 1TK | Fresenius Medical Care Nephrologica Deutschland GmbH | 50 | | | | | | |

| | | | | | 100 | N18-N18 | | | | | |

| 1323256 | pramipeksool, 0,088mg | N04BC05 | EZAPREV 0,088 MG, tablett, 30TK | UAB Norameda | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1339332 | pramipeksool, 0,088mg | N04BC05 | PRAMIPEXOLE ORION, tablett, 30TK | Orion Corporation | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1041242 | pramipeksool, 0,088mg | N04BC05 | MIRAPEXIN, tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1041242 | pramipeksool, 0,088mg | N04BC05 | MIRAPEXIN, tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1323256 | pramipeksool, 0,088mg | N04BC05 | EZAPREV 0,088 MG, tablett, 30TK | UAB Norameda | 50 | | | | | | |

| 1323728 | pramipeksool, 0,088mg | N04BC05 | PRAMIPEXOLE PORTFARMA, tablett, 30TK | Portfarma ehf | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1373611 | pramipeksool, 0,088mg | N04BC05 | OPRYMEA, tablett, 30TK | KRKA d.d., Novo Mesto | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1323267 | pramipeksool, 0,18mg | N04BC05 | EZAPREV 0,18 MG, tablett, 30TK | UAB Norameda | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1339354 | pramipeksool, 0,18mg | N04BC05 | PRAMIPEXOLE ORION, tablett, 30TK | Orion Corporation | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1323728 | pramipeksool, 0,088mg | N04BC05 | PRAMIPEXOLE PORTFARMA, tablett, 30TK | Portfarma ehf | 50 | | | | | | |

| 1041253 | pramipeksool, 0,18mg | N04BC05 | MIRAPEXIN, tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1373611 | pramipeksool, 0,088mg | N04BC05 | OPRYMEA, tablett, 30TK | KRKA d.d., Novo Mesto | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1339354 | pramipeksool, 0,18mg | N04BC05 | PRAMIPEXOLE ORION, tablett, 30TK | Orion Corporation | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1041253 | pramipeksool, 0,18mg | N04BC05 | MIRAPEXIN, tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1323267 | pramipeksool, 0,18mg | N04BC05 | EZAPREV 0,18 MG, tablett, 30TK | UAB Norameda | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1323762 | pramipeksool, 0,18mg | N04BC05 | PRAMIPEXOLE PORTFARMA, tablett, 30TK | Portfarma ehf | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1373666 | pramipeksool, 0,18mg | N04BC05 | OPRYMEA, tablett, 30TK | KRKA d.d., Novo Mesto | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1450998 | pramipeksool, 0,26mg | N04BC05 | MIRAPEXIN, toimeainet prolongeeritult vabastav tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| 1450998 | pramipeksool, 0,26mg | N04BC05 | MIRAPEXIN, toimeainet prolongeeritult vabastav tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1451023 | pramipeksool, 0,52mg | N04BC05 | MIRAPEXIN, toimeainet prolongeeritult vabastav tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1451023 | pramipeksool, 0,52mg | N04BC05 | MIRAPEXIN, toimeainet prolongeeritult vabastav tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| 1323313 | pramipeksool, 0,7mg | N04BC05 | EZAPREV 0,7 MG, tablett, 100TK | UAB Norameda | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1323784 | pramipeksool, 0,7mg | N04BC05 | PRAMIPEXOLE PORTFARMA, tablett, 30TK | Portfarma ehf | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1339400 | pramipeksool, 0,7mg | N04BC05 | PRAMIPEXOLE ORION, tablett, 30TK | Orion Corporation | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1041264 | pramipeksool, 0,7mg | N04BC05 | MIRAPEXIN, tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1323313 | pramipeksool, 0,7mg | N04BC05 | EZAPREV 0,7 MG, tablett, 100TK | UAB Norameda | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1323784 | pramipeksool, 0,7mg | N04BC05 | PRAMIPEXOLE PORTFARMA, tablett, 30TK | Portfarma ehf | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1041264 | pramipeksool, 0,7mg | N04BC05 | MIRAPEXIN, tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1373824 | pramipeksool, 0,7mg | N04BC05 | OPRYMEA, tablett, 30TK | KRKA d.d., Novo Mesto | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1451067 | pramipeksool, 1,05mg | N04BC05 | MIRAPEXIN, toimeainet prolongeeritult vabastav tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1451067 | pramipeksool, 1,05mg | N04BC05 | MIRAPEXIN, toimeainet prolongeeritult vabastav tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1451135 | pramipeksool, 2,1mg | N04BC05 | MIRAPEXIN, toimeainet prolongeeritult vabastav tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1451168 | pramipeksool, 3,15mg | N04BC05 | MIRAPEXIN, toimeainet prolongeeritult vabastav tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1451168 | pramipeksool, 3,15mg | N04BC05 | MIRAPEXIN, toimeainet prolongeeritult vabastav tablett, 30TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1026201 | pravastatiin, 20mg | C10AA03 | LIPOSTAT 20 MG, tablett, 30TK | Bristol-Myers Squibb Gyogyszerkereskedel mi Kft. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1118034 | pravastatiin, 20mg | C10AA03 | PRAVAHEXAL 20 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

@@ -2929,18 +2930,18 @@

| 1118056 | pravastatiin, 40mg | C10AA03 | PRAVAHEXAL 40 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1065776 | prednisoloon, 5mg | H02AB06 | PREDNISOLON-RICHTER, tablett, 100TK | Gedeon Richter Plc. | 100 | G70-G70 | Neuroloog, Pediaater | esmane | | | |

| | | | | | 75 | N00-N08 | Pediaater, Nefroloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 100 | G70-G70 | Pediaater, Neuroloog | esmane | | | |

| | | | | | 100 | C00-D48 | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| 1031702 | prednisoloon+salitsüül hape, 0,2%+0,4% | D07XA81 | ALPICORT, nahalahus, 100ml 1TK | Dr. August Wolff GmbH & Co. KG Arzneimittel | 50 | | | | | | |

| 1208652 | pregabaliin, 150mg | N03AX16 | LYRICA, kõvakapsel, 14TK | Pfizer Limited | 50 | | | | | | |

@@ -2961,60 +2962,60 @@

| 1028696 | propüültiouratsiil, 50mg | H03BA02 | TIOTIL, tablett, 100TK | Nevadapharma AB | 50 | | | | | | |

| 1078310 | pseudoefedriin+ loratadiin, 240mg+10mg | R01BA89 | CLARINASE, toimeainet prolongeeritult vabastav tablett, 7TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1141311 | pseudoefedriin+ tsetirisiin, 120mg+5mg | R01BA93 | CIRRUS, toimeainet prolongeeritult vabastav tablett, 14TK | UCB Pharma OY Finland | 50 | | | | | | |

| 1074451 | püridostigmiinbromiid, 60mg | N07AA02 | KALYMIN 60 N, tablett, 100TK | AWD. pharma GmbH & Co.KG | 100 | G70-G70 | Pediaater, Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1059218 | ramipriil, 10mg | C09AA05 | CARDACE, tablett, 28TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1074451 | püridostigmiinbromiid, 60mg | N07AA02 | KALYMIN 60 N, tablett, 100TK | AWD. pharma GmbH & Co.KG | 50 | | | | | | |

| | | | | | 100 | G70-G70 | Neuroloog, Pediaater | esmane | | | |

| 1169939 | ramipriil, 10mg | C09AA05 | RAMIPRIL ACTAVIS 10MG, tablett, 28TK | Actavis Nordic A/S | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1190078 | ramipriil, 10mg | C09AA05 | AMPRIL 10 MG, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1059218 | ramipriil, 10mg | C09AA05 | CARDACE, tablett, 28TK | Sanofi-Aventis Estonia OÜ | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1153527 | ramipriil, 10mg | C09AA05 | RAMICOR 10 MG, tablett, 30TK | HEXAL AG | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1169939 | ramipriil, 10mg | C09AA05 | RAMIPRIL ACTAVIS 10MG, tablett, 28TK | Actavis Nordic A/S | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1190078 | ramipriil, 10mg | C09AA05 | AMPRIL 10 MG, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1359121 | ramipriil, 10mg | C09AA05 | RAMIGAMMA, tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1005826 | ramipriil, 2,5mg | C09AA05 | CARDACE 2,5 MG, tablett, 28TK | Sanofi-Aventis Estonia OÜ | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1074743 | ramipriil, 2,5mg | C09AA05 | CARDACE 2,5 MG, tablett, 98TK | Sanofi-Aventis Estonia OÜ | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1153381 | ramipriil, 2,5mg | C09AA05 | RAMICOR 2,5 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1189953 | ramipriil, 2,5mg | C09AA05 | AMPRIL 2,5 MG, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1359121 | ramipriil, 10mg | C09AA05 | RAMIGAMMA, tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1189953 | ramipriil, 2,5mg | C09AA05 | AMPRIL 2,5 MG, tablett, 30TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1005826 | ramipriil, 2,5mg | C09AA05 | CARDACE 2,5 MG, tablett, 28TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1074743 | ramipriil, 2,5mg | C09AA05 | CARDACE 2,5 MG, tablett, 98TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1153381 | ramipriil, 2,5mg | C09AA05 | RAMICOR 2,5 MG, tablett, 30TK | HEXAL AG | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1358940 | ramipriil, 2,5mg | C09AA05 | RAMIGAMMA, tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1005859 | ramipriil, 5mg | C09AA05 | CARDACE 5 MG, tablett, 28TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1169849 | ramipriil, 5mg | C09AA05 | RAMIPRIL ACTAVIS 5MG, tablett, 28TK | Actavis Nordic A/S | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1169883 | ramipriil, 5mg | C09AA05 | RAMIPRIL ACTAVIS 5MG, tablett, 98TK | Actavis Nordic A/S | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1190034 | ramipriil, 5mg | C09AA05 | AMPRIL 5 MG, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1005859 | ramipriil, 5mg | C09AA05 | CARDACE 5 MG, tablett, 28TK | Sanofi-Aventis Estonia OÜ | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1074754 | ramipriil, 5mg | C09AA05 | CARDACE 5 MG, tablett, 98TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1153459 | ramipriil, 5mg | C09AA05 | RAMICOR 5 MG, tablett, 30TK | HEXAL AG | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1169849 | ramipriil, 5mg | C09AA05 | RAMIPRIL ACTAVIS 5MG, tablett, 28TK | Actavis Nordic A/S | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1169883 | ramipriil, 5mg | C09AA05 | RAMIPRIL ACTAVIS 5MG, tablett, 98TK | Actavis Nordic A/S | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1190034 | ramipriil, 5mg | C09AA05 | AMPRIL 5 MG, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1359031 | ramipriil, 5mg | C09AA05 | RAMIGAMMA, tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1141715 | ramipriil+ hüdroklorotiasiid, 5mg+25mg | C09BA05 | CARDACE PLUS, tablett, 28TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1190179 | ramipriil+ hüdroklorotiasiid, 5mg+25mg | C09BA05 | AMPRIL HD 5MG/25MG, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1153459 | ramipriil, 5mg | C09AA05 | RAMICOR 5 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1359031 | ramipriil, 5mg | C09AA05 | RAMIGAMMA, tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1190179 | ramipriil+ hüdroklorotiasiid, 5mg+25mg | C09BA05 | AMPRIL HD 5MG/25MG, tablett, 30TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1021936 | ramipriil+hüdroklorotia siid, 2,5mg+12,5mg | C09BA05 | CARDACE COMP, tablett, 28TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1113657 | ramipriil+hüdroklorotia siid, 2,5mg+12,5mg | C09BA05 | CO-RAMICOR 2,5 MG/12,5 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1190269 | ramipriil+hüdroklorotia siid, 2,5mg+12,5mg | C09BA05 | AMPRIL HL 2,5MG/12,5MG, tablett, 30TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1113680 | ramipriil+hüdroklorotia siid, 5mg+25mg | C09BA05 | CO-RAMICOR 5 MG/25 MG, tablett, 30TK | HEXAL AG | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1190269 | ramipriil+hüdroklorotia siid, 2,5mg+12,5mg | C09BA05 | AMPRIL HL 2,5MG/12,5MG, tablett, 30TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1141715 | ramipriil+hüdroklorotia siid, 5mg+25mg | C09BA05 | CARDACE PLUS, tablett, 28TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1113680 | ramipriil+hüdroklorotia siid, 5mg+25mg | C09BA05 | CO-RAMICOR 5 MG/25 MG, tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

@@ -3033,15 +3034,15 @@

| | | | | | 50 | D50-D50 | | | | 3,00 | |

| 1011025 | raud(III)hüdroksiid- polümaltoos kompleks, 10mg 1ml | B03AB02 | FERRUM LEK, siirup, 100ml 1TK | Lek Pharmaceuticals d.d. | 75 | D50-D50 | | | | | rasedatele |

| | | | | | 50 | D50-D50 | | | | 3,00 | |

| 1070930 | reboksetiin, 4mg | N06AX18 | EDRONAX, tablett, 60TK | Pfizer Enterprises SARL | 50 | | | | | | |

| 1070930 | reboksetiin, 4mg | N06AX18 | EDRONAX, tablett, 60TK | Pfizer Italia s.r.l. | 50 | | | | | | |

| 1044380 | retinool+ dekspantenool, 20TÜ+20mg 1g | S01XA80 | OFTAN A-PANT, silmasalv, 3.5g 1TK | SANTEN OY | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1161447 | ribaviriin, 200mg | J05AB04 | COPEGUS, õhukese polümeerikattega tablett, 168TK | Roche Eesti OÜ | 100 | B18.2-B18.2 | Infektsionist, Gastroenteroloog | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| | | | | | 50 | | | | | | |

| 1073034 | ribaviriin, 200mg | J05AB04 | REBETOL, kõvakapsel, 140TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1161447 | ribaviriin, 200mg | J05AB04 | COPEGUS, õhukese polümeerikattega tablett, 168TK | Roche Eesti OÜ | 50 | | | | | | |

| 1073034 | ribaviriin, 200mg | J05AB04 | REBETOL, kõvakapsel, 140TK | SCHERING-PLOUGH EUROPE | 100 | B18.2-B18.2 | Gastroenteroloog, Infektsionist | | | | kroonilise progresseeruva C- viirushepatiidi näidustusel vastavalt Eesti Gastroenteroloogide Seltsi ja Eesti Infektsionistide Seltsi 2006. a ravijuhisele |

| | | | | | 50 | | | | | | |

| 1035289 | rilusool, 50mg | N07XX02 | RILUTEK, õhukese polümeerikattega tablett, 56TK | Aventis Pharma SA | 50 | | | | | | |

| 1032804 | risatriptaan, 10mg | N02CC04 | MAXALT, suukaudne lüofilisaat, 2TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| 1107593 | risedroonhape, 35mg | M05BA07 | ACTONEL 35 MG OAW, õhukese polümeerikattega tablett, 4TK | Sanofi-Aventis Estonia OÜ | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

@@ -3049,35 +3050,35 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1298257 | risedroonhape, 35mg | M05BA07 | NORIFAZ, õhukese polümeerikattega tablett, 4TK | Zaklad Farmaceutyczny Adamed Pharma S.A. | 50 | | | | | | |

| | | | | | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| 1310757 | risedroonhape, 35mg | M05BA07 | RISONATE, õhukese polümeerikattega tablett, 4TK | Teva Pharma B.V. | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| | | | | | 50 | | | | | | |

| 1285680 | risedroonhape, 35mg | M05BA07 | RISENDROS 35MG, õhukese polümeerikattega tablett, 4TK | Zentiva, k.s. | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| | | | | | 50 | | | | | | |

| 1285703 | risedroonhape, 35mg | M05BA07 | RISENDROS 35MG, õhukese polümeerikattega tablett, 12TK | Zentiva, k.s. | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| | | | | | 50 | | | | | | |

| 1298257 | risedroonhape, 35mg | M05BA07 | NORIFAZ, õhukese polümeerikattega tablett, 4TK | Zaklad Farmaceutyczny Adamed Pharma S.A. | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1298336 | risedroonhape, 35mg | M05BA07 | RISEDRONATE SODIUM ACTAVIS, õhukese polümeerikattega tablett, 4TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1285703 | risedroonhape, 35mg | M05BA07 | RISENDROS 35MG, õhukese polümeerikattega tablett, 12TK | Zentiva, k.s. | 50 | | | | | | |

| | | | | | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| 1301229 | risedroonhape, 35mg | M05BA07 | RIBIDRON, õhukese polümeerikattega tablett, 4TK | ratiopharm GmbH | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1298336 | risedroonhape, 35mg | M05BA07 | RISEDRONATE SODIUM ACTAVIS, õhukese polümeerikattega tablett, 4TK | Actavis Group PTC ehf | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| | | | | | 50 | | | | | | |

| 1301229 | risedroonhape, 35mg | M05BA07 | RIBIDRON, õhukese polümeerikattega tablett, 4TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna |

| 1060456 | risperidoon, 1mg | N05AX08 | RISPOLEPT 1 mg, õhukese polümeerikattega tablett, 60TK | Johnson & Johnson UAB | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| | | | | | 50 | | | | | | |

| 1119855 | risperidoon, 1mg | N05AX08 | RISPEN 1, õhukese polümeerikattega tablett, 20TK | Zentiva, k.s. | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1151952 | risperidoon, 1mg | N05AX08 | RISPERIDON ACTAVIS 1MG, õhukese polümeerikattega tablett, 60TK | Actavis Nordic A/S | 50 | | | | | | |

| 1119855 | risperidoon, 1mg | N05AX08 | RISPEN 1, õhukese polümeerikattega tablett, 20TK | Zentiva, k.s. | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1151952 | risperidoon, 1mg | N05AX08 | RISPERIDON ACTAVIS 1MG, õhukese polümeerikattega tablett, 60TK | Actavis Nordic A/S | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| | | | | | 50 | | | | | | |

| 1041028 | risperidoon, 1mg 1ml | N05AX08 | RISPOLEPT, suukaudne lahus, 100ml 1TK | Johnson & Johnson UAB | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| | | | | | 50 | | | | | | |

| 1122129 | risperidoon, 25mg | N05AX08 | RISPOLEPT CONSTA 25MG, toimeainet prolongeeritult vabastava süstesuspensiooni pulber ja lahusti, 1TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1067509 | risperidoon, 2mg | N05AX08 | RISPOLEPT 2 mg, õhukese polümeerikattega tablett, 60TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1067509 | risperidoon, 2mg | N05AX08 | RISPOLEPT 2 mg, õhukese polümeerikattega tablett, 60TK | Johnson & Johnson UAB | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

@@ -3085,25 +3086,25 @@

| | | | | | 50 | | | | | | |

| 1151963 | risperidoon, 2mg | N05AX08 | RISPERIDON ACTAVIS 2MG, õhukese polümeerikattega tablett, 20TK | Actavis Nordic A/S | 50 | | | | | | |

| 1151974 | risperidoon, 2mg | N05AX08 | RISPERIDON ACTAVIS 2MG, õhukese polümeerikattega tablett, 60TK | Actavis Nordic A/S | 50 | | | | | | |

| 1151974 | risperidoon, 2mg | N05AX08 | RISPERIDON ACTAVIS 2MG, õhukese polümeerikattega tablett, 60TK | Actavis Nordic A/S | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| | | | | | 50 | | | | | | |

| 1122130 | risperidoon, 37,5mg | N05AX08 | RISPOLEPT CONSTA 37,5MG, toimeainet prolongeeritult vabastava süstesuspensiooni pulber ja lahusti, 1TK | Johnson & Johnson UAB | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1067521 | risperidoon, 3mg | N05AX08 | RISPOLEPT 3 mg, õhukese polümeerikattega tablett, 60TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1119912 | risperidoon, 3mg | N05AX08 | RISPEN 3, õhukese polümeerikattega tablett, 20TK | Zentiva, k.s. | 50 | | | | | | |

| 1151985 | risperidoon, 3mg | N05AX08 | RISPERIDON ACTAVIS 3MG, õhukese polümeerikattega tablett, 20TK | Actavis Nordic A/S | 50 | | | | | | |

| 1067521 | risperidoon, 3mg | N05AX08 | RISPOLEPT 3 mg, õhukese polümeerikattega tablett, 60TK | Johnson & Johnson UAB | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| | | | | | 50 | | | | | | |

| 1119912 | risperidoon, 3mg | N05AX08 | RISPEN 3, õhukese polümeerikattega tablett, 20TK | Zentiva, k.s. | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| | | | | | 50 | | | | | | |

| 1151985 | risperidoon, 3mg | N05AX08 | RISPERIDON ACTAVIS 3MG, õhukese polümeerikattega tablett, 20TK | Actavis Nordic A/S | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1151996 | risperidoon, 3mg | N05AX08 | RISPERIDON ACTAVIS 3MG, õhukese polümeerikattega tablett, 60TK | Actavis Nordic A/S | 50 | | | | | | |

| 1067532 | risperidoon, 4mg | N05AX08 | RISPOLEPT 4 mg, õhukese polümeerikattega tablett, 60TK | Johnson & Johnson UAB | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| | | | | | 50 | | | | | | |

| 1067532 | risperidoon, 4mg | N05AX08 | RISPOLEPT 4 mg, õhukese polümeerikattega tablett, 60TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1119967 | risperidoon, 4mg | N05AX08 | RISPEN 4, õhukese polümeerikattega tablett, 20TK | Zentiva, k.s. | 50 | | | | | | |

@@ -3114,12 +3115,12 @@

| 1152010 | risperidoon, 4mg | N05AX08 | RISPERIDON ACTAVIS 4MG, õhukese polümeerikattega tablett, 60TK | Actavis Nordic A/S | 50 | | | | | | |

| 1122141 | risperidoon, 50mg | N05AX08 | RISPOLEPT CONSTA 50MG, toimeainet prolongeeritult vabastava süstesuspensiooni pulber ja lahusti, 1TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1381665 | rivaroksabaan, 10mg | B01AX06 | XARELTO, õhukese polümeerikattega tablett, 10TK | Bayer Schering Pharma AG | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1381676 | rivaroksabaan, 10mg | B01AX06 | XARELTO, õhukese polümeerikattega tablett, 30TK | Bayer Schering Pharma AG | 50 | | | | | | |

| 1225741 | ropinirool, 2mg | N04BC04 | REQUIP-MODUTAB, toimeainet prolongeeritult vabastav tablett, 28TK | SMITHKLINE BEECHAM plc | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1225741 | ropinirool, 2mg | N04BC04 | REQUIP-MODUTAB, toimeainet prolongeeritult vabastav tablett, 28TK | SMITHKLINE BEECHAM plc | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1225752 | ropinirool, 2mg | N04BC04 | REQUIP-MODUTAB, toimeainet prolongeeritult vabastav tablett, 42TK | SMITHKLINE BEECHAM plc | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

@@ -3133,72 +3134,72 @@

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| 1225819 | ropinirool, 8mg | N04BC04 | REQUIP-MODUTAB, toimeainet prolongeeritult vabastav tablett, 28TK | SMITHKLINE BEECHAM plc | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1436677 | ropinirool, 8mg | N04BC04 | ROLPRYNA SR 8MG, toimeainet prolongeeritult vabastav tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1436677 | ropinirool, 8mg | N04BC04 | ROLPRYNA SR 8MG, toimeainet prolongeeritult vabastav tablett, 28TK | KRKA d.d., Novo Mesto | 100 | G20-G20 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1385861 | rosuvastatiin, 10mg | C10AA07 | ZARANTA, õhukese polümeerikattega tablett, 30TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1106053 | rosuvastatiin, 10mg | C10AA07 | CRESTOR, õhukese polümeerikattega tablett, 28TK | AstraZeneca UK Limited | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1384758 | rosuvastatiin, 10mg | C10AA07 | ROXARDIO, õhukese polümeerikattega tablett, 30TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1384859 | rosuvastatiin, 10mg | C10AA07 | ROSUVASTATIN TEVA 10 MG, õhukese polümeerikattega tablett, 28TK | Teva Pharma B.V. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1396874 | rosuvastatiin, 10mg | C10AA07 | ROSUCARD 10MG, õhukese polümeerikattega tablett, 30tabl | Zentiva, k.s. | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1385906 | rosuvastatiin, 20mg | C10AA07 | ZARANTA, õhukese polümeerikattega tablett, 30TK | Gedeon Richter Plc. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1106132 | rosuvastatiin, 20mg | C10AA07 | CRESTOR, õhukese polümeerikattega tablett, 28TK | AstraZeneca UK Limited | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1384950 | rosuvastatiin, 20mg | C10AA07 | ROSUVASTATIN TEVA 20 MG, õhukese polümeerikattega tablett, 28TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1397099 | rosuvastatiin, 20mg | C10AA07 | ROSUCARD 20MG, õhukese polümeerikattega tablett, 30tabl | Zentiva, k.s. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1473476 | rosuvastatiin, 20mg | C10AA07 | ROXARDIO, õhukese polümeerikattega tablett, 30TK | Sandoz d.d. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1396874 | rosuvastatiin, 10mg | C10AA07 | ROSUCARD 10MG, õhukese polümeerikattega tablett, 30tabl | Zentiva, k.s. | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1397099 | rosuvastatiin, 20mg | C10AA07 | ROSUCARD 20MG, õhukese polümeerikattega tablett, 30tabl | Zentiva, k.s. | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1473476 | rosuvastatiin, 20mg | C10AA07 | ROXARDIO, õhukese polümeerikattega tablett, 30TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1005512 | salbutamool, 100mcg 1annust | R03AC02 | VENTOLIN, inhalatsiooniaerosool, suspensioon, 200annust 1TK | Glaxo Group Ltd | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1010697 | salbutamool, 100mcg 1annust | R03AC02 | ECOSAL EASI-BREATHE, inhalatsiooniaerosool, suspensioon, 200annust 1TK | TEVA Czech Industries s.r.o. | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| 1031308 | salbutamool, 200mcg 1annust | R03AC02 | VENTOLIN DISKUS, inhalatsioonipulber, 60annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| 1004319 | salbutamool, 400mcg 1ml | R03CC02 | VENTOLIN SYRUP, siirup, 150ml 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| 1004948 | salbutamool, 5000mcg 1ml | R03AC02 | VENTOLIN, nebuliseeritav lahus, 20ml 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | J45-J45 | | | | | |

| 1004948 | salbutamool, 5000mcg 1ml | R03AC02 | VENTOLIN, nebuliseeritav lahus, 20ml 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 75 | J45-J45 | | | | | |

| | | | | | 50 | | | | | | |

| 1000405 | salmeterool, 25mcg 1annust | R03AC12 | SEREVENT, inhalatsiooniaerosool, suspensioon, 120annust 1TK | GlaxoSmithKline Export Ltd | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| 1000405 | salmeterool, 25mcg 1annust | R03AC12 | SEREVENT, inhalatsiooniaerosool, suspensioon, 120annust 1TK | GlaxoSmithKline Export Ltd | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1007907 | salmeterool, 50mcg 1annust | R03AC12 | SEREVENT DISKUS 50 MCG, inhalatsioonipulber, 60annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1107346 | salmeterool+ flutikasoon, 25mcg+125mcg 1annust | R03AK82 | SERETIDE INHALER, inhalatsiooniaerosool, suspensioon, 120annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

@@ -3206,14 +3207,14 @@

| 1107357 | salmeterool+ flutikasoon, 25mcg+250mcg 1annust | R03AK82 | SERETIDE INHALER, inhalatsiooniaerosool, suspensioon, 120annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1107335 | salmeterool+ flutikasoon, 25mcg+50mcg 1annust | R03AK82 | SERETIDE INHALER, inhalatsiooniaerosool, suspensioon, 120annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| 1037607 | salmeterool+ flutikasoon, 50mcg+100mcg 1annust | R03AK82 | SERETIDE DISKUS 100, inhalatsioonipulber, 60annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1037595 | salmeterool+ flutikasoon, 50mcg+250mcg 1annust | R03AK82 | SERETIDE DISKUS 250, inhalatsioonipulber, 60annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| 1153167 | salmeterool+ flutikasoon, 50mcg+500mcg 1annust | R03AK82 | SERETIDE DISKUS 500, inhalatsioonipulber, 60annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| 1153167 | salmeterool+flutikasoo n, 50mcg+500mcg 1annust | R03AK82 | SERETIDE DISKUS 500, inhalatsioonipulber, 60annust 1TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

@@ -3222,160 +3223,160 @@

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1027077 | sertindool, 16mg | N05AE03 | SERDOLECT, õhukese polümeerikattega tablett, 28TK | H. LUNDBECK A/S | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1027088 | sertindool, 20mg | N05AE03 | SERDOLECT, õhukese polümeerikattega tablett, 28TK | H. LUNDBECK A/S | 50 | | | | | | |

| 1027088 | sertindool, 20mg | N05AE03 | SERDOLECT, õhukese polümeerikattega tablett, 28TK | H. LUNDBECK A/S | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1027055 | sertindool, 4mg | N05AE03 | SERDOLECT, õhukese polümeerikattega tablett, 30TK | H. LUNDBECK A/S | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1027055 | sertindool, 4mg | N05AE03 | SERDOLECT, õhukese polümeerikattega tablett, 30TK | H. LUNDBECK A/S | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1008638 | sertraliin, 50mg | N06AB06 | ZOLOFT, õhukese polümeerikattega tablett, 28TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1110856 | sertraliin, 50mg | N06AB06 | SERTRAL 50 MG, õhukese polümeerikattega tablett, 28TK | Sandoz d.d. | 50 | | | | | | |

| 1125302 | sertraliin, 50mg | N06AB06 | SERLIFT, õhukese polümeerikattega tablett, 30TK | Ranbaxy (UK) Limited | 50 | | | | | | |

| 1239218 | sertraliin, 50mg | N06AB06 | SERTRALINE-TEVA 50 MG, õhukese polümeerikattega tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| 1110856 | sertraliin, 50mg | N06AB06 | SERTRAL 50 MG, õhukese polümeerikattega tablett, 28TK | Sandoz d.d. | 50 | | | | | | |

| 1143100 | sertraliin, 50mg | N06AB06 | ASENTRA, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1152391 | sertraliin, 50mg | N06AB06 | SERTRALIN "GENERICON" 50MG, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 50 | | | | | | |

| 1189841 | sertraliin, 50mg | N06AB06 | SERTRALIN ACTAVIS 50 MG, õhukese polümeerikattega tablett, 28TK | Actavis Nordic A/S | 50 | | | | | | |

| 1123074 | sevelameer, 800mg | V03AE02 | RENAGEL, õhukese polümeerikattega tablett, 180TK | Genzyme Europe B.V. | 50 | | | | | | |

| | | | | | 100 | N18-N18 | Nefroloog, Pediaater | | | | juhul, kui kaltsiumipõhine fosforisiduja on vastunäidustatud (seerumi kaltsiumisisaldus >2,54 mmol/l) |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1221039 | sildenafiil, 20mg | G04BE03 | REVATIO, õhukese polümeerikattega tablett, 90TK | Pfizer Limited | 100 | I27.0-I27.0 | Pulmonoloog, Pediaater, Reumatoloog, Kardioloog | | | | NYHA III-IV kl idiopaatilise või süsteemse sidekoehaigusega seotud pulmonaalse arteriaalse hüpertensiooniga patsientidele, kelle ravi alustamine ja jätkamine sildenafiiliga on hinnatud konsiiliumi (vähemalt 3 vastava eriala spetsialisti) poolt vastavaks Eesti Pulmonoloogide Seltsi, Eesti Kardioloogide Seltsi, Eesti Reumatoloogide Seltsi ja Eesti Lastearstide Seltsi 2007. a tunnustatud ravijuhisele |

| | | | | | 50 | I27.0-I27.0 | Reumatoloog, Kardioloog, Pulmonoloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1080166 | simvastatiin, 10mg | C10AA01 | SIMVACOR, õhukese polümeerikattega tablett, 30TK | HEXAL AG | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1113534 | simvastatiin, 10mg | C10AA01 | SIMVOR, õhukese polümeerikattega tablett, 30TK | Ranbaxy (UK) Limited | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1163023 | simvastatiin, 10mg | C10AA01 | ZOCOR 10 MG, õhukese polümeerikattega tablett, 28TK | Merck Sharp & Dohme OÜ | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1010765 | simvastatiin, 10mg | C10AA01 | SIMGAL, õhukese polümeerikattega tablett, 28TK | TEVA Czech Industries s.r.o. | 50 | | | | | | |

| | | | | | 100 | N18-N18 | Pediaater, Nefroloog | | | | juhul, kui kaltsiumipõhine fosforisiduja on vastunäidustatud (seerumi kaltsiumisisaldus >2,54 mmol/l) |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1221039 | sildenafiil, 20mg | G04BE03 | REVATIO, õhukese polümeerikattega tablett, 90TK | Pfizer Limited | 50 | I27.0-I27.0 | Reumatoloog, Kardioloog, Pediaater, Pulmonoloog | | | | |

| | | | | | 100 | I27.0-I27.0 | Reumatoloog, Kardioloog, Pediaater, Pulmonoloog | | | | NYHA III-IV kl idiopaatilise või süsteemse sidekoehaigusega seotud pulmonaalse arteriaalse hüpertensiooniga patsientidele, kelle ravi alustamine ja jätkamine sildenafiiliga on hinnatud konsiiliumi (vähemalt 3 vastava eriala spetsialisti) poolt vastavaks Eesti Pulmonoloogide Seltsi, Eesti Kardioloogide Seltsi, Eesti Reumatoloogide Seltsi ja Eesti Lastearstide Seltsi 2007. a tunnustatud ravijuhisele |

| 1010271 | simvastatiin, 10mg | C10AA01 | VASILIP, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1147429 | simvastatiin, 10mg | C10AA01 | SIMVAGAMMA 10MG, õhukese polümeerikattega tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1083934 | simvastatiin, 10mg | C10AA01 | SIMVASTATIN- RATIOPHARM, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1436880 | simvastatiin, 10mg | C10AA01 | SIMVASTATIN PFIZER, õhukese polümeerikattega tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1080177 | simvastatiin, 20mg | C10AA01 | SIMVACOR, õhukese polümeerikattega tablett, 30TK | HEXAL AG | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1080740 | simvastatiin, 20mg | C10AA01 | ZOCOR 20 MG, õhukese polümeerikattega tablett, 28TK | Merck Sharp & Dohme OÜ | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1113523 | simvastatiin, 20mg | C10AA01 | SIMVOR, õhukese polümeerikattega tablett, 30TK | Ranbaxy (UK) Limited | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1010260 | simvastatiin, 20mg | C10AA01 | VASILIP, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1147463 | simvastatiin, 20mg | C10AA01 | SIMVAGAMMA 20MG, õhukese polümeerikattega tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1010776 | simvastatiin, 20mg | C10AA01 | SIMGAL, õhukese polümeerikattega tablett, 28TK | TEVA Czech Industries s.r.o. | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1083956 | simvastatiin, 20mg | C10AA01 | SIMVASTATIN- RATIOPHARM, õhukese polümeerikattega tablett, 30TK | ratiopharm GmbH | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1121038 | simvastatiin, 20mg | C10AA01 | SIMVASTATIN NYCOMED 20MG, õhukese polümeerikattega tablett, 30TK | Nycomed Sefa AS | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1436970 | simvastatiin, 20mg | C10AA01 | SIMVASTATIN PFIZER, õhukese polümeerikattega tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1129698 | simvastatiin, 30mg | C10AA01 | SIMVACOR, õhukese polümeerikattega tablett, 30TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| 1129698 | simvastatiin, 30mg | C10AA01 | SIMVACOR, õhukese polümeerikattega tablett, 30TK | HEXAL AG | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1129700 | simvastatiin, 40mg | C10AA01 | SIMVACOR, õhukese polümeerikattega tablett, 30TK | HEXAL AG | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1147508 | simvastatiin, 40mg | C10AA01 | SIMVAGAMMA 40MG, õhukese polümeerikattega tablett, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1437061 | simvastatiin, 40mg | C10AA01 | SIMVASTATIN PFIZER, õhukese polümeerikattega tablett, 30TK | Pfizer Europe MA EEIG | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| | | | | | 50 | | | | | | |

| 1437061 | simvastatiin, 40mg | C10AA01 | SIMVASTATIN PFIZER, õhukese polümeerikattega tablett, 30TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 75 | E78-E78 | | | | | kui dieetravi järgselt ei ole kolesterooli sisaldus veres vähenenud alla 8,0 mmol/l |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1107739 | siroliimus, 1mg | L04AA10 | RAPAMUNE, kaetud tablett, 30TK | Wyeth Europe Ltd. | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| 1286568 | sitagliptiin, 100mg | A10BH01 | JANUVIA, õhukese polümeerikattega tablett, 28TK | Merck Sharp & Dohme | 50 | | | | | | |

| | | | | | 75 | E14-E14, E11-E11 | | | | | suukaudseks kolmikraviks metformiini ja sulfonüüluurea preparaadiga vastavalt Eesti 2008. a II tüüpi diabeedi ravijuhisele |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1041185 | somatropiin, 12mg | H01AC01 | GENOTROPIN, süstelahuse pulber ja lahusti, 1TK | Pfizer Enterprises SARL | 50 | | | | | | |

| 1043705 | somatropiin, 24TÜ | H01AC01 | SAIZEN 8 MG CLICK.EASY, süstelahuse pulber ja lahusti, 1TK | Merck Serono S.p.A. | 50 | | | | | | |

| 1022072 | somatropiin, 5,3mg | H01AC01 | GENOTROPIN, süstelahuse pulber ja lahusti, 1TK | Pfizer Enterprises SARL | 50 | | | | | | |

| Ravimi- kood | Toimeaine, toimeaine sisaldus | ATC kood | Ravim, pakendi suurus | Müügiloa hoidja | Soodus- tus % — 100 — 50 | Diagnoos — C64-C64 | Eriala — Onkoloog | Esmane | Vanus üle | Vanus alla | Märkused — patsientidele, kellel ravi alustamine ja jätkamine sorafeniibiga on hinnatud konsiiliumi (vähemalt kolme onkoloogi) poolt vastavaks järgmistele kriteeriumidele: diagnoositud IV staadiumis heledarakuline neeru kartsinoom, eelnev interferoonravi on osutunud ebaefektiivseks või talumatuks, patsiendi üldseisund ECOG kriteeriumide järgi on 0-1 ja haiguse prognoos MSKCC kriteeriumide järgi hea kuni keskmine ning mitte enam kui 3 ravikuu möödumisel on saavutatud täielik või osaline ravivastus või haigu |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1034491 | sotalool, 160mg | C07AA07 | SOTAHEXAL 160 MG, tablett, 20TK | HEXAL AG | 75 | I47-I49 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1034480 | sotalool, 80mg | C07AA07 | SOTAHEXAL 80 MG, tablett, 20TK | HEXAL AG | 75 | I47-I49 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1034491 | sotalool, 160mg | C07AA07 | SOTAHEXAL 160 MG, tablett, 20TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I47-I49 | Kardioloog, Pediaater | esmane | | | |

| 1034480 | sotalool, 80mg | C07AA07 | SOTAHEXAL 80 MG, tablett, 20TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I47-I49 | Pediaater, Kardioloog | esmane | | | |

| 1071863 | sotalool, 80mg | C07AA07 | SOTAHEXAL 80 MG, tablett, 50TK | HEXAL AG | 50 | | | | | | |

| | | | | | 75 | I47-I49 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 75 | I47-I49 | Pediaater, Kardioloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1023310 | spiramütsiin, 3000000TÜ | J01FA02 | ROVAMYCINE, õhukese polümeerikattega tablett, 10TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| 1001091 | spironolaktoon, 100mg | C03DA01 | SPIRIX, tablett, 20TK | Nycomed Sefa AS | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| 1001091 | spironolaktoon, 100mg | C03DA01 | SPIRIX, tablett, 20TK | Nycomed Sefa AS | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1120790 | spironolaktoon, 100mg | C03DA01 | SPIROGAMMA 100, tablett, 20TK | WÖRWAG PHARMA GmbH & Co. KG | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| 1120790 | spironolaktoon, 100mg | C03DA01 | SPIROGAMMA 100, tablett, 20TK | WÖRWAG PHARMA GmbH & Co. KG | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| 1120813 | spironolaktoon, 100mg | C03DA01 | SPIROGAMMA 100, tablett, 100TK | WÖRWAG PHARMA GmbH & Co. KG | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| 1120824 | spironolaktoon, 100mg | C03DA01 | SPIROGAMMA 100, tablett, 50TK | WÖRWAG PHARMA GmbH & Co. KG | 75 | I50-I50 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1120813 | spironolaktoon, 100mg | C03DA01 | SPIROGAMMA 100, tablett, 100TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1000944 | spironolaktoon, 25mg | C03DA01 | SPIRIX, tablett, 20TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1120824 | spironolaktoon, 100mg | C03DA01 | SPIROGAMMA 100, tablett, 50TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| 1000944 | spironolaktoon, 25mg | C03DA01 | SPIRIX, tablett, 20TK | Nycomed Sefa AS | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1014848 | spironolaktoon, 25mg | C03DA01 | VEROSPIRON, tablett, 20TK | Gedeon Richter Plc. | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

@@ -3383,43 +3384,43 @@

| 1001013 | spironolaktoon, 50mg | C03DA01 | SPIRIX, tablett, 20TK | Nycomed Sefa AS | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| 1042018 | spironolaktoon, 50mg | C03DA01 | VEROSPIRON, kõvakapsel, 30TK | Gedeon Richter Plc. | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| 1042018 | spironolaktoon, 50mg | C03DA01 | VEROSPIRON, kõvakapsel, 30TK | Gedeon Richter Plc. | 50 | | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| 1071650 | spironolaktoon, 50mg | C03DA01 | SPIRIX, tablett, 100TK | Nycomed Sefa AS | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| 1004993 | spironolaktoon, 50mg | C03DA01 | SPIRONOLACTON- RATIOPHARM 50MG, tablett, 20TK | ratiopharm GmbH | 75 | I50-I50 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1120712 | spironolaktoon, 50mg | C03DA01 | SPIROGAMMA 50, tablett, 20TK | WÖRWAG PHARMA GmbH & Co. KG | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1120723 | spironolaktoon, 50mg | C03DA01 | SPIROGAMMA 50, tablett, 50TK | WÖRWAG PHARMA GmbH & Co. KG | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1120734 | spironolaktoon, 50mg | C03DA01 | SPIROGAMMA 50, tablett, 100TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| 1071650 | spironolaktoon, 50mg | C03DA01 | SPIRIX, tablett, 100TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| 1186949 | strontsiumranelaat, 2g | M05BX03 | PROTELOS, suukaudse suspensiooni graanulid, 28TK | Les Laboratoires Servier | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna ja kellel esineb kaasuvalt raske neerupuudulikkus või söögitoru akalaasia, striktuur, düskineesia või põletik (N17-19; K22.0; K22.2; K22.4; K20) |

| | | | | | 50 | | | | | | |

| 1008818 | sulfametoksasool+trim etoprim, 40mg+8mg 1ml | J01EE01 | BACTRIM, siirup, 100ml 1TK | Roche Eesti OÜ | 50 | | | | | | |

| 1016086 | sulfametoksasool+trim etoprim, 800mg+160mg | J01EE01 | BERLOCID, tablett, 20TK | Berlin-Chemie AG (Menarini Group) | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1040612 | sulpiriid, 100mg | N05AL01 | BETAMAKS, tablett, 30TK | Grindeks | 50 | | | | | | |

| 1004993 | spironolaktoon, 50mg | C03DA01 | SPIRONOLACTON- RATIOPHARM 50MG, tablett, 20TK | ratiopharm GmbH | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1120712 | spironolaktoon, 50mg | C03DA01 | SPIROGAMMA 50, tablett, 20TK | WÖRWAG PHARMA GmbH & Co. KG | 75 | I50-I50 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1120723 | spironolaktoon, 50mg | C03DA01 | SPIROGAMMA 50, tablett, 50TK | WÖRWAG PHARMA GmbH & Co. KG | 100 | I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| 1120734 | spironolaktoon, 50mg | C03DA01 | SPIROGAMMA 50, tablett, 100TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| | | | | | 75 | I50-I50 | | | | | |

| | | | | | 100 | I27.0-I27.0 | | | | | |

| 1186949 | strontsiumranelaat, 2g | M05BX03 | PROTELOS, suukaudse suspensiooni graanulid, 28TK | Les Laboratoires Servier | 50 | | | | | | |

| | | | | | 75 | M80-M80 | | | | | patsientidele, kelle lülisamba või reieluukaela mineraalne tihedus on -2,5 SD või vähem DEXA meetodil määratuna ja kellel esineb kaasuvalt raske neerupuudulikkus või söögitoru akalaasia, striktuur, düskineesia või põletik (N17-19; K22.0; K22.2; K22.4; K20) |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1040612 | sulpiriid, 100mg | N05AL01 | BETAMAKS, tablett, 30TK | Grindeks | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| | | | | | 50 | | | | | | |

| 1040601 | sulpiriid, 200mg | N05AL01 | BETAMAKS, tablett, 30TK | Grindeks | 50 | | | | | | |

| 1040601 | sulpiriid, 200mg | N05AL01 | BETAMAKS, tablett, 30TK | Grindeks | 100 | F20-F29 | Psühhiaater | | | | vastavalt Eesti ravijuhisele ning arvestades Eesti Psühhiaatrite Seltsi poolt väljatöötatud kriteeriume üleminekuks konventsionaalselt atüüpilisele antipsühhootikumile |

| | | | | | 50 | | | | | | |

| 1040623 | sulpiriid, 50mg | N05AL01 | BETAMAKS, tablett, 30TK | Grindeks | 50 | | | | | | |

| 1018482 | sultamitsilliin, 375mg | J01CR04 | UNASYN, õhukese polümeerikattega tablett, 12TK | Pfizer Europe MA EEIG | 50 | | | | | | juhul, kui esmavaliku antibiootikum ei ole efektiivne või on vastunäidustatud |

@@ -3440,15 +3441,15 @@

| 1277962 | sumatriptaan, 50mg | N02CC01 | SUMATRIPTAN ACTAVIS, kaetud tablett, 2TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1277995 | sumatriptaan, 50mg | N02CC01 | SUMATRIPTAN ACTAVIS, kaetud tablett, 6TK | Actavis Group PTC ehf | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1353305 | sunitiniib, 12,5mg | L01XE04 | SUTENT, kõvakapsel, 28TK | Pfizer Limited | 100 | C64-C64 | Onkoloog | | | | patsientidele, kellel ravi alustamine ja jätkamine sunitiniibiga on hinnatud konsiiliumi (vähemalt kolme onkoloogi) poolt vastavaks järgmistele kriteeriumidele: diagnoositud IV staadiumis heledarakuline neeru kartsinoom, patsiendi üldseisund ECOG kriteeriumide järgi on 0-1 ja haiguse prognoos MSKCC kriteeriumide järgi hea kuni keskmine ning mitte enam kui 3 ravikuu möödumisel on saavutatud täielik või osaline ravivastus või haigus püsib stabiilsena |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1353293 | sunitiniib, 25mg | L01XE04 | SUTENT, kõvakapsel, 28TK | Pfizer Limited | 100 | C64-C64 | Onkoloog | | | | patsientidele, kellel ravi alustamine ja jätkamine sunitiniibiga on hinnatud konsiiliumi (vähemalt kolme onkoloogi) poolt vastavaks järgmistele kriteeriumidele: diagnoositud IV staadiumis heledarakuline neeru kartsinoom, patsiendi üldseisund ECOG kriteeriumide järgi on 0-1 ja haiguse prognoos MSKCC kriteeriumide järgi hea kuni keskmine ning mitte enam kui 3 ravikuu möödumisel on saavutatud täielik või osaline ravivastus või haigus püsib stabiilsena |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1353305 | sunitiniib,12,5mg | L01XE04 | SUTENT, kovakapsel, 28TK | Pfizer Limited | 50 | | | | | | |

| | | | | | 100 | C64-C64 | Onkoloog | | | | patsient idele, kellel ravi alustamine ja jatkamine sunitiniibiga on hinnatud konsiiliumi (vahemalt kolme onkoloogi) pool! vastavaks jargmistele kriteeriumidele: diagnoositud IV staadiumis heledarakuline neeru kartsinoom, pat siendi uldseisund ECOG kriteeriumide jargi on 0-1 ja haigu se prognoos MSKCC kriteeriumide jargi hea kuni keskmine ning mitte enam kui 3 ravikuu mobdumisel on saavutatud taielik voi osaline r avivastus voi haigus pusib stabiilsena |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1353293 | sunitiniib, 25mg | L01XE04 | SUTENT, kovakapsel, 28TK | Pfizer Limited | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

@@ -3464,11 +3465,11 @@

| | | | | | 50 | | | | | | |

| 1119271 | ziprasidoon, 60mg | N05AE04 | ZELDOX, kõvakapsel, 56TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1119316 | ziprasidoon, 80mg | N05AE04 | ZELDOX, kõvakapsel, 56TK | Pfizer Europe MA EEIG | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| | | | | | 50 | | | | | | |

| 1119316 | ziprasidoon, 80mg | N05AE04 | ZELDOX, kõvakapsel, 56TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| | | | | | 100 | F20-F29 | Psühhiaater | | | | kui risperidoon on ebaefektiivne, vastunäidustatud või põhjustab olulisi kõrvaltoimeid |

| 1110722 | zolmitriptaan, 2,5mg | N02CC03 | ZOMIG RAPIMELT, suus dispergeeruv tablett, 2TK | AstraZeneca UK Limited | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1005815 | zuklopentiksool, 10mg | N05AF05 | CISORDINOL, õhukese polümeerikattega tablett, 50TK | H. LUNDBECK A/S | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

@@ -3489,15 +3490,15 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1294703 | takroliimus, 1mg | L04AD02 | ADVAGRAF, toimeainet prolongeeritult vabastav kõvakapsel, 100TK | Astellas Pharma Europe B.V. | 100 | Z94-Z94, T86-T86 | | | | | patsientidele, kellel esineb kõrge immunoloogiline risk (PRA>20%), korduvsiirdamise puhul, maksasiirdamise puhul, kopsusiirdamise puhul, steroidresistentse ägeda äratõukereaktsiooni ravi järgselt ning müokardiinfarkti või müokardi revaskulariseeriva protseduuri järgselt |

| 1294657 | takroliimus, 5mg | L04AD02 | ADVAGRAF, toimeainet prolongeeritult vabastav kõvakapsel, 30TK | Astellas Pharma Europe B.V. | 100 | Z94-Z94, T86-T86 | | | | | patsientidele, kellel esineb kõrge immunoloogiline risk (PRA>20%), korduvsiirdamise puhul, maksasiirdamise puhul, kopsusiirdamise puhul, steroidresistentse ägeda äratõukereaktsiooni ravi järgselt ning müokardiinfarkti või müokardi revaskulariseeriva protseduuri järgselt |

| 1002665 | tamoksifeen, 20mg | L02BA01 | NOLVADEX D, tablett, 30TK | AstraZeneca UK Limited | 100 | D18.1-D18.1 | Pulmonoloog, Onkoloog | | | | |

| | | | | | 100 | C00-D48 | Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1015704 | tamoksifeen, 20mg | L02BA01 | TAMOXIFEN "EBEWE", tablett, 30TK | Ebewe Pharma Ges.m.b.H Nfg.KG | 50 | | | | | | |

| 1002665 | tamoksifeen, 20mg | L02BA01 | NOLVADEX D, tablett, 30TK | AstraZeneca UK Limited | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Onkoloog | | | | |

| | | | | | 100 | D18.1-D18.1 | Pulmonoloog, Onkoloog | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1015704 | tamoksifeen, 20mg | L02BA01 | TAMOXIFEN "EBEWE", tablett, 30TK | Ebewe Pharma Ges.m.b.H Nfg.KG | 50 | | | | | | |

| | | | | | 100 | D18.1-D18.1 | Onkoloog, Pulmonoloog | | | | |

| | | | | | 100 | C00-D48 | Onkoloog | | | | |

| 1154528 | tamsulosiin, 0,4mg | G04CA02 | OMNIC TOCAS, toimeainet prolongeeritult vabastav tablett, 30TK | Astellas Pharma Europe B.V. | 50 | | | | | | |

| 1436015 | tamsulosiin, 0,4mg | G04CA02 | TANYZ ERAS 0.4MG, toimeainet prolongeeritult vabastav tablett, 30TK | Krka d.d. Novo Mesto | 50 | | | | | | |

| 1188143 | tamsulosiin, 0,4mg | G04CA02 | FLOSIN 0,4MG, toimeainet modifitseeritult vabastav kõvakapsel, 30TK | Menarini International Operations Luxembourg S.A. | 50 | | | | | | |

@@ -3505,12 +3506,12 @@

| 1195826 | tamsulosiin, 0,4mg | G04CA02 | OMSAL, toimeainet prolongeeritult vabastav kõvakapsel, 30TK | Gedeon Richter Plc. | 50 | | | | | | |

| 1206773 | tamsulosiin, 0,4mg | G04CA02 | FOKUSIN, toimeainet modifitseeritult vabastav kõvakapsel, 30TK | Nycomed GmbH | 50 | | | | | | |

| 1390463 | tamsulosiin+dutasteriid , 0,4mg+0,5mg | G04CA52 | COMBODART, kõvakapsel, 30TK | GlaxoSmithKline Eesti OÜ | 50 | | | | | | |

| 1046292 | telmisartaan, 40mg | C09CA07 | MICARDIS, tablett, 28TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1046292 | telmisartaan, 40mg | C09CA07 | MICARDIS, tablett, 28TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1060524 | telmisartaan, 40mg | C09CA07 | PRITOR, tablett, 28TK | Bayer Schering Pharma AG | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1046258 | telmisartaan, 80mg | C09CA07 | MICARDIS, tablett, 28TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1046258 | telmisartaan, 80mg | C09CA07 | MICARDIS, tablett, 28TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1183519 | telmisartaan, 80mg | C09CA07 | PRITOR, tablett, 28TK | Bayer Schering Pharma AG | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

@@ -3526,10 +3527,10 @@

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1367524 | telmisartaan+hüdroklor otiasiid, 80mg+25mg | C09DA07 | MICARDISPLUS, tablett, 28TK | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1368110 | telmisartaan+hüdroklor otiasiid, 80mg+25mg | C09DA07 | PRITORPLUS 80/25 MG, tablett, 28TK | Bayer Schering Pharma AG | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1114995 | temosolomiid, 100mg | L01AX03 | TEMODAL, kõvakapsel, 5TK | SCHERING-PLOUGH EUROPE | 100 | C71-C71 | Onkoloog | | | | konsiiliumi (vähemalt 3 onkoloogi ühise) otsuse alusel heas üldseisundis patsiendile (WHO funktsionaalne klass 0...1) |

| | | | | | 50 | | | | | | |

| 1368110 | telmisartaan+hüdroklor otiasiid, 80mg+25mg | C09DA07 | PRITORPLUS 80/25 MG, tablett, 28TK | Bayer Schering Pharma AG | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1114995 | temosolomiid, 100mg | L01AX03 | TEMODAL, kõvakapsel, 5TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| | | | | | 100 | C71-C71 | Onkoloog | | | | konsiiliumi (vähemalt 3 onkoloogi ühise) otsuse alusel heas üldseisundis patsiendile (WHO funktsionaalne klass 0...1) |

| 1303232 | temosolomiid, 140mg | L01AX03 | TEMODAL, kõvakapsel, 5TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| | | | | | 100 | C71-C71 | Onkoloog | | | | konsiiliumi (vähemalt 3 onkoloogi ühise) otsuse alusel heas üldseisundis patsiendile (WHO funktsionaalne klass 0...1) |

@@ -3539,25 +3540,25 @@

| | | | | | 50 | | | | | | |

| 1114973 | temosolomiid, 20mg | L01AX03 | TEMODAL, kõvakapsel, 5TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| | | | | | 100 | C71-C71 | Onkoloog | | | | konsiiliumi (vähemalt 3 onkoloogi ühise) otsuse alusel heas üldseisundis patsiendile (WHO funktsionaalne klass 0...1) |

| 1115019 | temosolomiid, 250mg | L01AX03 | TEMODAL, kõvakapsel, 5TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| 1115019 | temosolomiid, 250mg | L01AX03 | TEMODAL, kõvakapsel, 5TK | SCHERING-PLOUGH EUROPE | 100 | C71-C71 | Onkoloog | | | | konsiiliumi (vähemalt 3 onkoloogi ühise) otsuse alusel heas üldseisundis patsiendile (WHO funktsionaalne klass 0...1) |

| | | | | | 50 | | | | | | |

| 1114951 | temosolomiid, 5mg | L01AX03 | TEMODAL, kõvakapsel, 5TK | SCHERING-PLOUGH EUROPE | 50 | | | | | | |

| | | | | | 100 | C71-C71 | Onkoloog | | | | konsiiliumi (vähemalt 3 onkoloogi ühise) otsuse alusel heas üldseisundis patsiendile (WHO funktsionaalne klass 0...1) |

| 1114951 | temosolomiid, 5mg | L01AX03 | TEMODAL, kõvakapsel, 5TK | SCHERING-PLOUGH EUROPE | 100 | C71-C71 | Onkoloog | | | | konsiiliumi (vähemalt 3 onkoloogi ühise) otsuse alusel heas üldseisundis patsiendile (WHO funktsionaalne klass 0...1) |

| | | | | | 50 | | | | | | |

| 1033861 | teofülliin, 200mg | R03DA04 | TEOTARD, toimeainet prolongeeritult vabastav kõvakapsel, 40TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1124031 | teofülliin, 200mg | R03DA04 | RETAFYLLIN, toimeainet prolongeeritult vabastav tablett, 100TK | Orion Corporation | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1124042 | teofülliin, 300mg | R03DA04 | RETAFYLLIN, toimeainet prolongeeritult vabastav tablett, 100TK | Orion Corporation | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1124031 | teofülliin, 200mg | R03DA04 | RETAFYLLIN, toimeainet prolongeeritult vabastav tablett, 100TK | Orion Corporation | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| 1124042 | teofülliin, 300mg | R03DA04 | RETAFYLLIN, toimeainet prolongeeritult vabastav tablett, 100TK | Orion Corporation | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1033850 | teofülliin, 350mg | R03DA04 | TEOTARD, toimeainet prolongeeritult vabastav kõvakapsel, 40TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | J45-J45 | Pediaater, Pulmonoloog | esmane | | | |

| | | | | | 75 | J45-J45 | Pulmonoloog, Pediaater | esmane | | | |

| 1034345 | terbinafiin, 10mg 1g | D01AE15 | LAMISIL, nahasprei, lahus, 30ml 1TK | Novartis Finland OY | 50 | | | | | | |

| 1158724 | terbinafiin, 250mg | D01BA02 | TERBINAFINE SANDOZ 250 MG, tablett, 14TK | Sandoz d.d. | 50 | | | | | | |

| 1002766 | terbinafiin, 250mg | D01BA02 | LAMISIL, tablett, 14TK | Novartis Finland OY | 50 | | | | | | |

@@ -3566,18 +3567,18 @@

| 1176308 | terbinafiin, 250mg | D01BA02 | TERBINAFIN ACTAVIS, tablett, 14TK | Actavis Nordic A/S | 50 | | | | | | |

| 1176319 | terbinafiin, 250mg | D01BA02 | TERBINAFIN ACTAVIS, tablett, 28TK | Actavis Nordic A/S | 50 | | | | | | |

| 1213614 | terbinafiin, 250mg | D01BA02 | TERBINAFIN NYCOMED, tablett, 28TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Onkoloog, Hematoloog | | | | |

| 1022623 | testosteroon, 250mg 1ml | G03BA03 | SUSTANON, süstelahus, 1ml 1TK | N.V. ORGANON | 50 | | | | | | |

| | | | | | 100 | C00-D48 | Hematoloog, Onkoloog | | | | |

| 1169445 | testosteroon, 250mg 1ml | G03BA03 | NEBIDO, süstelahus, 4ml 1TK | Bayer Schering Pharma AG | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1022588 | testosteroon, 40mg | G03BA03 | ANDRIOL TESTOCAPS, pehmekapsel, 60TK | N.V. ORGANON | 50 | | | | | | |

| 1022588 | testosteroon, 40mg | G03BA03 | ANDRIOL TESTOCAPS, pehmekapsel, 60TK | N.V. ORGANON | 100 | C00-D48 | Onkoloog, Hematoloog | | | | |

| | | | | | 100 | C00-D48 | Hematoloog, Onkoloog | | | | |

| 1014163 | tetratsükliin, 250mg | J01AA07 | TETRACYCLIN NYCOMED, õhukese polümeerikattega tablett, 24TK | Nycomed Sefa AS | 100 | A50-A53 | Dermatoveneroloog | | | | |

| | | | | | 50 | | | | | | |

| 1014163 | tetratsükliin, 250mg | J01AA07 | TETRACYCLIN NYCOMED, õhukese polümeerikattega tablett, 24TK | Nycomed Sefa AS | 50 | | | | | | |

| | | | | | 100 | A50-A53 | Dermatoveneroloog | | | | |

| 1017403 | tetratsükliin, 30mg 1g | D06AA04 | IMEX, salv, 20g 1TK | Merz Pharmaceuticals GmbH | 50 | | | | | | |

| 1019360 | tianeptiin, 12,5mg | N06AX14 | COAXIL, kaetud tablett, 30TK | Les Laboratoires Servier | 50 | | | | | | |

| 1034165 | tiboloon, 2,5mg | G03CX01 | LIVIAL, tablett, 28TK | N.V. ORGANON | 50 | | | | | | |

@@ -3585,55 +3586,55 @@

| | | | | | 50 | | | | | | |

| 1038956 | timolool, 1mg 1g | S01ED01 | TIMOSAN, silmageel, 5g 1TK | SANTEN OY | 50 | | | | | | |

| | | | | | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| 1112634 | timolool, 2,5mg 1ml | S01ED01 | OFTAN TIMOLOL, silmatilgad, lahus, 5ml 1TK | SANTEN OY | 50 | | | | | | |

| 1112634 | timolool, 2,5mg 1ml | S01ED01 | OFTAN TIMOLOL, silmatilgad, lahus, 5ml 1TK | SANTEN OY | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1078062 | timolool, 5mg 1ml | S01ED01 | NYOLOL 0,5%, silmatilgad, lahus, 5ml 1TK | Novartis Finland OY | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1112645 | timolool, 5mg 1ml | S01ED01 | OFTAN TIMOLOL, silmatilgad, lahus, 5ml 1TK | SANTEN OY | 50 | | | | | | |

| | | | | | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| 1078062 | timolool, 5mg 1ml | S01ED01 | NYOLOL 0,5%, silmatilgad, lahus, 5ml 1TK | Novartis Finland OY | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1112645 | timolool, 5mg 1ml | S01ED01 | OFTAN TIMOLOL, silmatilgad, lahus, 5ml 1TK | SANTEN OY | 100 | H40-H42 | Oftalmoloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1252976 | timolool+bimatoprost, 5mg+0,3mg 1ml | S01ED82 | GANFORT, silmatilgad, lahus, 3ml 1TK | Allergan Pharmaceuticals Ireland | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1341324 | timolool+dorsolamiid, 5mg+20mg 1ml | S01ED80 | DOTIZOLIL, silmatilgad, lahus, 5ml 1TK | Sandoz d.d. | 50 | | | | | | |

| 1392207 | timolool+brinsolamiid, 5mg+10mg 1ml | S01ED83 | AZARGA, silmatilgad, suspensioon, 5ml 1TK | Alcon Laboratories Ltd. (Ühendkuningriik) | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1393062 | timolool+latanoprost, 5mg+50mcg 1ml | S01ED84 | XALACOM, silmatilgad, lahus, 2.5ml 3TK | Pfizer Enterprises SARL | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1088254 | timolool+latanoprost, 5mg+50mcg 1ml | S01ED51 | XALACOM, silmatilgad, lahus, 2.5ml 1TK | Pfizer Enterprises SARL | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1243763 | timolool+travoprost, 5mg+40mcg 1ml | S01ED81 | DUOTRAV, silmatilgad, lahus, 2.5ml 1TK | Alcon Laboratories Ltd. (Ühendkuningriik) | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| 1004375 | tioguaniin, 40mg | L01BB03 | LANVIS, tablett, 25TK | Glaxo Wellcome UK Limited trading as Glaxo Wellcome Operations | 50 | | | | | | |

| 1111341 | tiokthape (alfa- lipoehape), 600mg | A16AX01 | THIOCTACID HR, õhukese polümeerikattega tablett, 30TK | Meda Pharma GmbH & Co. KG | 50 | | | | | | |

| 1173822 | tisanidiin, 2mg | M03BX02 | SIRDALUD, tablett, 30TK | Novartis Finland OY | 75 | G82-G82, G81-G81 | | | | | |

| | | | | | 50 | | | | | | |

| 1290237 | tisanidiin, 2mg | M03BX02 | TIZANIDINE-TEVA, tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| 1290237 | tisanidiin, 2mg | M03BX02 | TIZANIDINE-TEVA, tablett, 30TK | Teva Pharma B.V. | 75 | G82-G82, G81-G81 | | | | | |

| | | | | | 50 | | | | | | |

| 1211599 | tisanidiin, 4mg | M03BX02 | SIRDALUD, tablett, 30TK | Novartis Finland OY | 75 | G82-G82, G81-G81 | | | | | |

| | | | | | 50 | | | | | | |

| 1290361 | tisanidiin, 4mg | M03BX02 | TIZANIDINE-TEVA, tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| | | | | | 75 | G82-G82, G81-G81 | | | | | |

| 1211599 | tisanidiin, 4mg | M03BX02 | SIRDALUD, tablett, 30TK | Novartis Finland OY | 50 | | | | | | |

| | | | | | 75 | G82-G82, G81-G81 | | | | | |

| 1290361 | tisanidiin, 4mg | M03BX02 | TIZANIDINE-TEVA, tablett, 30TK | Teva Pharma B.V. | 75 | G82-G82, G81-G81 | | | | | |

| | | | | | 50 | | | | | | |

| 1012543 | tobramütsiin, 3mg 1g | S01AA12 | TOBREX, silmasalv, 3.5g 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| 1150120 | tobramütsiin, 3mg 1ml | S01AA12 | TOBREX 2X, silmatilgad, lahus, 5ml 1TK | Alcon Cusi S.A. | 50 | | | | | | |

| | | | | | 100 | E70.0-E70.1 | | | | | |

| 7000131 | toitained ilma fenüülalaniinita, | | XP MAXAMAID (ORANGE FLAVOURED) pulber, pulber, 500g N4 | SHS International | 100 | E70.0-E70.1 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | E70.0-E70.1 | | | | | |

| 7000142 | toitained ilma fenüülalaniinita, | | XP MAXAMAID (UNFLAVOURED) pulber, pulber, 500g N4 | SHS International | 100 | E70.0-E70.1 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 7000153 | toitained ilma fenüülalaniinita, | | XP MAXAMUM (ORANGE FLAVOURED) pulber, pulber, 500g N4 | SHS International | 100 | E70.0-E70.1 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | E70.0-E70.1 | | | | | |

| | | | | | 100 | E70.0-E70.1 | | | | | |

| 7000186 | toitained ilma fenüülalaniinita, | | DUOCAL Supersoluble , pulber, 400 g | SHS | 50 | | | | | | |

@@ -3646,21 +3647,21 @@

| 1043301 | tolterodiin, 1mg | G04BD07 | DETRUSITOL 1 MG, õhukese polümeerikattega tablett, 28TK | Pfizer Enterprises SARL | 50 | | | | | | |

| 1284498 | tolterodiin, 2mg | G04BD07 | UROFLOW 2, õhukese polümeerikattega tablett, 28TK | Zentiva, k.s. | 50 | | | | | | |

| 1043312 | tolterodiin, 2mg | G04BD07 | DETRUSITOL 2 MG, õhukese polümeerikattega tablett, 28TK | Pfizer Enterprises SARL | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1309878 | topiramaat, 100mg | N03AX11 | TOPIRAMATE ORION, õhukese polümeerikattega tablett, 60TK | Orion Corporation | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1076778 | topiramaat, 100mg | N03AX11 | TOPAMAX, õhukese polümeerikattega tablett, 60TK | Johnson & Johnson UAB | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1076846 | topiramaat, 200mg | N03AX11 | TOPAMAX, õhukese polümeerikattega tablett, 60TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1239825 | topiramaat, 100mg | N03AX11 | TOPIRAMATE SANDOZ 100 MG, õhukese polümeerikattega tablett, 60TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1309902 | topiramaat, 200mg | N03AX11 | TOPIRAMATE ORION, õhukese polümeerikattega tablett, 60TK | Orion Corporation | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1309812 | topiramaat, 25mg | N03AX11 | TOPIRAMATE ORION, õhukese polümeerikattega tablett, 60TK | Orion Corporation | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

@@ -3672,8 +3673,8 @@

| | | | | | 50 | | | | | | |

| 1239757 | topiramaat, 50mg | N03AX11 | TOPIRAMATE SANDOZ 50 MG, õhukese polümeerikattega tablett, 60TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1158050 | torasemiid, 100mg | C03CA04 | TORASEMID HEXAL 100 MG TABLETID, tablett, 30TK | HEXAL AG | 50 | | | | | | |

@@ -3707,13 +3708,13 @@

| 1015377 | tramadool, 50mg | N02AX02 | TRAMAL, kõvakapsel, 20TK | Grünenthal GmbH | 50 | | | | | | |

| 1015580 | tramadool, 50mg | N02AX02 | TRAMADOL KRKA, kõvakapsel, 20TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1032679 | tramadool, 50mg | N02AX02 | TRAMADOL LANNACHER, õhukese polümeerikattega tablett, 20TK | LANNACHER HEILMITTEL GmbH | 50 | | | | | | |

| 1074765 | trandolapriil, 2mg | C09AA10 | GOPTEN, kõvakapsel, 28TK | Abbott Laboratories Baltics SIA | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1233290 | trandolapriil+verapamiil , 2mg+180mg | C09BB10 | TARKA, toimeainet modifitseeritult vabastav tablett, 28TK | Abbott Laboratories Baltics SIA | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1074765 | trandolapriil, 2mg | C09AA10 | GOPTEN, kõvakapsel, 28TK | Abbott Laboratories Baltics SIA | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1233290 | trandolapriil+verapamiil , 2mg+180mg | C09BB10 | TARKA, toimeainet modifitseeritult vabastav tablett, 28TK | Abbott Laboratories Baltics SIA | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1051816 | traneksaamhape, 100mg 1ml | B02AA02 | CYKLOKAPRON, süstelahus, 5ml 10TK | Pfizer Enterprises SARL | 50 | | | | | | |

| 1083316 | traneksaamhape, 500mg | B02AA02 | CYKLOKAPRON, õhukese polümeerikattega tablett, 20TK | Meda AB | 50 | | | | | | |

| 1130454 | travoprost, 40mcg 1ml | S01EE04 | TRAVATAN, silmatilgad, lahus, 2.5ml 1TK | ALCON LABORATORIES (UK) Ltd. | 100 | H40-H42 | Oftalmoloog | esmane | | | |

@@ -3725,7 +3726,7 @@

| 1401411 | trimetasidiin, 35mg | C01EB15 | TRIMETAZIDINE ACTAVIS, toimeainet modifitseeritult vabastav tablett, 60TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1016312 | trimetoprim, 100mg | J01EA01 | TRIMETOP 100MG, tablett, 30TK | VITABALANS OY | 50 | | | | | | |

| 1040397 | triptoreliin, 3,75mg | L02AE04 | DIPHERELINE 3,75 MG, toimeainet prolongeeritult vabastava süstesuspensiooni pulber ja lahusti, 1TK | Ipsen Pharma | 50 | | | | | | |

| | | | | | 75 | E22.8-E22.8 | Endokrinoloog, Pediaater | | | | |

| | | | | | 75 | E22.8-E22.8 | Pediaater, Endokrinoloog | | | | |

| | | | | | 75 | N80-N80 | Günekoloog | | | | III-IV astme endometrioosi põdevatele patsientidele |

| 1007963 | tromantadiin, 1% | D06BB02 | VIRU-MERZ SEROL GEEL, geel, 2g 1TK | Merz Pharmaceuticals GmbH | 50 | | | | | | |

| 1123850 | tropikamiid, 5mg 1ml | S01FA06 | MYDRIACYL, silmatilgad, lahus, 15ml 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

@@ -3755,138 +3756,138 @@

| 1219801 | tsefuroksiim, 500mg | J01DC02 | XORIMAX, kaetud tablett, 10TK | Sandoz GmbH | 50 | | | | | | |

| 1073641 | tselekoksiib, 100mg | M01AH01 | CELEBREX, kõvakapsel, 20TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1073731 | tselekoksiib, 200mg | M01AH01 | CELEBREX, kõvakapsel, 10TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1077836 | tsetirisiin, 10mg | R06AE07 | ZYRTEC, tablett, 30TK | UCB Pharma Oy Finland | 50 | | | | | | |

| 1077836 | tsetirisiin, 10mg | R06AE07 | ZYRTEC, tablett, 30TK | UCB Pharma OY Finland | 50 | | | | | | |

| 1098918 | tsetirisiin, 10mg | R06AE07 | CETIRIZIN ACTAVIS, õhukese polümeerikattega tablett, 30TK | Actavis UK Limited | 50 | | | | | | |

| 1121870 | tsetirisiin, 10mg | R06AE07 | ACETERIN, õhukese polümeerikattega tablett, 30TK | Sandoz d.d. | 50 | | | | | | |

| 1022869 | tsetirisiin, 10mg 1ml | R06AE07 | ZYRTEC, suukaudsed tilgad, lahus, 20ml 1TK | UCB Pharma Oy Finland | 50 | | | | | | |

| 1022869 | tsetirisiin, 10mg 1ml | R06AE07 | ZYRTEC, suukaudsed tilgad, lahus, 20ml 1TK | UCB Pharma OY Finland | 50 | | | | | | |

| 1043356 | tsetroreliks, 0,25mg | H01CC02 | CETROTIDE, süstelahuse pulber ja lahusti, 1TK | Merck Serono Europe Limited | 50 | | | | | | |

| 1205132 | tsinakaltseet, 30mg | H05BX01 | MIMPARA, õhukese polümeerikattega tablett, 28TK | Amgen Europe B.V. | 50 | | | | | | |

| | | | | | 100 | N18-N18 | Nefroloog, Pediaater | | | | vastavalt Eesti Nefroloogide Seltsi, Sotsiaalministeeriumi ja Eesti Haigekassa poolt tunnustatud ravijuhisele |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1205176 | tsinakaltseet, 60mg | H05BX01 | MIMPARA, õhukese polümeerikattega tablett, 28TK | Amgen Europe B.V. | 50 | | | | | | |

| | | | | | 100 | N18-N18 | Pediaater, Nefroloog | | | | vastavalt Eesti Nefroloogide Seltsi, Sotsiaalministeeriumi ja Eesti Haigekassa poolt tunnustatud ravijuhisele |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1205176 | tsinakaltseet, 60mg | H05BX01 | MIMPARA, õhukese polümeerikattega tablett, 28TK | Amgen Europe B.V. | 100 | N18-N18 | Nefroloog, Pediaater | | | | vastavalt Eesti Nefroloogide Seltsi, Sotsiaalministeeriumi ja Eesti Haigekassa poolt tunnustatud ravijuhisele |

| | | | | | 50 | | | | | | |

| 1205211 | tsinakaltseet, 90mg | H05BX01 | MIMPARA, õhukese polümeerikattega tablett, 28TK | Amgen Europe B.V. | 100 | N18-N18 | Pediaater, Nefroloog | | | | vastavalt Eesti Nefroloogide Seltsi, Sotsiaalministeeriumi ja Eesti Haigekassa poolt tunnustatud ravijuhisele |

| | | | | | 50 | | | | | | |

| 1196388 | tsinkatsetaatdihüdraat, 25mg | A16AX05 | WILZIN, kõvakapsel, 250TK | Orphan Europe SARL | 100 | E83.0-E83.0 | Gastroenteroloog, Neuroloog | esmane | | | |

| 1196377 | tsinkatsetaatdihüdraat, 50mg | A16AX05 | WILZIN, kõvakapsel, 250TK | Orphan Europe SARL | 100 | E83.0-E83.0 | Gastroenteroloog, Neuroloog | esmane | | | |

| 1196388 | tsinkatsetaatdihüdraat, 25mg | A16AX05 | WILZIN, kõvakapsel, 250TK | Orphan Europe SARL | 100 | E83.0-E83.0 | Neuroloog, Gastroenteroloog | esmane | | | |

| 1196377 | tsinkatsetaatdihüdraat, 50mg | A16AX05 | WILZIN, kõvakapsel, 250TK | Orphan Europe SARL | 100 | E83.0-E83.0 | Neuroloog, Gastroenteroloog | esmane | | | |

| 1008953 | tsinnarisiin, 25mg | N07CA02 | STUGERON, tablett, 50TK | Johnson & Johnson UAB | 50 | | | | | | |

| 1013353 | tsinnarisiin, 75mg | N07CA02 | CINNARON, kõvakapsel, 50TK | REMEDICA LTD. | 50 | | | | | | |

| 1019944 | tsiprofibraat, 100mg | C10AB08 | LIPANOR, kõvakapsel, 30TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| 1005488 | tsiprofloksatsiin, 250mg | J01MA02 | CIPRINOL, õhukese polümeerikattega tablett, 10TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1005488 | tsiprofloksatsiin, 250mg | J01MA02 | CIPRINOL, õhukese polümeerikattega tablett, 10TK | KRKA d.d., Novo Mesto | 100 | E84-E84 | Pediaater, Pulmonoloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| 1070895 | tsiprofloksatsiin, 250mg | J01MA02 | CIFLOXINAL, tablett, 20TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| | | | | | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| | | | | | 100 | E84-E84 | Pulmonoloog, Pediaater | | | | |

| 1070895 | tsiprofloksatsiin, 250mg | J01MA02 | CIFLOXINAL, tablett, 20TK | PRO. MED. CS. PRAHA a.s. | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| | | | | | 100 | E84-E84 | Pediaater, Pulmonoloog | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1223851 | tsiprofloksatsiin, 250mg | J01MA02 | CIPROFLOXACIN SANDOZ 250MG, õhukese polümeerikattega tablett, 10TK | Sandoz d.d. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1223851 | tsiprofloksatsiin, 250mg | J01MA02 | CIPROFLOXACIN SANDOZ 250MG, õhukese polümeerikattega tablett, 10TK | Sandoz d.d. | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 100 | E84-E84 | Pediaater, Pulmonoloog | | | | |

| | | | | | 50 | | | | | | |

| 1042827 | tsiprofloksatsiin, 3mg 1ml | S01AX13 | CILOXAN, silmatilgad, lahus, 5ml 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| 1005545 | tsiprofloksatsiin, 500mg | J01MA02 | CIPRINOL, õhukese polümeerikattega tablett, 10TK | KRKA d.d., Novo Mesto | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | E84-E84 | Pediaater, Pulmonoloog | | | | |

| 1223929 | tsiprofloksatsiin, 500mg | J01MA02 | CIPROFLOXACIN SANDOZ 500MG, õhukese polümeerikattega tablett, 10TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 100 | E84-E84 | Pulmonoloog, Pediaater | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| 1042827 | tsiprofloksatsiin, 3mg 1ml | S01AX13 | CILOXAN, silmatilgad, lahus, 5ml 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| 1005545 | tsiprofloksatsiin, 500mg | J01MA02 | CIPRINOL, õhukese polümeerikattega tablett, 10TK | KRKA d.d., Novo Mesto | 100 | E84-E84 | Pulmonoloog, Pediaater | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| 1223929 | tsiprofloksatsiin, 500mg | J01MA02 | CIPROFLOXACIN SANDOZ 500MG, õhukese polümeerikattega tablett, 10TK | Sandoz d.d. | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | E84-E84 | Pulmonoloog, Pediaater | | | | |

| 1083552 | tsitalopraam, 10mg | N06AB04 | CITALEC 10, õhukese polümeerikattega tablett, 30TK | Zentiva a.s. | 50 | | | | | | |

| 1176465 | tsitalopraam, 10mg | N06AB04 | CITALANORM GENERICON, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 50 | | | | | | |

| 1218361 | tsitalopraam, 10mg | N06AB04 | CITALOPRAM - TEVA 10MG, õhukese polümeerikattega tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| 1083563 | tsitalopraam, 20mg | N06AB04 | CITALEC 20, õhukese polümeerikattega tablett, 30TK | Zentiva a.s. | 50 | | | | | | |

| 1109517 | tsitalopraam, 20mg | N06AB04 | PRAM 20MG, õhukese polümeerikattega tablett, 28TK | G.L. Pharma GmbH | 50 | | | | | | |

| 1176634 | tsitalopraam, 20mg | N06AB04 | CITALANORM GENERICON, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1185409 | tsitalopraam, 20mg | N06AB04 | CITALOPRAM ACTAVIS 20 MG, õhukese polümeerikattega tablett, 28TK | Actavis Nordic A/S | 50 | | | | | | |

| 1070525 | tsitalopraam, 20mg | N06AB04 | CIPRAMIL 20 MG, õhukese polümeerikattega tablett, 28TK | H. LUNDBECK A/S | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1109517 | tsitalopraam, 20mg | N06AB04 | PRAM 20MG, õhukese polümeerikattega tablett, 28TK | LANNACHER HEILMITTEL GmbH | 50 | | | | | | |

| 1112937 | tsitalopraam, 20mg | N06AB04 | CIRAL 20 MG, kaetud tablett, 28TK | Sandoz d.d. | 50 | | | | | | |

| 1176634 | tsitalopraam, 20mg | N06AB04 | CITALANORM GENERICON, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 50 | | | | | | |

| 1218462 | tsitalopraam, 20mg | N06AB04 | CITALOPRAM - TEVA 20MG, õhukese polümeerikattega tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| 1176803 | tsitalopraam, 40mg | N06AB04 | CITALANORM GENERICON, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 50 | | | | | | |

| 1185533 | tsitalopraam, 40mg | N06AB04 | CITALOPRAM ACTAVIS 40 MG, õhukese polümeerikattega tablett, 28TK | Actavis Nordic A/S | 50 | | | | | | |

| 1106806 | tsitalopraam, 40mg | N06AB04 | CIRAL 40 MG, kaetud tablett, 28TK | Sandoz d.d. | 50 | | | | | | |

| 1176803 | tsitalopraam, 40mg | N06AB04 | CITALANORM GENERICON, õhukese polümeerikattega tablett, 30TK | Genericon Pharma GmbH | 50 | | | | | | |

| 1218563 | tsitalopraam, 40mg | N06AB04 | CITALOPRAM - TEVA 40MG, õhukese polümeerikattega tablett, 30TK | Teva Pharma B.V. | 50 | | | | | | |

| 7000175 | tsitrulliin, | | L-CITRULLINE , pulber, 100 g | SHS | 50 | | | | | | |

| 1021790 | tsüklofosfamiid, 50mg | L01AA01 | ENDOXAN, kaetud tablett, 50TK | Baxter Oncology GmbH | 100 | C00-D48 | Hematoloog, Onkoloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | N00-N08 | Pediaater, Nefroloog | | | | |

| | | | | | 100 | C00-D48 | Onkoloog, Hematoloog | | | | |

| 1123760 | tsüklopentolaat, 10mg 1ml | S01FA04 | CYCLOGYL, silmatilgad, lahus, 15ml 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1008559 | tsüklosporiin, 100mg | L04AD01 | SANDIMMUN NEORAL, pehmekapsel, 50TK | Novartis Finland OY | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| 1098840 | tsüklosporiin, 100mg | L04AD01 | EQUORAL 100 MG, pehmekapsel, 50TK | TEVA Czech Industries s.r.o. | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| 1123760 | tsüklopentolaat, 10mg 1ml | S01FA04 | CYCLOGYL, silmatilgad, lahus, 15ml 1TK | s.a. ALCON- COUVREUR n.v. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| 1008526 | tsüklosporiin, 25mg | L04AD01 | SANDIMMUN NEORAL, pehmekapsel, 50TK | Novartis Finland OY | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 75 | N00-N08 | Pediaater, Nefroloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| 1098840 | tsüklosporiin, 100mg | L04AD01 | EQUORAL 100 MG, pehmekapsel, 50TK | TEVA Czech Industries s.r.o. | 50 | | | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1098828 | tsüklosporiin, 25mg | L04AD01 | EQUORAL 25 MG, pehmekapsel, 50TK | TEVA Czech Industries s.r.o. | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1113264 | tsüklosporiin, 100mg | L04AD01 | CICLOSPORIN SANDOZ 100 MG, pehmekapsel, 50TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| 1008526 | tsüklosporiin, 25mg | L04AD01 | SANDIMMUN NEORAL, pehmekapsel, 50TK | Novartis Finland OY | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | N00-N08 | Pediaater, Nefroloog | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1008548 | tsüklosporiin, 50mg | L04AD01 | SANDIMMUN NEORAL, pehmekapsel, 50TK | Novartis Finland OY | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 100 | D60-D64 | Hematoloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| 1098839 | tsüklosporiin, 50mg | L04AD01 | EQUORAL 50 MG, pehmekapsel, 50TK | TEVA Czech Industries s.r.o. | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 75 | N00-N08 | Pediaater, Nefroloog | | | | |

| | | | | | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| 1113231 | tsüklosporiin, 25mg | L04AD01 | CICLOSPORIN SANDOZ 25 MG, pehmekapsel, 50TK | Sandoz d.d. | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | N00-N08 | Pediaater, Nefroloog | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 100 | Z94-Z94, T86-T86 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1113253 | tsüklosporiin, 50mg | L04AD01 | CICLOSPORIN SANDOZ 50 MG, pehmekapsel, 50TK | Sandoz d.d. | 100 | Z94-Z94, T86-T86 | | | | | |

| | | | | | 100 | D60-D64 | Pediaater, Hematoloog | | | | |

| | | | | | 75 | N00-N08 | Nefroloog, Pediaater | | | | |

| | | | | | 50 | | | | | | |

| 1064124 | tsüproteroon, 50mg | G03HA01 | ANDROCUR, tablett, 50TK | Bayer Schering Pharma AG | 50 | | | | | | |

| 1341177 | tsüproteroon+ östrogeen, 2mg+0,035mg | G03HB01 | CYPRETIL, kaetud tablett, 21TK | ratiopharm GmbH | 50 | | | | | | |

| 1018370 | tsüproteroon+ östrogeen+ östrogeen, 1mg+2mg/0+2mg | G03HB01 | CLIMEN, kaetud tablett, 10TK / 11TK | Bayer Schering Pharma AG | 50 | | | | | | |

@@ -3894,110 +3895,110 @@

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1014488 | tsüproteroon+östrogee n, 2mg+0,035mg | G03HB01 | DIANE, kaetud tablett, 21TK | Bayer Schering Pharma AG | 50 | | | | | | |

| 1122084 | tsüproteroon+östrogee n, 2mg+35mcg | G03HB01 | FEMINA-35, kaetud tablett, 21TK | Nycomed Sefa AS | 50 | | | | | | |

| 1040779 | tõrvad, 1% | D05AA84 | POLYTAR LIQUID, šampoon, 150ml 1TK | Stiefel Laboratories (Ireland) Ltd. | 75 | M07-M07, L40-L40 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1044818 | ursodeoksükoolhape, 250mg | A05AA02 | URSOFALK, kõvakapsel, 50TK | Dr. Falk Pharma GmbH | 50 | | | | | | |

| 1040779 | tõrvad, 1% | D05AA84 | POLYTAR LIQUID, šampoon, 150ml 1TK | Stiefel Laboratories (Ireland) Ltd. | 50 | | | | | | |

| | | | | | 75 | M07-M07, L40-L40 | | | | | |

| 1016985 | ursodeoksükoolhape, 250mg | A05AA02 | URSOSAN, kõvakapsel, 50TK | PRO. MED. CS. PRAHA a.s. | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| 1016301 | valatsikloviir, 500mg | J05AB11 | VALTREX, õhukese polümeerikattega tablett, 10TK | Glaxo Wellcome Operations | 50 | | | | | | |

| 1300936 | valatsikloviir, 500mg | J05AB11 | VALACICLOVIR ACTAVIS 500MG, õhukese polümeerikattega tablett, 10TK | Actavis Group PTC ehf | 50 | | | | | | |

| 1369593 | valatsikloviir, 500mg | J05AB11 | VALACICLOVIR PORTFARMA 500 MG, õhukese polümeerikattega tablett, 10TK | Portfarma ehf | 50 | | | | | | |

| 1078185 | valproehape, 1000mg | N03AG01 | ORFIRIL LONG 1000 MG, toimeainet prolongeeritult vabastavad graanulid, 100TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| 1078185 | valproehape, 1000mg | N03AG01 | ORFIRIL LONG 1000 MG, toimeainet prolongeeritult vabastavad graanulid, 100TK | Desitin Arzneimittel GmbH | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1043592 | valproehape, 150mg | N03AG01 | CONVULEX 150 MG, gastroresistentne pehmekapsel, 100TK | G.L. Pharma GmbH | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1076419 | valproehape, 150mg | N03AG01 | ORFIRIL LONG 150 MG, toimeainet prolongeeritult vabastav kõvakapsel, 100TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1076419 | valproehape, 150mg | N03AG01 | ORFIRIL LONG 150 MG, toimeainet prolongeeritult vabastav kõvakapsel, 100TK | Desitin Arzneimittel GmbH | 100 | G40-G40 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1108246 | valproehape, 150mg | N03AG01 | ORFIRIL 150, gastroresistentne tablett, 100TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1108246 | valproehape, 150mg | N03AG01 | ORFIRIL 150, gastroresistentne tablett, 100TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1086555 | valproehape, 300mg | N03AG01 | DEPAKINE CHRONO 300 mg, toimeainet prolongeeritult vabastav tablett, 100TK | Sanofi-Aventis Estonia OÜ | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| 1108257 | valproehape, 300mg | N03AG01 | ORFIRIL 300, gastroresistentne tablett, 100TK | Desitin Arzneimittel GmbH | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1252190 | valproehape, 300mg | N03AG01 | ABSENOR, toimeainet prolongeeritult vabastav tablett, 100TK | Orion Corporation Orion Pharma | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| 1076341 | valproehape, 500mg | N03AG01 | ORFIRIL LONG 500 MG, toimeainet prolongeeritult vabastavad graanulid, 100TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| 1043604 | valproehape, 300mg | N03AG01 | CONVULEX 300 MG, gastroresistentne pehmekapsel, 100TK | G.L. Pharma GmbH | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1086544 | valproehape, 500mg | N03AG01 | DEPAKINE CHRONO 500 MG, toimeainet prolongeeritult vabastav tablett, 30TK | Sanofi-Aventis Estonia OÜ | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1224605 | valproehape, 300mg | N03AG01 | VALPROATE SODIUM SANDOZ 300MG, toimeainet prolongeeritult vabastav tablett, 100TK | Sandoz d.d. | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1224638 | valproehape, 500mg | N03AG01 | VALPROATE SODIUM SANDOZ 500MG, toimeainet prolongeeritult vabastav tablett, 30TK | Sandoz d.d. | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| | | | | | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| 1108257 | valproehape, 300mg | N03AG01 | ORFIRIL 300, gastroresistentne tablett, 100TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1252190 | valproehape, 300mg | N03AG01 | ABSENOR, toimeainet prolongeeritult vabastav tablett, 100TK | Orion Corporation Orion Pharma | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1076341 | valproehape, 500mg | N03AG01 | ORFIRIL LONG 500 MG, toimeainet prolongeeritult vabastavad graanulid, 100TK | Desitin Arzneimittel GmbH | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1086544 | valproehape, 500mg | N03AG01 | DEPAKINE CHRONO 500 MG, toimeainet prolongeeritult vabastav tablett, 30TK | Sanofi-Aventis Estonia OÜ | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1224672 | valproehape, 500mg | N03AG01 | VALPROATE SODIUM SANDOZ 500MG, toimeainet prolongeeritult vabastav tablett, 100TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| 1252202 | valproehape, 500mg | N03AG01 | ABSENOR, toimeainet prolongeeritult vabastav tablett, 100TK | Orion Corporation Orion Pharma | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1043581 | valproehape, 50mg 1ml | N03AG01 | CONVULEX, siirup, 100ml 1TK | G.L. Pharma GmbH | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1043581 | valproehape, 50mg 1ml | N03AG01 | CONVULEX, siirup, 100ml 1TK | G.L. Pharma GmbH | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1108268 | valproehape, 600mg | N03AG01 | ORFIRIL 600, gastroresistentne tablett, 50TK | Desitin Arzneimittel GmbH | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| 1025536 | valproehape, 60mg 1ml | N03AG01 | ORFIRIL SAFT, suukaudne lahus, 250ml 1TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1108268 | valproehape, 600mg | N03AG01 | ORFIRIL 600, gastroresistentne tablett, 50TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| 1025536 | valproehape, 60mg 1ml | N03AG01 | ORFIRIL SAFT, suukaudne lahus, 250ml 1TK | Desitin Arzneimittel GmbH | 50 | | | | | | |

| | | | | | 100 | G40-G40 | Neuroloog | esmane | | | |

| 1092844 | valsartaan, 160mg | C09CA03 | DIOVAN, õhukese polümeerikattega tablett, 28TK | Novartis Finland OY | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1250378 | valsartaan, 160mg | C09CA03 | VALSACOR, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1250389 | valsartaan, 160mg | C09CA03 | VALSACOR, õhukese polümeerikattega tablett, 56TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1406809 | valsartaan, 160mg | C09CA03 | SUVARTAR 160MG, õhukese polümeerikattega tablett, 28TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1092844 | valsartaan, 160mg | C09CA03 | DIOVAN, õhukese polümeerikattega tablett, 28TK | Novartis Finland OY | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1250378 | valsartaan, 160mg | C09CA03 | VALSACOR, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1250389 | valsartaan, 160mg | C09CA03 | VALSACOR, õhukese polümeerikattega tablett, 56TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1406809 | valsartaan, 160mg | C09CA03 | SUVARTAR 160MG, õhukese polümeerikattega tablett, 28TK | Sandoz d.d. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1434495 | valsartaan, 160mg | C09CA03 | VALZAP, õhukese polümeerikattega tablett, 28TK | Zentiva, k.s. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1421233 | valsartaan, 320mg | C09CA03 | VALSACOR, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

@@ -4008,49 +4009,50 @@

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1406663 | valsartaan, 80mg | C09CA03 | SUVARTAR 80MG, õhukese polümeerikattega tablett, 28TK | Sandoz d.d. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1434473 | valsartaan, 80mg | C09CA03 | VALZAP, õhukese polümeerikattega tablett, 28TK | Zentiva, k.s. | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| | | | | | 50 | | | | | | |

| 1434518 | valsartaan+ hüdroklorotiasiid, 160mg+12,5mg | C09DA03 | VALZAP H, õhukese polümeerikattega tablett, 28TK | Zentiva, k.s. | 50 | | | | | | |

| 1434473 | valsartaan, 80mg | C09CA03 | VALZAP, õhukese polümeerikattega tablett, 28TK | Zentiva, k.s. | 50 | | | | | | |

| | | | | | 75 | I15-I15, I50-I50, I10- I13 | | | | | |

| 1402681 | valsartaan+hüdroklorot iasiid, 12,5mg+80mg | C09DA03 | SUVARTAR HCT 80 MG/12,5 MG, õhukese polümeerikattega tablett, 28TK | Sandoz d.d. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1086027 | valsartaan+hüdroklorot iasiid, 160mg+12,5mg | C09DA03 | CO-DIOVAN, õhukese polümeerikattega tablett, 28TK | Novartis Finland OY | 50 | | | | | | |

| 1324314 | valsartaan+hüdroklorot iasiid, 160mg+12,5mg | C09DA03 | VALSACOMBI, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1405921 | valsartaan+hüdroklorot iasiid, 160mg+12,5mg | C09DA03 | SUVARTAR HCT 160 MG/12,5 MG, õhukese polümeerikattega tablett, 28TK | Sandoz d.d. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1434518 | valsartaan+hüdroklorot iasiid, 160mg+12,5mg | C09DA03 | VALZAP H, õhukese polümeerikattega tablett, 28TK | Zentiva, k.s. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1086072 | valsartaan+hüdroklorot iasiid, 160mg+25mg | C09DA03 | CO-DIOVAN, õhukese polümeerikattega tablett, 28TK | Novartis Finland OY | 50 | | | | | | |

| 1324235 | valsartaan+hüdroklorot iasiid, 160mg+25mg | C09DA03 | VALSACOMBI, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1434530 | valsartaan+ hüdroklorotiasiid, 80mg+12,5mg | C09DA03 | VALZAP H, õhukese polümeerikattega tablett, 28TK | Zentiva, k.s. | 50 | | | | | | |

| 1457557 | valsartaan+hüdroklorot iasiid, 320mg+12,5mg | C09DA03 | VALSACOMBI, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1031342 | valsartaan+hüdroklorot iasiid, 80mg+12,5mg | C09DA03 | CO-DIOVAN, õhukese polümeerikattega tablett, 28TK | Novartis Finland OY | 50 | | | | | | |

| 1324156 | valsartaan+hüdroklorot iasiid, 80mg+12,5mg | C09DA03 | VALSACOMBI, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1434530 | valsartaan+hüdroklorot iasiid, 80mg+12,5mg | C09DA03 | VALZAP H, õhukese polümeerikattega tablett, 28TK | Zentiva, k.s. | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1402681 | valsartaan+hüdroklorot iasiid, 12,5mg+80mg | C09DA03 | SUVARTAR HCT 80 MG/12,5 MG, õhukese polümeerikattega tablett, 28TK | Sandoz d.d. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1086027 | valsartaan+hüdroklorot iasiid, 160mg+12,5mg | C09DA03 | CO-DIOVAN, õhukese polümeerikattega tablett, 28TK | Novartis Finland OY | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1324314 | valsartaan+hüdroklorot iasiid, 160mg+12,5mg | C09DA03 | VALSACOMBI, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1405921 | valsartaan+hüdroklorot iasiid, 160mg+12,5mg | C09DA03 | SUVARTAR HCT 160 MG/12,5 MG, õhukese polümeerikattega tablett, 28TK | Sandoz d.d. | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1086072 | valsartaan+hüdroklorot iasiid, 160mg+25mg | C09DA03 | CO-DIOVAN, õhukese polümeerikattega tablett, 28TK | Novartis Finland OY | 50 | | | | | | |

| 1324235 | valsartaan+hüdroklorot iasiid, 160mg+25mg | C09DA03 | VALSACOMBI, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1457557 | valsartaan+hüdroklorot iasiid, 320mg+12,5mg | C09DA03 | VALSACOMBI, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1324156 | valsartaan+hüdroklorot iasiid, 80mg+12,5mg | C09DA03 | VALSACOMBI, õhukese polümeerikattega tablett, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1031342 | valsartaan+hüdroklorot iasiid, 80mg+12,5mg | C09DA03 | CO-DIOVAN, õhukese polümeerikattega tablett, 28TK | Novartis Finland OY | 50 | | | | | | |

| 1008335 | varfariin, 3mg | B01AA03 | MAREVAN, tablett, 100TK | Orion Corporation | 50 | | | | | | |

| | | | | | 75 | I47-I49 | | | | | |

| 1008335 | varfariin, 3mg | B01AA03 | MAREVAN, tablett, 100TK | Orion Corporation | 75 | I47-I49 | | | | | |

| | | | | | 100 | I80-I82, Z95.2- Z95.2, I26-I26, T82- T82, I67.6-I67.6, I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| 1008368 | varfariin, 5mg | B01AA03 | MAREVAN FORTE, tablett, 100TK | Orion Corporation | 75 | I47-I49 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 100 | I80-I82, Z95.2- Z95.2, I26-I26, T82- T82, I67.6-I67.6, I27.0-I27.0 | | | | | |

| | | | | | 50 | | | | | | |

| 1068791 | venlafaksiin, 150mg | N06AX16 | EFEXOR XR, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

| 1261741 | venlafaksiin, 150mg | N06AX16 | VENLAFAXIN MEDOCHEMIE XR 150 MG, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | Medochemie Ltd | 50 | | | | | | |

| 1319419 | venlafaksiin, 150mg | N06AX16 | VENLAFAXINE ORION, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | Orion Corporation | 50 | | | | | | |

| 1068791 | venlafaksiin, 150mg | N06AX16 | EFEXOR XR, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1435205 | venlafaksiin, 150mg | N06AX16 | VENLAFAXINE PORTFARMA, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | Portfarma ehf | 50 | | | | | | |

| 1232468 | venlafaksiin, 150mg | N06AX16 | ALVENTA, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1306325 | venlafaksiin, 150mg | N06AX16 | VENLAGAMMA 150 MG, toimeainet prolongeeritult vabastav kõvakapsel, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| 1316405 | venlafaksiin, 150mg | N06AX16 | ARGOFAN 150 SR, toimeainet prolongeeritult vabastav tablett, 30TK | Zentiva a.s. | 50 | | | | | | |

| 1435205 | venlafaksiin, 150mg | N06AX16 | VENLAFAXINE PORTFARMA, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | Portfarma ehf | 50 | | | | | | |

| 1232266 | venlafaksiin, 37,5mg | N06AX16 | ALVENTA, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | KRKA d.d., Novo Mesto | 50 | | | | | | |

| 1068858 | venlafaksiin, 75mg | N06AX16 | EFEXOR XR, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1261684 | venlafaksiin, 75mg | N06AX16 | VENLAFAXIN MEDOCHEMIE XR 75 MG, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | Medochemie Ltd | 50 | | | | | | |

| 1319396 | venlafaksiin, 75mg | N06AX16 | VENLAFAXINE ORION, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | Orion Corporation | 50 | | | | | | |

| 1068858 | venlafaksiin, 75mg | N06AX16 | EFEXOR XR, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | Pfizer Europe MA EEIG | 50 | | | | | | |

| 1435182 | venlafaksiin, 75mg | N06AX16 | VENLAFAXINE PORTFARMA, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | Portfarma ehf | 50 | | | | | | |

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |

@@ -4058,15 +4060,14 @@

| 1281709 | venlafaksiin, 75mg | N06AX16 | VENLAFAXIN-RATIOPHARM 75MG, toimeainet prolongeeritult vabastav kõvakapsel, 30TK | ratiopharm GmbH | 50 | | | | | | |

| 1306246 | venlafaksiin, 75mg | N06AX16 | VENLAGAMMA 75 MG, toimeainet prolongeeritult vabastav kõvakapsel, 30TK | WÖRWAG PHARMA GmbH & Co. KG | 50 | | | | | | |

| 1316371 | venlafaksiin, 75mg | N06AX16 | ARGOFAN 75 SR, toimeainet prolongeeritult vabastav tablett, 30TK | Zentiva a.s. | 50 | | | | | | |

| 1435182 | venlafaksiin, 75mg | N06AX16 | VENLAFAXINE PORTFARMA, toimeainet prolongeeritult vabastav kõvakapsel, 28TK | Portfarma ehf | 50 | | | | | | |

| 1017267 | verapamiil, 120mg | C08DA01 | ISOPTIN RETARD 120 MG, toimeainet prolongeeritult vabastav tablett, 20TK | Abbott GmbH & Co. KG | 50 | | | | | | |

| 1017267 | verapamiil, 120mg | C08DA01 | ISOPTIN RETARD 120 MG, toimeainet prolongeeritult vabastav tablett, 20TK | Abbott GmbH & Co. KG | 75 | I47-I49 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1073157 | verapamiil, 120mg | C08DA01 | ISOPTIN RETARD 120 MG, toimeainet prolongeeritult vabastav tablett, 100TK | Abbott GmbH & Co. KG | 50 | | | | | | |

| | | | | | 75 | I47-I49 | Pediaater, Kardioloog | esmane | | | |

| 1073157 | verapamiil, 120mg | C08DA01 | ISOPTIN RETARD 120 MG, toimeainet prolongeeritult vabastav tablett, 100TK | Abbott GmbH & Co. KG | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| 1073180 | verapamiil, 240mg | C08DA01 | ISOPTIN RETARD, toimeainet prolongeeritult vabastav tablett, 100TK | Abbott GmbH & Co. KG | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 75 | I47-I49 | Kardioloog, Pediaater | esmane | | | |

| 1073180 | verapamiil, 240mg | C08DA01 | ISOPTIN RETARD, toimeainet prolongeeritult vabastav tablett, 100TK | Abbott GmbH & Co. KG | 75 | I47-I49 | Kardioloog, Pediaater | esmane | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

| | | | | | 50 | | | | | | |

| 1073405 | verapamiil, 80mg | C08DA01 | VERAPAMIL- RATIOPHARM 80 MG, õhukese polümeerikattega tablett, 50TK | ratiopharm GmbH | 75 | I47-I49 | Pediaater, Kardioloog | esmane | | | |

| | | | | | 75 | I10-I13, I15-I15 | | | | | |

@@ -4092,5 +4093,5 @@

| 1021161 | östramustiin, 140mg | L01XX11 | ESTRACYT, kõvakapsel, 100TK | Pfizer Enterprises SARL | 50 | | | | | | |

| 1022634 | östriool, 500mcg | G03CA04 | OVESTIN, vaginaalsuposiit, 15TK | N.V. ORGANON | 50 | | | | | | |

📎 [Original PDF: EHKloetelu_juuni.pdf](https://www.riigiteataja.ee/aktilisa/EHKloetelu_juuni.pdf)

📎 [Original PDF: Eesti Haigekassa ravimite loetelu_01092011.pdf](https://www.riigiteataja.ee/aktilisa/Eesti Haigekassa ravimite loetelu_01092011.pdf)

2011-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2011-05-15

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2011-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2010-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2010-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2010-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2010-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2009-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2009-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2009-08-08

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2009-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2009-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2008-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2008-10-25

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2008-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2008-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2008-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2007-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2007-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2007-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2007-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2006-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2006-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2006-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2006-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2005-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2005-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2005-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2005-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2004-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2004-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2004-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2004-03-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2003-12-31

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2003-09-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2003-06-30

Eesti Haigekassa ravimite loetelu

View changes Text at this date

2003-02-28

Eesti Haigekassa ravimite loetelu

original version Text at this date